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The structure of the small intestine is designed to maximize its main function, namely 
the digestion of food into low molecular mass components and their subsequent 
absorption. The epithelial lining of the small intestine forms invaginations, called crypts 
of Lieberkühn, and finger-like structures protruding into the intestinal lumen, called villi. 
Notably, the small intestine is characterized by one of the highest turnover rate in our 
body, with the lower third of the crypt representing the main site where epithelial cells 
are generated de novo from resident stem cells. To date, five differentiated epithelial 
lineages have been characterized in the small intestine: enterocytes, Paneth, goblet, 
enteroendocrine, and tuft cells. These five lineages all arise from slender cells located in 
the crypt bottom called crypt base columnar cells (CBCs). CBCs are marked by expression 
of the seven-pass transmembrane receptor Leucine-rich repeat-containing G-protein 
coupled receptor 5 (Lgr5) and are thought to represent the main stem cell type of the 
small and large intestine. With the only exception of Paneth cells located at the crypt 
base in close physical contact with Lgr5+ CBCs, the differentiated cell types migrate 
upwards towards the top of the villus where they undergo apoptosis and are shed into 
the gut lumen. 
Paneth cells (PCs) are responsible for a plethora of functions both in intestinal 
homeostasis and in response to dietary changes and tissue insults. Apart from controlling 
the bacterial flora through secretion of antimicrobial compounds, Paneth cells play a 
causal role in the pathogenesis of inflammatory bowel disease. More recently, it was 
shown that they also exert an essential niche function in regulating intestinal stemness. 
Even 145 years after their discovery, research on Paneth cells is still revealing novel and 
fascinating aspects of their multi-tasking and context-dependent identity.
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PANETh CELLS:  FROM SChWALBE AND PANETh TO 
ThE DISCOVERy OF ThEIR SECRETORy ROLE
early  studies  ant ic ipate Paneth cel ls ’  mult i - tasking funct ional  nature
Granulated cells in the fundus of the crypts of Lieberkühn were first described in 1872, 
along with the other cells of the intestinal epithelium, by Gustav A. Schwalbe, a German 
anatomist, histologist and anthropologist1. Nevertheless, they take their name from 
Joseph Paneth, an Austrian histologist and physiologist who first performed their detailed 
morphological analysis in 18882. For many decades after their discovery however, the 
role of Paneth cells (PCs) remained obscure due to mainly observational studies limited 
by the available methods and mostly focused on the morphological features of PCs and 
their granular payload.
In 1899 W. Möller reported on the presence of Paneth cells in several animal species 
including mouse, guinea pig, hox, sheep, and horse3. Given the broad spectrum of species 
found to host Paneth cells and to feature acidophilic granules and mucus in the small 
intestinal epithelial lining, the question arose whether they represented independent 
zymogenic cells or were involved in mucus production4. Bizzozero claimed to have found 
cells with a dual Paneth/goblet cell fate, therefore raising the possibility of Paneth cells 
representing goblet cells precursors4. Few years later, Klein brought evidence supporting 
the independent zymogenic function of Paneth cells, distinct from goblet cells, based 
on staining analysis with mucus-specific dyes5. Mols and Cowdry studied the effects 
of different diets in murine Paneth cells and observed that their intracellular content 
changed depending on the specific diet fed6,7, thus suggesting, already at these very 
early days, specific roles for this cell type in metabolism and nutrient sensing to be 
confirmed nearly a century later8,9. 
In 1937 hertzog analyzed Paneth cells in man and reported on their reduced 
abundancy in the duodenum. Also PCs multiplicity and distribution did not appear to 
be influenced by sex or age and, of note, they occasionally appeared in colon, stomach 
and appendix in association with pathological conditions10. The latter observation led 
to additional studies on the alleged function of Paneth cells in disease11-16. The most 
accurate description came from studies by K. Lewin who described and counted the 
appearance and number of Paneth cells in the small and large intestine. Of note, 
Paneth cell multiplicity was shown to be affected upon inflammation depending on the 
specific type of pathology and the degree of the inflammatory damage. Decreased PC 
numbers were found in acute inflammation of the small intestine and in Crohn’s disease. 
Interestingly, Paneth cells were also found to proliferate upon inflammation16-18. Contrary 
to what observed in the small intestine, an increased number of Paneth cell was found 
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in the colon in association with ulcerative colitis and other inflammatory diseases of 
the distal bowel. As of today, it is still unclear whether Paneth cell metaplasia (PCM), 
i.e. the appearance of Paneth cells in the large intestine, plays any functional role in the 
tissue response to inflammatory insults and in the increased colon cancer risk associated 
with inflammatory bowel disease (IBD). The role of Paneth cells in IBD will be discussed 
further in depth in a later section of this chapter. 
Paneth cells have also been observed within intestinal tumors: several studies 
have reported on the presence of lysozyme-positive neoplastic cells in adenomas and 
carcinomas of the colon, often with proliferative features. The number of Paneth cells in 
colonic tumors was higher in proximal lesions when compared with distal neoplasias19. 
Notably, Paneth cells have been observed in colonic tumors from patients with but 
also without a history of inflammatory bowel diseases. As for the biogenesis of PCM in 
the colonic mucosa, early studies proposed that these Paneth-like cells arise through 
metaplastic changes brought about by the altered inflammatory and/or neoplastic 
milieu19. The term Paneth cell metaplasia (from the Greek metaplasmos = change in 
form) was therefore employed to indicate the conversion of a cell type into another. 
Metaplastic Paneth cells have been found in a broad spectrum of pathological conditions 
ranging from inflammatory bowel diseases to cancer20,21.
The origin and fate of Paneth cells and their context-dependent proliferative state 
were investigated by Cheng and Leblond who found that PCs exists in a variety of 
maturation stages in vivo as a measure of the size of their granules (23% with granules 
smaller than 2µM and classified as ‘young’ PCs; 63% with granules between 2-3 µM; and 
14% ‘old’ PCs with granules larger than 3 µM)22. These studies also showed that Paneth 
cells were post-mitotic in homeostatic conditions and persisted for long terms at the 
bottom of the crypt, unlike most intestinal epithelial cells that actively migrate upwards 
along the crypt-villus axis to be then exfoliated by apoptosis within 5-6 days. 
Paneth cel ls :  the secretory bodyguards of  the crypt 
The large acidophilic granules apically secreted into the crypt lumen that earmark Paneth 
cells have been the object of several electron microscopy studies. The secretory function 
of the Paneth cell is prominent throughout its different subcellular compartments 
featuring an extensive Golgi apparatus and very pronounced endoplasmic reticulum. 
however, the function of the secretory granules remained elusive until lysozyme was 
identified as one of their main components23. As lysozyme is a strong antibacterial agent, 
a role was proposed for Paneth cells in host defense mechanisms in response to bacterial 
flora. 
Subsequently, two additional families of antimicrobial proteins, namely secretory 
phospholipases (e.g. Pla2g2a)24, endowed with additional lipid modifying function, and 
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α-defensins (also known as cryptdins for their location at the bottom of the crypt)25,26 
were found to be expressed by murine Paneth cells and specifically localized in their 
secretory granules. 
These studies sparked several additional efforts towards the elucidation of the 
mechanisms underlying Paneth cell secretion and the environmental stimuli that trigger 
it. To this aim, whole crypts were detached from the lamina propria and exposed to 
bacteria such as Salmonella typhimurium, Escherichia Coli, or Staphyloccocus Aureus. A 
potent induction of granule secretion and consequent antibacterial activity was observed 
upon stimulation of these ex-vivo isolated crypts with bacterial cells. More than 90% of 
the microorganisms to which the crypts were exposed were killed. Notably, most of the 
antimicrobial activity appeared to be elicited by cryptdins, as shown by the observed 
70% reduction in bactericidal function of the granules upon exposure to antibodies 
directed against cryptdin and cryptdin-like enzymes. Exocytosis of Paneth cell granules 
was also observed upon exposure to bacterial surface products such as lypolysaccharide 
(LPS) in a dose-dependent manner27. Furthermore, granule secretion can be triggered by 
a broad range of stimuli including acetylcholinergic28,29 and toll-like receptor agonists30,31. 
More recent studies suggest that secretion of the granules by Paneth cells is triggered 
by bacterial cells or antigens in an indirect way and requires interferon gamma, mainly 
secreted by leukocytes co-isolated with the crypts. To prove that stimulation of Paneth 
cell secretion is indirectly stimulated by bacterial antigens, crypts were cultured ex-vivo 
as self-renewing organoids or “mini-guts” (this technique is more accurately described 
further in this chapter) and the basal or luminal side of such structures exposed to LPS, 
flagellin, peptidoglycan (PGN), heat-inactivated E. Coli, and live bacterial cells32. No 
change in Paneth cell morphology or granule secretion was observed after 12 hours. 
Furthermore, no changes in intracellular or secreted lysozyme expression were observed. 
Paneth cell expression of bacterial receptors like Cd14 and Toll-like receptors 2,3,7,8, 
and 9 remained unchanged in the cultured organoids when compared to Paneth cells 
in vivo, the latter also indicating that these receptors are retained in ex-vivo cultured 
crypts. Consequently, several inflammatory molecules were tested for their capacity to 
induce discharge of Paneth cell granules. Among several molecules including interleukin 
22 (IL22) and 6 (IL6), tumor necrosis factor (TNF), and interferon gamma (IFN-γ), only the 
latter proved to be a potent inducer of granule secretion by Paneth cells32. 
Additional in vivo experimental evidence for the role of IFN-γ as the main 
inflammatory molecule responsible for granule extrusion was provided by injecting 
wild-type and IFN-γ knock-out mice with anti-CD3 antibody to trigger T cell activation 
and interferon gamma expression. When wild-type mice were administered the CD3 
antibody, Paneth cells degranulated as shown by decreased lysozyme content. Notably, 
no Paneth cell degranulation or any decrease in Paneth cell multiplicity was observed in 
15
INTRODuCTION
in CD3-treated IFN-γ knock-out mice32.
Paneth cell granule secretion was also shown to be mediated by calcium fluxes. By 
tracking Ca2+ dynamics in ex vivo crypts during granules secretion, a biphasic increase 
in cytosolic Ca2+ was revealed with the first phase mainly arising from intracellular 
storage, whereas the second depends on extracellular calcium uptake33. The second 
rise in cytosolic Ca2+ can be reduced by selectively blocking the calcium activated 
potassium channel IKCa1 (by means of clotrimazole (CLT) or charybdotoxin (ChTX)), and 
by measuring the levels of cryptdin secretion. The observed 50% reduction in secretion 
also corresponded to a similar reduction in antibacterial activity of crypts exposed to S. 
typhymurium27,33,34.
The antimicrobial peptides (AMPs) secreted by Paneth cells have been proposed 
to encompass two main functions: i. protect the host from enteric pathogens; and ii. 
keep in balance and shape the composition of the microbiome35. These two deeply 
intertwined functions are of great relevance since the composition and number of 
Paneth cells might unfavorably alter the composition of microbiota, a condition known 
as dysbiosis, thus rendering the host more susceptible to a variety of infectious and non-
infectious diseases36-41. 
The analysis and study of AMPs like defensins in the mouse is made more difficult 
by the complex genomic structure encompassing several gene paralogs within a single 
locus, and by the strain-dependent composition of AMPs among inbred mice42-44.
As previously stated, Paneth cells are found in a wide range of species3. Likewise, 
AMPs have also been conserved throughout evolution45. One notable difference is 
represented by the presence of multiple defensins expressed by PCs in a broad spectrum 
of mammalian species, whereas their human counterparts only encode for two, i.e. 
defensin 5 and 6 (hD5, hD6)46,47. The function, activity and structure of defensins have 
been discussed in depth in several literature reviews45,48-50.
the intest inal  crypt  stem cel l  n iche
The d iscovery  of  the intest inal  stem cel l
The crypts of Lieberkühn were for long time suspected to harbor the elusive intestinal 
stem cells responsible to preserve homeostasis in one of the most dynamic and 
regenerative epithelial tissues. Indeed, seminal studies by Cheng and Leblond identified 
cycling cells located at the very bottom of the intestinal crypt, the so-called crypt base 
columnar cells or CBC’s, and proposed them as the stem cells of the gut epithelium. 
Experimental evidence for the identity of CBCs as stem cells of the adult gut was 
provided by Nick Barker in the laboratory led by hans Clevers, based on the identification 
of the transmembrane receptor Lgr5 (Leucine-rich repeat-containing G-protein coupled 
receptor 5) as a specific marker of cycling CBCs. Lineage tracing experiments were 
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performed with a knock-in mouse model expressing both a green fluorescent protein 
(GFP) and a tamoxifen inducible C-recombinase under the control of the endogenous 
Lgr5 gene promoter (Lgr5-eGFP-IRES-CreERt2)51. These mice, when bred with Rosa26-
LacZ reporter animals and induced by tamoxifen, allow the excision of the roadblock 
(i.e. the stop sequences flanked by LoxP sites located upstream of the LacZ gene) and 
transcription of the reporter gene by Cre protein expression only in Lgr5+ cells. In this 
way, LacZ expression, easily detectable by X-gal staining, will mark Lgr5+ cells and their 
cellular progeny. upon tamoxifen treatment, Lgr5-eGFP-IRES-CreERt2 mice gave rise to 
long ribbons of blue labelled cells starting from the bottom of the crypt to the villus tip. 
These blue ribbons persisted in the intestine of the mice for more than 300 days and 
encompassed all the intestinal cell lineages, thus showing that Lgr5+ have long term self-
renewal and multipotent differentiation capacity both in the small and large intestine. 
Although stem cells have long been thought to divide infrequently, the intestinal 
epithelium almost entirely renews its cellular composition every 5 days suggestive of an 
actively proliferating stem or precursor cell. By using the above Lgr5 knock-in mice, CBCs 
have been shown to divide approx. every 16 hours52. Another common view on stem 
cells is relative to their mitotic division modality, i.e. in symmetric vs. asymmetric fashion 
giving rise to two daughter cells with equal (two stem or two committed cells) or distinct 
(one stem cell and one committed progenitor) cell fates, respectively. By employing 
Lgr5-eGFP-IRES-CreERt2 mice bred with the Rosa26-confetti reporter, it was shown that 
Lgr5+ stem cells divide symmetrically and that the follow a neutral drift dynamic52. 
Several studies suggested that stem cells in epithelial tissues come in two flavors: 
rapidly and slowly cycling53. Lgr5+ cells divide every 16 hours and as such represent 
frequently cycling stem cells thought to underlie intestinal homeostasis under 
physiological conditions. A more quiescent or slowly cycling stem cell type located at 
position +4 from the crypt base was first identified by Chris Potten in 1974 based on its 
label-retaining properties54. Only several years later the first gene marker was identified 
to earmark the +4 label-retaining cells, namely the Bmi1 (B cell-specific Moloney 
murine leukemia virus integration site 1) gene. By following a lineage tracing approach 
analogous to that employed for the Lgr5+ CBCs, Bmi1+ cells at the +4 position were 
shown to give rise to all the differentiated lineages of the small intestine55. Additional 
genes have also been proposed to specifically mark a subset of slowly dividing stem 
cells such as mTert, Hopx, and Lrig156-58. Although lineage tracing provides valuable 
information on specific cell types and their progeny, it mainly relies on the specificity 
of the gene promoter under which the Cre recombinase is driven. In situ hybridization 
(ISh) analysis on single RNA molecules indicated that none of the aforementioned (+4) 
markers is uniquely expressed at a single position along the crypt-villus axis59. however, 
this is likely to be true for the vast majority of the genes/markers expressed by stem and 
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progenitor cells in the lower intestinal crypt. Most recently, the laboratory led by Eduard 
Battle identified a specific RNA binding protein called Mex3a that, in combination with 
Lgr5, marks a specific population of quiescent stem cells resident in the lower crypt also 
located at around position +3/+460. Single cell RNAseq analysis of individual Lgr5+ stem 
cells revealed the presence two populations differing by their cycling rates with Mex3A 
expression earmarking the slowly cycling Lgr5+ subpopulation. Lineage tracing analysis 
using Mex3A knock-in mice bred with the Rosa26 reporter line conformed that Mex3a+/
Lgr5+ cells represent bona fide infrequently dividing stem cells in vivo60.
The presence of quiescent stem cells is of functional relevance as they have been 
proposed to underlie the regenerative response by compensating for the loss of rapid 
cycling Lgr5+ CBCs upon tissue insults61. In the small intestine, tissue regeneration 
upon injury conditions has been shown to rely on the de-differentiation of terminally 
committed cells. Terminally differentiated cells have long been thought to be unable 
to rewire their cell fate and re-enter the cell cycle and acquire pluripotency. Recently 
however, distinct differentiated lineages of the small intestine, i.e. Paneth cells and 
Alpi+ enterocytes, have been shown to act as stem/progenitor-like cells upon tissue 
injury62,63. The issue of plasticity as an intrinsic property of specific intestinal cell lineages 
raises several questions on the underlying pathways and molecular cues which are of 
relevance for our understanding of analogous mechanisms in pathological conditions 
such as tumor plasticity and resistance to therapy.
Paneth cel ls  and crypt  development
Both the small and large intestinal epithelium develop by tubulogenesis from the 
posterior endoderm following extensive folding64,65. The embryonic gut tube is lined by 
a simple epithelium that condenses to form a pseudostratified epithelium where all the 
cells are attached to the basement membrane. Around e14, the gut epithelium assumes 
a columnar form while it forms protruding structures called villi. Lineage specification is 
initiated at around e17 in proliferating cells confined in the intervillus region from where 
they subsequently invaginate to form intestinal crypts. Notably, whereas in the mouse 
crypt development occurs at early postnatal stages and is completed by the time of 
weaning, in man it occurs in utero66. 
Notwithstanding the absence of fully mature and granulated Paneth cells in the 
mouse intestinal epithelium during the first two postnatal weeks, expression of defensins 
1 and 6 was found in scattered fashion throughout the newborn intestinal lining thus 
raising the possibility of an innate immune role for these peptides at early perinatal 
stages66. 
De novo crypt formation occurs through a process called ‘crypt fission’, a rate-limiting 
event in intestinal expansion and growth that consists in its essence of the division of 
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a crypt into two daughter crypts67,68. Crypt fission represents a form of epithelial tube 
branching through which the newly formed crypts of Lieberkühn divide and multiply 
thus extending and widening the intestinal tract during postnatal development. The 
lumen of the resulting two daughter crypts can be of equal or unequal length as the 
result of symmetric and asymmetric crypt fission, respectively. however, the cellular and 
molecular mechanisms underlying crypt fission are still poorly understood. 
Recently, Inke Nathke and collaborators observed that the number and relative 
position of Paneth cells and Lgr5+ CBCs at the bottom of the crypt are critical for the 
initiation of crypt fission69. Analysis of crypts undergoing fission revealed that the 
process can be divided into an early and a late phase69. During early fission, a change 
in cell patterning occurs with Paneth cells absent from the middle of the crypt bottom 
due to their migration to either side of the site of bifurcation/branching. Simultaneously 
to this side clustering of Paneth cells, Lgr5+ CBCs form a distinct cluster in the middle of 
the crypt base thus marking the bifurcation site where, during the late fission phase, the 
epithelial lining is expanded upwards until the duplication of the two daughter crypts is 
completed. 
The specific cell patterning observed during crypt fission reflects the intrinsic cell 
properties of Lgr5+ CBCs and Paneth cells, the latter showing high stiffness and increased 
adhesion to the basement membrane. high β4 integrin expression allows Paneth cells to 
firmly anchor to the basement membrane when compared with other cell types. 
In confirmation of previous studies showing that inhibition of ephrin (Eph) signaling 
causes misplacement of Paneth cells from the crypt base70, inhibitory Eph protein 
fragments have been found to induce their mislocalization in ex vivo organoids though 
without altering the rate of crypt fission. however, altering PC localization skewed the 
balance between symmetric and asymmetric fission in favor of the latter, likely due to 
the formation of new branches further away from the crypts. Cell adhesion and integrin 
levels appear to play a central role in this process as shown by the observed 50% reduction 
in crypt fission in the presence of a β4 integrin antibody. It is therefore plausible to 
postulate that the enhanced adhesion, a feature of Paneth cells when compared to their 
neighboring cells, plays a key functional role in the early phase of crypt fission69.
Paneth-speci f ic  s ignal ing pathways:  Wnt and Notch
Experimental evidence links de novo crypt formation to canonical Wnt signaling in 
view of the involvement of two of its downstream target genes (EphB and cMyc) in the 
migration and compartmentalization of Paneth and Lgr5+ cells within the lower crypt. 
Cell migration within the crypt occurs in bidirectional fashion: whereas enteroendocrine 
cells, goblet cells, and enterocytes migrate upwards along the crypt-villus axis, Paneth 
cells descend in opposite direction toward the bottom of the crypts. In the mouse 
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prenatal intestine, the EphB2 and EphB3 receptors and their ligand Ephrin-B1 are 
expressed in complementary domains: both receptors and ligand are co-expressed 
in cells located at the periphery of the intervillus pockets, whereas expression of the 
EphB2 and 3 earmarks the cells present at the very bottom of the pockets70. In the adult 
small intestine, the expression pattern of the two ephrin receptors appears to be more 
complex with EphB3 being restricted to Paneth cells in the crypt bottom whereas EphB2 
expression earmarks the entire crypt bottom until position +4. 
EphB3 receptor knock-out mice are characterized by misplaced Paneth cells 
throughout the crypt-villus axis, a phenotype not observed in EphB2-/- mice. Therefore, 
expression of the EphB3 receptor in Paneth cells appears necessary for their correct 
positioning at the bottom crypt70. Furthermore, the nuclear b-catenin accumulation 
characteristic of Paneth cells at the bottom of the crypt was lost in their misplaced 
equivalents in EphB3-/- mice thus indicating a non-cell autonomous and localization-
dependent regulation of Wnt signaling in PCs70. As previously mentioned, Wnt signaling 
plays a pivotal role in the intestinal epithelium with both Lgr5+ CBCs and Paneth cells 
are characterized by the accumulation of b-catenin in the nucleus where it binds with 
members of the family of Tcf transcription factors thus driving the expression of Wnt 
target genes71. 
Cytosolic levels of b-catenin are tightly controlled by a multi-protein complex 
encompassing the tumor suppressors Apc (Adenomatous polyposis coli) and Axin, 
the Ser/Thr kinases GSK3β (glycogen synthase kinase 3-beta) and CK1 (casein kinase 
1), protein phosphatase 2A (PP2A), and the E3-ubiquitin ligase β-TrCP. In the absence 
of Wnt ligands, this “destruction complex” phosphorylates b-catenin promoting its 
ubiquitinilation and degradation by the proteasome72. Of note, canonical Wnt/b-catenin 
signaling has been shown to induce maturation of Paneth cells in the mouse small 
intestine: expression of the Paneth-specific gene program is lost in the intestine of Tcf4-/-
embryos73. In particular, failure to express defensins and cryptdins caused Paneth cells 
maturation defects. Also, the frizzled (Fzd) family of receptors encompasses integral 
membrane proteins featuring seven transmembrane-spanning domains function 
in canonical Wnt signaling. Remarkably, Fzd5 knock-out mice exhibit an identical 
phenotype to that of EphB3-/- animals with misplaced Paneth cells with no b-catenin 
nuclear accumulation, in confirmation of the positional cues provided by Wnt signals 
along the crypt-villus axis70,73. The Wnt-driven maturation of Paneth cells and their 
pronounced nuclear b-catenin accumulation is intriguing in view of the essential role 
played by canonical Wnt signaling in the regulation of stemness in the intestinal crypt. 
hence, the same pathway controls the onset and maintenance of both multipotent and 
fully differentiated (and post-mitotic) lineages. 
Studies aiming at the identification of the Wnt signals required for Paneth cell 
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maturation and maintenance have been performed by first establishing the expression 
patterns of Wnt ligands in the intestinal epithelium (i.e. Wnt3; uniquely expressed in PCs) 
and in the surrounding mesenchyme (Wnt2b, Wnt 4 and Wnt 5a). Notably, conditional 
ablation of Wnt3 throughout the intestinal epithelium (Wnt3fl/fl/VilCreERT2) does not affect 
Paneth cells, indicative of functional redundancy between mesenchymal and epithelial 
Wnt ligands in vivo74. The latter was confirmed i. by the impaired growth of ex vivo 
cultured crypt organoids derived from the Wnt3fl/fl/VilCreERT2 mice upon removal of the 
floxed Wnt3 allele, and ii. by the ability of exogenously added Wnt3 to rescue the growth 
impairment74. 
The orphan G protein-coupled receptor Lgr4 is expressed in small intestinal crypts 
above the PC zone (i.e. in the TA region), and in CBCs and in a subset of Paneth cells75. 
Lgr4-/- mice show reduced epithelial proliferation without any significant defect in 
the differentiation of absorptive, enteroendocrine and goblet cell lineages. however, 
absence of specific PC markers such as lysozyme and cryptdin 4 was also noticed in Lgr4-
/- mice, likely indicative of a Paneth cell maturation defect. Accordingly, ex vivo cultured 
crypts from the Lgr4 knock-out mice failed to form fully mature organoids and showed 
decreased expression levels of several stem cell-specific markers and Wnt targets such 
as Axin2, Sox9, and Lgr5. Accordingly, re-activation of Wnt signaling by addition of 
lithium chloride (LiCl) to the organoid culture medium partially rescued their growth 
impairment75. 
Among the Wnt targets observed to play a key role in Paneth cell onset, Sox9 is 
expressed before the appearance of PCs in the embryonal gut and its expression 
overlaps with that of cryptdins in the intervillus pockets. Inducible genetic ablation of 
Sox9 results in the disappearance of Paneth cells and a decrease of goblet cells76,77. As a 
consequence of the altered tissue morphology and absence of Paneth cells, the crypts 
of Sox9fl/fl mice present an enlarged proliferative compartment extended to the whole 
crypt bottom76,77. Constitutive Sox9 expression as a consequence of loss of Apc function 
has also been shown to induce formation of ectopic Paneth cells in the mouse colon78. By 
employing a colon-specific promotor (Cdx2) to delete the Apc tumor suppressor gene, 
it was shown that adenoma formation is accompanied by the appearance of ectopic 
lysozyme-expressing Paneth-like cells. These metaplastic PCs were observed in regions 
outside of the crypt base, often at new crypt budding sites, coincident with high Sox9 
expression as the result of the induced Apc deletion. The latter is not surprising in view 
the role of Sox9 as Wnt target but it is noteworthy that Sox9 upregulation in the colon 
of these mice preceded the changes in b-catenin subcellular localization possibly due 
its easier detection, when compared to β-catenin stabilization, at early time points 
after Apc inactivation in the colon epithelium78. 
Alongside canonical Wnt, also Notch signaling plays an important role in Paneth 
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cell differentiation and maturation, mainly through one of its downstream targets 
genes, namely Math1 encoding for a basic helix loop helix (bhLh) transcription factor. 
Studies performed on Math1 knock-out mice revealed the ablation of all secretory 
lineages including Paneth and goblet cells, and enteroendocrine cells79. Thus, Math1 
is required for progenitor cells to commit towards a secretory fate. Notably, studies 
performed on mosaic Math1 null crypts showed that commitment towards a secretory 
fate improves regeneration upon small bowel resection (SBR). Math1-deficient crypts 
showed decreased regenerative capacity after SBR when compared to proficient crypts, 
suggesting that secretory lineages may play a (niche) role in the response to tissue 
injury80. 
Constitutive expression of an active form of the Notch 1 receptor in the intestinal 
epithelium causes signs of malnourishment at postnatal day 1 (P1) and death at P3 as 
a consequence of the inhibition of all secretory lineages, a phenotype opposite to that 
observed in Hes1 knock-out mice characterized by an excess of secretory cells at the 
expenses of enterocytes81. hence, constitutive Notch 1 expression upregulates Hes1 
expression while downregulating Math1, a key gene in secretory lineage development. 
Notch signaling inhibition has also been studied: mice treated with dibenzazepine 
(DBZ) showed an increment in Paneth cells numbers, with abnormal lysozyme staining, 
i.e. cytoplasmic and diffused rather than in the characteristic granular pattern, indicative 
of alterations in Paneth cells formation upon Notch signaling inhibition82. upon further 
analysis, both the number and size of Paneth cell granules were shown to be decreased 
in addition to the expression of goblet-specific markers, suggesting the establishment 
of an intermediate phenotype in between the Paneth and goblet lineages upon Notch 
signaling inhibition. These findings highlight the importance of Notch signaling in 
terminal differentiation of Paneth cells82. Screens performed on Math1-proficient and 
-deficient mice led to the identification of the target genes of this transcription factor 
critical for the establishment of the secretory cell fate83. The Gfi1 gene was found to be 
significantly downregulated upon Math1 ablation. Likewise, Gfi1 knock-out mice were 
deprived of mature Paneth cells together with a significant reduction of goblet cells 
and an increase in enteroendocrine cells. In these mice, secretory progenitors although 
already committed, are unable to differentiate into mature Paneth cells83. 
Another Paneth-specific gene known to affect Notch signaling in the crypt bottom 
encodes for the receptor of colony stimulation factor 1 (Csf1r), whose Csf1 ligand 
is expressed by cells in close proximity to PCs. Csf1 receptor-deficient mice (Csf1r-/-) 
are characterized by a marked reduction in fully mature Paneth cells84,85. Goblet cell 
multiplicity was also highly increased as a consequence of the Csf1r genetic ablation 
indicative of faulty cell fate determination in the common goblet and Paneth cell 
precursor. These results were also confirmed in ex-vivo cultured crypts, where Csf1r-/- 
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organoids showed decreased clonogenicity and size, and reduced number of budding 
events. These experiments also suggested a role in Paneth cell maintenance for the Csf1 
receptor: conditional Csf1r deletion by villin-Cre in organoids resulted in Paneth cells 
loss86. 
In view of the main secretory function of Paneth cells, it is not surprising that proteins 
involved in vesicle trafficking and secretion play significant roles in PC maturation. 
In particular, two classes of vesicle proteins have been investigated in gut epithelial 
homeostasis, namely Rab8A and αSNAP (soluble N-ethylmaleimide-sensitive factor-
attachment protein alpha). The Rab family of small GTPases regulates both the sorting of 
transported molecules to the correct vesicles and vesicle delivery to target membranes. 
Of note, Rab8A has been linked to trafficking and secretion of Wnt ligands as it mediates 
anterograde transport of Gpr177 (wntless), a Wnt-specific transmembrane transporter. 
Rab8a-/- mice lack fully mature Paneth cells and are instead characterized by 
immature cells with decreased numbers of granules87. Expression analysis of the 
intestinal epithelium of Rab8a-/- mice showed downregulation of several Wnt targets 
such as Axin2 and Ascl2 together with decreased nuclear b-catenin levels and reduced 
lysozyme and cryptdin 5 expression. When cultured ex vivo, crypts from Rab8a-/- mice 
showed less budding events and decreased clonogenicity. Accordingly, the negative 
effect brought about by Rab8A ablation can be rescued by adding Wnt3 in the organoid 
medium. The observed effect on cell maturation seems to be specific for Paneth cells 
and Wnt secretion, as goblet cell numbers, mucin trafficking, packaging and secretion 
were unaltered87.
Trafficking and delivery to target membranes is followed by vesicle fusion that 
requires the SNARE complex, the post-fusion disassembling of which is regulated by the 
aforementioned factor αSNAP. A pronounced reduction in Paneth cell differentiation 
was reported in ex vivo cultured crypts derived from mice carrying a single amino acid 
substitution in the αSNAP gene leading to its decreased expression in the intestine88. 
These results point to a selective inhibition of terminal differentiation of Paneth cells 
due to the αSNAP gene defect and to a novel functional role for vesicle trafficking and 
fusion in the regulation of secretory cell fate.
Paneth cel ls  const itute the main epithel ia l  intest inal  stem cel l  n iche
The physical association of Paneth cells and Lgr5+ CBCs at the bottom of the crypt is 
suggestive of an additional function for this multi-tasking secretory lineage, namely as 
niche cells capable of regulating the activity of stem cells in homeostasis and during 
regeneration upon tissue insults. Toshi Sato and collaborators in the Clevers’ laboratory 
noticed that Lgr5+ stem cells were extremely inefficient when employed to establish 
ex vivo organoids unless co-cultured with Paneth cells, which increased organoid 
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multiplicity by at least 20-fold89. Based on this seminal study, Paneth cells were proposed 
to represent the main epithelial niche for Lgr5+ stem cells. 
As discussed above, Wnt and Notch signaling play rate-limiting roles in regulating 
both stemness and in establishing secretory lineage fate; likewise, a tightly controlled 
balance between the two pathways is crucial to regulate intestinal homeostasis90. 
Specific Wnt and Notch factors encoded by Paneth cells, namely Wnt3, Dll1, and Dll4 
(delta-like ligands 1 and 4), underlie their niche function89. The organoid assay (further 
discussed below) and the possibility of culturing these two cell types ex vivo has been 
instrumental for the identification of these and other key regulatory niche cues91. 
Due to their close physical association with Lgr5+ cells, Paneth cells exert their 
niche function both through secreted short-range factors and by membrane-bound 
signaling ligands. Moreover, apart from their signalling modalities, Paneth cells provide 
additional support to Lgr5+ stem cells in a contact-dependent manner92. Although these 
requirements are well-established for rapidly cycling Lgr5+ CBCs, little is known about 
the niche requirements of other stem cell types, e.g. the more quiescent stem cells 
located at position +4. 
Additional stem cell niche factors are thought to be secreted by the surrounding 
stroma. In particular myofibroblasts have been shown to secrete Wnt ligands93. Studies 
on Porcupine (Porcn), a gene encoding for an O-acetyltransferase essential for Wnt 
ligands secretion, showed that its genetic ablation in epithelial cells does not impair 
intestinal homeostasis and regeneration upon tissue insults. however, concomitant 
genetic Porcn ablation and administration of a specific porcupine inhibitor (C90) 
leading to impaired Wnt secretion in both the epithelial and stromal compartment, 
significantly reduced Lgr5+ CBCs multiplicity in homeostasis and stalled proliferation and 
recovery after tissue injury94. These studies highlight the relative stromal vs. epithelial 
contribution in the secretion of Wnt and other ligands known to regulate intestinal 
stemness and must be taken into consideration when addressing the in vivo niche role of 
Paneth cells. Accordingly, in vivo depletion of Paneth cells, as observed in Sox9 knock-out 
mice, does not results in any major differentiation defect among the different intestinal 
epithelial cell lineages76. Likewise, deletion of the Atoh1/Math1 gene encoding for a 
transcription factor necessary for the commitment of secretory lineages, results in a 
loss of Paneth cells without affecting epithelial morphology and homeostasis95. Similar 
results were obtained by knocking out other genes (e.g. Gfi183, Spdef96). however, it is 
unclear whether the apparent absence of Paneth cells in these mouse models is limited 
to fully mature PCs or is extended to its immature progenitors which could still exert 
some of the relevant niche functions. Also, as reported below, Paneth cells are likely 
to play key roles (both as niche and stem-like cells) in the regeneration of the intestinal 
epithelium upon inflammation and other forms of tissue injury. As such, mouse models 
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depleted of Paneth cells should be challenged by inflammatory insults to fully evaluate 
the consequences of their partial or complete loss.
Paneth cells have mainly been studied in inbred C57BL/6J (B6) mice. This is of 
relevance as expression of PC-specific genes and pathways may differ among distinct 
inbred strains and as such differentially affect their secretory, niche, and other functions 
as illustrated by the case of the secretory phospholipase A2 (Pla2g2a). The Pla2g2a gene, 
specifically expressed in Paneth cells, represents a major genetic modifier of intestinal 
tumor multiplicity in the ApcMin mouse model97,98. While the C57BL/6J strain carries a 
null secretory phospholipase A2 allele (Pla2g2a-/-) due to a stop codon mutation, other 
inbred strains (e.g. FVB, AKR, BALB/C) are Pla2g2a-proficient (Pla2g2a+/+). When bred 
into the ApcMin/+ background, B6 animals show a strikingly high multiplicity of upper 
GI adenomas (approx. 90). In contrast, ApcMin/+/Pla2g2a+/+ mice are characterized by a 
pronounced reduction in intestinal tumor numbers. In a recent study, our laboratory 
has shown that the intracellular pool of phospholipase A2 downregulates Wnt signaling 
during homeostasis by modifying the subcellular localization of the yes associated 
protein 1 (yap1) protein99. upon inflammation, Pla2g2a is secreted into the lumen from 
where it activates a cascade of downstream signaling events culminating in the synthesis 
of prostaglandins and Wnt activation, thus supporting the regenerative response to the 
inflammatory insults99. 
Overall, it appears that Paneth cells exert their niche function throughout a complex 
and diverse network of secretory auto- and paracrine pathways and by their physical 
association with stem cells.
Paneth cel ls  and nutr ient  sensing:  a  matter  of  metabol ism?
As mentioned earlier in this chapter, already the first studies on Paneth cells observed 
a change in their content upon feeding mice with different diets6,7 thus suggesting a 
functional connection with metabolism. 
Although a set of defined factors including Notch and Wnt stimuli have been 
proposed to constitute the stem cell niche89, very little is known about the metabolic 
requirements of Lgr5+ CBCs and their niche. More recently, analysis of Paneth and Lgr5+ 
cells revealed a striking metabolic dichotomy: while Paneth cells are earmarked by high 
glycolytic activity, Lgr5+ CBCs rely on mitochondrial oxidative phosphorylation for their 
metabolic needs8. Notably, Paneth cells, characterized by a high glycolytic activity, secrete 
lactate which is taken up by the Lgr5+ stem cells to fuel oxidative phosphorylation. As 
such, Paneth cells provide a metabolic niche to Lgr5+ stem cells. 
Other studies involving dietary modulation suggested that Paneth cells play a major 
role in sensing the organism’s nutritional status. In particular, yilmaz et al. showed that, 
upon longevity-promoting calorie restriction (CR), PCs elicit Lgr5+ stem cell function by 
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downregulating mTORC1 (mechanistic target of rapamycin complex 1) signalling9. Of 
note, CR seems to primarily affect Paneth cells but not CBCs. 
mTORC1 inhibition in Paneth cells leads to the activation of the ectoenzyme bone 
stromal antigen 1 (Bst1) which in turn triggers the secretion of cyclic ADP ribose (cADPR). 
During caloric restriction, this paracrine factor is secreted by PCs and favors stem cell self-
renewal eventually resulting in an increase of Lgr5+ CBCs’ multiplicity. This effect could 
be mimicked in vivo by administration of rapamycin, the main mTORC1 pharmacological 
inhibitor. however, in a subsequent study, Igarashi and Guarente reported a more 
detailed analysis of the effects of CR with mTORC1 signalling being inhibited in PCs but 
upregulated in intestinal stem cells100. In this scenario, mTORC1 activation is mediated 
by SIRT1 in Lgr5+ cells leading to an increase in protein synthesis and an increase in CBC 
multiplicity. Notably, in this study the in vivo administration of rapamycin was shown 
to abolish CBC expansion rather than mimicking calorie restriction effects100. Although 
a model was proposed where PC signalling could override any direct nutrient sensing 
in Lgr5+ CBCs, further studies will be required to elucidate how drugs that modulate CR 
pathways may exert opposing effects on different cell types.
Cultur ing intest inal  crypts  ex  v ivo as  organoids
Seminal work by the laboratories led by h. Clevers and C. Kuo’s led to the establishment 
of novel 3D culture methods for the ex vivo culture of mouse intestinal crypts as 
organoids or “mini-guts”, i.e. long-lived and self-renewing structures recapitulating the 
crypt-villus organization of the intestine and encompassing both Lgr5+ and Paneth cells 
as the main units of the stem cell niche, in addition to other differentiated lineages91,101. 
Both methods successfully established long-term epithelial cultures from the small and 
large intestine by employing matrigel and collagen, respectively. Both studies identified 
R-spondin, the main ligand of the Lgr5 receptor and a potent canonical Wnt signaling 
amplifier, as the key growth factor for the successful organoid culture. Other important 
factors include the epithelial growth factor (EGF) and the Tgf- inhibitor Noggin. Organoid 
cultures are also partly dependent on the Wnt3A ligand, normally present in the 
basolateral membrane of Paneth cells102. Recently the combination of Wnt3A, R-spondin, 
and Noggin (WRN) has been found to be sufficient to grow ex vivo intestinal organoids 
from most companion and large animals103.
The availability of an ex vivo culture system that, although in the absence of a 
mesenchymal/stromal niche support, recapitulates the complex in vivo structure of the 
intestine, stimulated and improved additional studies through the genetic and biochemical 
modifications of the whole crypt or its specific cell lineage components8,99,104-106.
As organoids can also be established from patient-derived tumors, biobanks of human 
3D cultures are currently being established from tumor material and matched healthy 
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tissues for several purposes including the preclinical assessment of (chemo) therapeutic 
approaches, and studies of stem cell tracing and plasticity within neoplastic lesions, 
tumor heterogeneity and metabolism. The establishment and in vitro maintenance of 
organoids from patient-derived colon cancers requires different and specific factors 
depending on the tumor subtype, also in reflection of the heterogeneity of the spectrum 
of malignancies affecting the large bowel107.
As mentioned before, the main limitation of the currently available organoid culture 
methods is the lack of an intact stromal microenvironment. Also, since in its original 
formulation the protocol employs whole intestinal crypts as the biological substrate to 
establish organoids, this precludes functional studies of specific cell lineages within the 
stem cell niche, and in particular its two main components, namely the Lgr5+ CBCs and 
Paneth cells. 
In order to include and preserve the stromal and extracellular matrix (ECM) 
microenvironment where intestinal crypts normally reside, colonic stroma has been 
de- and re-cellularized with myofibroblasts, endothelial cells, and epithelial cells (whole 
organoids or sorted cells)108. This approach promises to provide additional insights into 
the normal gut physiology, not currently feasible with the canonical organoid culture 
protocol. 
As for the second limitation, Lgr5+ stem cells and PCs tend to physically interact 
when co-incubated to then give rise to organoids89. This key feature is the basis for the 
“organoid reconstitution assay” (ORA) further developed and implemented by us and 
others99,100. Sorting by FACS of CBCs and PCs allows their genetic and/or biochemical 
modification (or their isolation from genetically modified or treated mice) prior to their 
co-incubation and reconstitution into organoids, thus providing a handy functional study 
tool. A recent example of the usefulness of ORA, is represented by the demonstration of 
the striking metabolic dichotomy between Paneth cells (glycolytic) and Lgr5+ stem cells 
(oxidative phosphorylation) and the functional relevance of these metabolic needs for 
the maintenance of homeostasis8.
Paneth cel ls ,  dysbiosis ,  and inf lammatory bowel  disease
The intestinal microbiome hosts a diverse and abundant group of microorganisms known 
to be essential for gut homeostasis and development, as shown by studies on germ-
free mice. Several environmental factors affect the composition of the microbiome such 
as diet109,110, oxygen levels, and ph111. In the laboratory mouse, inbred strain-specific 
variations in the composition of the microbiome have been shown44, analogous to the 
observed variations in PCs’ multiplicity, distribution, and secretory function36. Dysbiosis 
i.e. the unfavorably altered composition of the microbiota is central to a broad spectrum 
of human pathologies, among other inflammatory bowel disease (IBD).
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The term IBD is comprehensive of two main chronic and relapsing pathologies of the 
intestinal tract, namely ulcerative colitis (uC) and Crohn’s disease (CD)112. Like many 
other pathological conditions such as diabetes, atherosclerosis, obesity, and cancer, IBD 
is nowadays thought to result from inappropriate inflammatory responses to dysbiosis 
in genetically susceptible individuals36. One of the main differences between uD and 
CD is the affected region of the gastrointestinal tract. ulcerative colitis is characterized 
by chronic inflammation of the colon, initiating in the rectal region and subsequently 
spreading proximally, with tissue damage usually limited to the mucosa or submucosa 
featuring local crypt inflammation (cryptitis) and abscesses with neutrophilic exudate 
in the lumen. Crohn’s disease instead affects both the large bowel and the distal part 
of the small intestinal tract, namely the ileum where Paneth cells are more abundant. 
At the microscopic level, CD’s distinctive features include thickening of the submucosa, 
transmural inflammation, fissuring ulceration and granulomas112. 
As a consequence of the primary role played by Paneth cells in the secretion of 
antimicrobial peptides and in the control of the gut microbiota during homeostasis, 
their dysfunction (either due to genetic defects or to environmental ‘stressors’ such 
as infections, obesity, and graft versus host disease) has been shown to be causative 
in a broad spectrum of dysbiosis-associated pathologies, including IBD36. The complex 
multifactorial nature of IBD can be in fact reduced to the interaction of a quartet of 
host-derived and environmental factors: the genetic predisposition and susceptibility 
of the host, the intestinal microbiota, the immune system, and the above-mentioned 
environmental stressors48. 
Genetic susceptibility predisposes the individual to IBD and, likewise, family history 
does represent a risk factor as shown by genome wide association studies (GWAS). A 
multitude (>150) of IBD associated single nucleotide polymorphisms (SNPs) have been 
established as risk loci, 28 of which common to both Crohn’s disease and ulcerative 
colitis. Of note, the very first genes to be identified are not only highly and specifically 
expressed in Paneth cells but also exert essential roles in PC’s secretory function113,114 
including host-bacterial interaction and response (e.g. NOD2)115,116, ER stress and 
unfolded protein response (XBP1)117, and autophagy (ATGL16L1)118,119.
Nod2 in  IBD and Paneth cel ls
Although its physiological function in the intestine remains elusive, the Nod2 gene, 
encoding for a a member of the nucleotide-binding oligomerization domain–leucine-
rich repeat (NOD-LRR) family of proteins, is specifically expressed in Paneth cells and 
is most pronounced in the ileum of both healthy controls and IBD patients120. A role 
in bacterial sensing through innate and adaptive immunity was initially hypothesized 
and later confirmed by the laboratory of Richard Flavell121. Strikingly, Paneth cells from 
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Nod2-deficient mice were not able to sense specific microbial antigens such as muramyl 
dipepetide (MDP), a conserved bacterial peptidoglycan. Nevertheless, Nod2-/- mice did 
not display any overt symptoms of intestinal inflammation, and were not significantly 
susceptible to DSS-induced colitis. however, they were resistant to lipopolysaccharide 
(i.e. Toll-like receptor agonists) challenge with MDP priming, in confirmation of the role of 
Nod2 in sensing and responding to bacterial antigens by activating the adaptive immune 
system either directly or by enhancing the production of α-defensins121. As such, Nod2 is 
essential to protect the host from intestinal bacterial infection. however, it still remains 
to be established whether the Paneth cell defect in MDP sensing is the only and even 
main mechanism through which Nod2 mutations are related to CD development. Rather 
than representing the main initiating factor for the disease, Nod2 gene defects might 
alter the physiological response to pathogenic bacteria and predispose the individual 
to CD. 
Additional studies in germ-free mice revealed that lack of lysozyme expression also 
characterizes Paneth cells from Nod2-/- mice due to specific lysosomal degradation122. 
When antimicrobial peptides are synthetized in Paneth cells, they are sorted into 
specialized secretory granules called dense core vesicles (DCV). Accordingly, Nod2 is also 
recruited to AMP-containing DCVs that, in turn, is required for the DCV localization of 
the multiprotein kinase Lrkk2 and the GTPase Rab2a122. Defects in the Nod2-Lrkk2-Rab2a 
axis result in the lysosomal degradation of lysozyme122.  
er stress  and unfolded protein response in  IBD and Paneth cel ls
As part of their secretory function, Paneth cells are characterized by a pronounced 
endoplasmic reticulum and Golgi apparatus, and by large secretory granules. As such, they 
act as protein factories responsible for the synthesis of many proteins with antimicrobial 
and essential for intestinal homeostasis. In secretory cells, nascent proteins enter the ER 
as unfolded polypeptide chains to complete folding and maturation. The folding capacity 
of the ER of secretory cells is targeted on the rate of nascent proteins entering the ER. 
Specific sensors monitor the ER lumen and signal to other cellular components. Whenever 
the rate of unfolded nascent proteins exceeds the folding capacity of the ER, a condition 
known as ER stress, the unfolded protein response (uPR) is triggered123. In this process, 
the molecular sensor and ER chaperone immunoglobulin binding protein B (BIP, hSPA5, 
or GRP78) plays a central role. During homeostatic conditions BIP is bound to the luminal 
side of three master regulators of the uPR response, namely transmembrane proteins 
inositol requiring 1 (IRE1), PKR-like ER kinase (PERK), and activating transcription factor 
6 (ATF6). upon ER stress activation, BIP dissociates from these sensors thus triggering 
their activation. The downstream pathways involve, among others, the Paneth-specific 
transcription factor X-box-binding protein-1 (XBP1) whose mRNA is converted upon ER 
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stress to an active form by the IRE-1 nuclease. This leads to the modulation of protein 
synthesis to adapt the ER folding capacity to the specific requirements of the cell. 
Whenever ER stress is not solved, apoptosis is triggered123-124. 
Paneth cells, as many secretory cells, are characterized by a basal ER stress level. 
Of note, the small intestine is the only tissue reported to date to express an isoform 
(IRE1β) of the proximal sensor IRE1125. Remarkably, in Xbp1 knock-out mice ER stress was 
detected in the intestinal epithelium through GRP78 upregulation in association with an 
inflammatory phenotype reminiscent of human IBD with crypt abscesses, ulcerations, 
and leukocyte infiltration117. Furthermore, Paneth cell with normal granules were barely 
detectable together with a substantially decreased expression of cryptdins 1, 4 and 5. 
Also, Paneth cell apoptosis, most likely triggered by the failure of solving ER stress, was 
a feature of Xbp1 genetic ablation. Last, Xbp1 knock-out mice were more susceptible to 
infection by gram-positive bacteria and to DSS-induced colitis. 
Autophagy in  IBD and Paneth cel ls
The term autophagy refers to the natural process through which cellular components like 
organelles or large protein complexes which cannot be removed by the proteasome, are 
degraded and recycled in orderly and regulated fashion through the lysosome. Although 
the original function of autophagy is likely to have arisen as an adaptation to starvation 
or nutrient deprivation, it has evolved as a quality control process for organelles and 
proteins and to regulate energy homeostasis126. Moreover, it is also employed by 
the cell to degrade microorganisms (also referred to as xenophagy), as shown by the 
increased susceptibility to infections caused by intracellular pathogens upon mutation 
of autophagy genes127. Autophagy can also be selective when it triggers the degradation 
of specific damaged organelles, such as mitochondria or peroxisomes. 
The formation of autophagic vesicles earmarks autophagy128 and is dependent on 
the translocation of the mTOR substrate complex from the cytosol to the ER. Through 
recruitment of PI3 kinases to the ER, vesicle formation and elongation is started. The 
final stage of this process is mediated by a number of autophagy (Atg)-related proteins, 
namely, Atg12, Atg5 and Atg16, which form a complex with Atg8 and phospholipid 
phosphoethanolamine (PE), that catalyzes further elongation and maturation of the 
autophagic vesicles. Once mature, they are transported to lysosomes where they 
undergo degradation.
The autophagy machinery interfaces with cellular stress and response pathways, 
including those controlling immune responses and, in turn, inflammation. Large 
autophagic vesicles were observed to be prominent in Paneth cells after irradiation129. 
Several mice carrying hypomorhic variants of different Atg genes (i.e. Atg16, Atg5, and 
Atg7) were characterized by apparently mature Paneth cells though with secretory 
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granules decreased in size and numbers119. Defects in granules exocytosis leading to 
decreased AMP secretion into the lumen and differences in microbiome composition 
were also reported in these mice119. 
Several defects in autophagy, autophagy-related genes, and Paneth cell morphology 
have been observed in IBD patients130. As previously mentioned, single nucleotide 
polymorphisms in the ATG and related genes were found by GWAS to predispose to 
IBD118,119,131. More recently, a seminal study by Adolph et al. has functionally linked ER 
stress and autophagy in a specific cell type, the Paneth cell132. here, mouse models were 
developed that were defective in the Xbp1 gene in the small intestine. upon induction of 
ER stress in the intestinal epithelium, autophagy was observed mostly at the bottom of the 
crypts where Paneth cells reside. To assess whether autophagy was induced to ameliorate 
ER stress, mice defective in both Xbp1 and Atg16L1 (or Atg7) in intestinal epithelium specific 
fashion132. These mice lacked uPR-induced autophagy resulting in constitutive ER stress in 
the absence of autophagy. Notably, the intestines of the double-mutant mice featured a 
strong inflammatory reaction with tissue damage reminiscent of Crohn’s disease. In view 
of the potent autophagy induction in Xbp1 defective mice at the bottom of the crypts, 
Paneth cells are likely to be the culprit of the CD-like phenotype of these mice. Indeed, 
Paneth-specific ablation of Xbp1 and Atg16L1 (or Atg7) recapitulated the phenotype of the 
above mice where the same genes were inhibited in the whole intestinal epithelium, thus 
providing additional experimental evidence for Paneth cells as the cellular site where ER 
stress and autophagy are functionally linked and as the origin of intestinal inflammation in 
IBD cases linked to ATG and ER stress loci132. As for the molecular mechanisms underlying 
the autophagy-driven amelioration of ER stress, upregulation of the NF-κB pathway was 
observed in the double-mutant mice. Accordingly, use of an NF-κB inhibitor led to a 
decrease in the overall number of cells undergoing apoptosis and a partial reversion of 
the inflammatory phenotype caused by the combined Xbp1 and Atg16L1 genetic deletion. 
Notably, NF-κB activation upon concomitant loss of Xbp1 and Atg16L1 function was not 
observed in germ-free mice again highlighting the relevance of the microbiome in these 
experimental settings and providing a suggestive functional connection between ER stress, 
autophagy and the microbiome in IBD132. 
The above findings open novel therapeutic scenarios for IBD patients, as illustrated 
by the use of NF-κB inhibitors to ameliorate and possibly resolve inflammation. Moreover, 
patients without single nucleotide polymorphisms in Atg-related genes, autophagy 
could be stimulated by treatment with rapamycin and mimicking caloric restriction9. 
Also, it is well-established that IBD patients carry an increased risk to colon cancer. From 
this perspective, the notion that Paneth cells are the site of origin of inflammation may 
also have implications for IBD-associated colon cancers in view of previous observations 
pointing at the capacity of PCs and their progenitors to de-differentiate and take active 
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part in the regenerative response to tissue damage62. Further studies will be required to 
elucidate whether Paneth cells might also represent the cell of origin of IBD-associated 
colorectal cancer. 
the role  of  immunity  and environmental  factors
The immune system plays important roles in IBD in response to bacterial antigens, proteins 
and RNA. Innate or in-born immunity is a pre-requisite for the activation of the adaptive 
immunity which in turn seems to be causative for the tissue damage in IBD. Animal models 
of IBD, along with a more detailed understanding of the immune response in the digestive 
tract, have led to an unifying hypothesis relative to the role of the immune system in IBD. 
An inappropriate mucosal immune response to normal intestinal components leads to a 
local imbalance in cytokines resulting in a neutrophil and monocyte influx with subsequent 
secretion of oxygen radicals and enzymes, leading to tissue damage133. 
The incomplete penetrance of IBD animal models and the heterogeneity of 
the disease can be accounted for by additional environmental factors. Several 
epidemiological studies have shown increased IBD risk in migrants from countries at low 
to high risk countries134. Furthermore, since the 19th century the incidence of IBD has 
steadily increased in westernized countries134. Diet and vitamin D intake are supposedly 
additional modifying risk factors to IBD. Low dietary fiber intake is associated with 
increased IBD risk as fibers are metabolized by bacteria into short chain fatty acids 
that inhibit transcription of pro-inflammatory mediators135,136. Furthermore low zinc 
intake might impair autophagy and modulate immune functions137,138. Additional factors 
correlated with higher risk of developing IBD are lack of exercise and sleep although 
more experimental evidence is needed to link the latter functionally to IBD139. 
Paneth cel ls  as  IBD-speci f ic  d isease markers
The broad range of processes coming together in IBD is indicative of the complexity and 
heterogeneity of the disease. In view of their striking multi-functionality ranging from 
the secretory and bactericidal function to innate gut immunity, Paneth cells seem to be 
endowed with the capacity to integrate cues from dietary nutrients and the microbiota, 
and translate them in to stem cell niche regulatory signals in homeostasis and tissue 
regeneration. Accordingly, changes in Paneth cells numbers and/or morphology or 
mutations in PC-specific genes underlie the etiology of at least a subset of IBD cases130. 
Stappenbeck and McGovern have proposed a classification of CD subtypes based on the 
detailed characterization of Paneth cell morphology (granules size and numbers) and IhC 
staining of AMPs like lysozyme (Lyz1) and defensins130. In this fashion Paneth cells can 
be studied retrospectively in archival resection specimens or from biopsies collected via 
endoscopy. 
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Paneth cel ls  as  stem cel l  n iche in  inf lammation
The stem cell niche role of Paneth cells has been mostly studied in homeostasis and 
little is known on their function upon inflammation. Several reports suggest a decrease 
in mature Paneth cells’ multiplicity in inflammation. One of the genes responsible for 
the incomplete maturation of Paneth cells in inflammation is protein kinase C iota or 
(Prcki). Prcki ablation in the intestinal epithelium did not affect Paneth cell number and 
granules. however, the PC-specific marker lysozyme was shown to co-localize with alcian 
blue positive cells characteristic of the goblet lineage. hence, inflammation triggers 
Paneth cell de-differentiation to acquire an intermediate secretory precursor of both 
Paneth and goblet cells140. Expression analysis of PRCKI in IBD patients revealed an 
inverse correlation with disease progression140. 
The secretory phospholipase A2 group 2a (Pla2g2a) gene was shown to be able to 
modify and improve the Paneth cell niche function upon inflammation99. Contrary to the 
role of Pla2g2a in homeostasis where the protein downregulates Wnt signaling in Paneth 
cells, gene- and protein-based assays showed highly increased Pla2g2a expression and 
secretion upon inflammation leading to an increase in canonical Wnt in Paneth cells. 
When secreted, Pla2g2a, next to exerting its antibacterial function, binds to the M-type 
phospholipase A2 receptor 1 (Pla2R1). This interaction triggers an autocrine cascade of 
downstream events culminating in increased Wnt signaling and improved regenerative 
response to the inflammatory tissue damage99. These observations open new therapeutic 
options by stimulating Paneth cell functions in IBD to improve tissue regeneration99.
CONCLuSIVE REMARKS 
Mult i - tasking Paneth cel ls  in  health and disease  
The strikingly broad spectrum of functions covered by Paneth cells is reflected by the 
plethora of molecular and cellular mechanisms through which these secretory cells have 
been linked to several human pathological conditions related to dysbiosis, from obesity 
to graft versus host disease, inflammation, and cancer. The more recently elucidated 
niche role of Paneth cells in supporting and modulating intestinal stem cell function 
possibly represents the integration hub of their multiple tasks. By sensing environmetal 
factors like dietary changes and/or inflammatory stimuli, PCs seem to be capable of 
translating them into modifications of stem cell numbers, activity, and regenerative 
capacity. This is achieved either directly or indirectly by coordinated stress sensors such 
as uPR, ER stress, autophagy, and possibly many others. And yet, we are possibly only 
scratching the surface of the true functional identity of PCs. Many fascinating aspects 
remain unsolved: what is, if any, the functional role of Paneth cell metaplasia in colonic 
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inflammation and cancer? Can mature Paneth cells and their secretory precursors, next 
to their niche funtion, directly contribute to the regenerative response to tissue insults 
by de-differentiating and acquiring stem-like properties? Analogous to their regulatory 
role in response to caloric restrictions, can Paneth-like cells located in the colon alter 
their metabolic needs and niche functions upon Western-style nutrients known to 
increase colon cancer risk? Ongoing and future studies will contribute to the elucidation 
of these and other questions and possibly lead to PC-tailored therapeutic strategies for 
IBD and GI-tract cancer patients.  
Figure 1. (A) At the bott om of the crypt of Lieberku€hn, Paneth cells (brown) and Lgr5+ stem cells 
(yellow) cluster away upon crypt fi ssion initi ati on (Langlands et al., 2016). The increased sti ff ness of 
Paneth cells forms harder regions on the sides of the branching crypt, in contrast with the “soft er” 
Lgr5+ stem cells positi oned in the center. (B) Schemati c diagram of the diff erenti ati on fates of the 
Lgr5+ stem cell and the genes that underlie the specifi c commitment steps. (C) Left : Paneth cells 
(brown) sustain the metabolism of Lgr5+ cells by using glucose as a substrate to secrete lactate 
that, during homeostasis, fuels oxidati ve phosphorylati on in Lgr5+ stem cells. Center and right: 
mTORC1 inhibiti on in Paneth cells leads to the secreti on of cyclic ADP ribose (cADPR). During 
caloric restricti on, mTORC1 is inhibited in Paneth cells leading the enhanced cADPR secreti on and 
increased Lgr5+ stem cell self-renewal and multi plicity
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Figure 2. (A) Inflammatory bowel disease (IBD) is a complex multifactorial disease dominated by 
four major cross-interacting components, namely the genetic background of the host, the gut 
microbiome, the host’s immune system, and the environment.
(B) Genetic depletion of the Xbp1 gene encoding for a key ER stress response proteincauses 
Paneth cell loss, increased apoptosis, and dysbiosis. Combined genetic loss of the Xbp1 and Atg16 
genes in Paneth cells results in diffused lysozyme staining reminiscent of IBD and transmural ileitis, 
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Abstract
The intestinal epithelium is characterized by an extremely rapid turnover rate. In mammals, the entire epithelial lining is renewed within 4 - 5
days. Adult intestinal stem cells reside at the bottom of the crypts of Lieberkühn, are earmarked by expression of the Lgr5 gene, and preserve
homeostasis through their characteristic high proliferative rate1. Throughout the small intestine, Lgr5+ stem cells are intermingled with specialized
secretory cells called Paneth cells. Paneth cells secrete antibacterial compounds (i.e., lysozyme and cryptdins/defensins) and exert a controlling
role on the intestinal flora. More recently, a novel function has been discovered for Paneth cells, namely their capacity to provide niche support to
Lgr5+ stem cells through several key ligands as Wnt3, EGF, and Dll12.
When isolated ex vivo and cultured in the presence of specific growth factors and extracellular matrix components, whole intestinal crypts give
rise to long-lived and self-renewing 3D structures called organoids that highly resemble the crypt-villus epithelial architecture of the adult small
intestine3. Organoid cultures, when established from whole crypts, allow the study of self-renewal and differentiation of the intestinal stem cell
niche, though without addressing the contribution of its individual components, namely the Lgr5+ and Paneth cells.
Here, we describe a novel approach to the organoid assay that takes advantage of the ability of Paneth and Lgr5+ cells to associate and form
organoids when co-cultured. This approach, here referred to as "organoid reconstitution assay" (ORA), allows the genetic and biochemical
modification of Paneth or Lgr5+ stem cells, followed by reconstitution into organoids. As such, it allows the functional analysis of the two main
components of the intestinal stem cell niche.
Video Link
The video component of this article can be found at https://www.jove.com/video/56329/
Introduction
The intestinal epithelium is the most rapidly self-renewing tissue in the mammalian body and, as such, has been the object of a plethora of
studies aimed at the identification and functional characterization of the adult stem cells residing at the bottom of the crypt of Lieberkühn,
earmarked by expression of the Lgr5 gene and dependent on canonical Wnt signals1. Notably, Lgr5+ stem cells are flanked and supported by
specialized niche cells, i.e. Paneth cells, which also depend on Wnt signaling for their maturation2. Together, these two cell types underlie self-
renewal of the intestinal epithelial lining and preserve the daily homeostatic equilibrium: Lgr5+ stem cells rapidly divide and give rise to progenitor
and more specialized intestinal epithelial cells; Paneth cells provide essential niche factors (e.g., Dll1, Wnt3, EGF) to Lgr5+ stem cells2. The
capacity of intestinal crypts when plated ex vivo to form organized and self-renewing structures called organoids, or "mini-guts", has been
exploited as an experimental tool to provide insight into processes such as self-renewal and differentiation in normal and pathological conditions
including cancer4. Organoid cultures have been established from several tissues, including the intestine, pancreas, liver, and kidney, from both
mouse and human samples4. The extraction method and the growth factors employed to develop these organoid cultures are tissue-specific and
designed to drive multi-lineage differentiation and mimic as closely as possible the original stem cell niche in vivo. Organoids may have potential
applications including the treatment of genetic diseases, the assessment of therapeutic efficacy in cancer, the analysis of drug toxicity, or the
study of organogenesis in vitro5.
Overall, the main limitation of organoid cultures when established from tissue samples is a lack of cell-specificity. For example, intestinal
organoids established from whole intestinal crypts do not allow the analysis of individual cellular components encompassed within the tissue
source (e.g., whole crypts contain Lgr5+, Paneth, and progenitor cells).
Here, we describe a novel method, referred to as ORA, that combines the advantages of intestinal organoid cultures with the functional analysis
of its most fundamental components, namely stem (Lgr5+) and niche (Paneth) cells. This is achieved through the unique ability of Paneth and
Lgr5+ cells to physically associate with each other when co-incubated and give rise to organoids2,6,10. We took advantage of this feature and pre-
treated the two cell types individually before allowing them to reconstitute organoids. When doing so, each cell component can be exposed to
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any given drug, growth factor, biochemical inhibitor, genetic modification, or chemical treatment prior to reconstitution and organoid formation.
Therefore, using the ORA assay will allow the determination of whether a specific drug treatment or genetic modification has a specific effect on
the stem cells or their niche counterpart.
Protocol
All procedures were done according to local animal welfare laws and guidelines.
1. Preparation of Instruments, Culture Media, and Dishes
1. Autoclave 1 set of intestinal scissors, normal scissors, and forceps in a sterile container.
2. Place a 96-well (flat bottom) dish in an incubator at 37 °C.
3. Prepare 10 mL of complete culture medium with the reagents listed in table of materials.
4. Incubate the complete medium at 37 °C in a water bath.
5. Thaw reconstituted basement membrane by placing it in an ice bucket. The reconstituted basement membrane will become liquid at 4 °C .
6. Fill 4 Petri dishes with cold phosphate-buffered saline or abbreviated PBS (4 °C).
2. Isolation of Small Intestinal Crypts
1. Sacrifice by CO2 inhalation a Lgr5-eGFP-IRES-CreERt2 mouse on a C57BL6/J background. Dissect the peritoneum longitudinally with a pair
of scissors.
2. Hold the stomach with the forceps and cut it transversally in half.
3. Using the intestinal scissors from now on, pull out the intestine and place it in a Petri dish containing PBS.
NOTE: Intestinal scissors have a sharp and a blunt tip. The blunt tip of these scissors is meant to not damage the crypt-villus architecture
while opening the intestine.
4. Start by placing the blunt tip into the stomach and gently push it through the pylorus. Proceed by cutting with the scissors and pulling with the
forceps.
5. Once the whole small intestine is opened longitudinally, wash it in cold PBS by holding it with the forceps and gently rinse it in the PBS
solution with U-shaped movements.
6. Once all the stool remnants are cleared, proceed to flatten the intestine on a cutting board, luminal side up. The luminal side is easily
recognizable by the absence of blood vessels and by its pale appearance when compared with the outer part.
7. With a glass slide, gently remove the villi by scraping the flattened intestine. Perform this step twice along the whole length of the tissue.
8. Cut the small intestine with a sterile surgical blade into 2 - 5 mm pieces.
9. Place the small intestinal fragments in a 50 mL tube containing 10 mL of ice cold PBS.
10. Clean the tissue fragments, removing any remaining impurities by pipetting them up and down in the PBS. Discard supernatant and repeat
this step until the PBS is completely clear.
11. Add 15 mL cold PBS, to bring the total final volume of PBS to 25 mL. Add 2 mM ethylenediaminetetraacetic acid (EDTA) and incubate for 45
min on a roller at 4 °C.
12. Discard the PBS/EDTA.
13. Add 10 mL of PBS and detach the crypts by harshly pipetting the tissue fragments up and down (at least three times). Collect the
supernatant.
14. Repeat step 2.13 four times. Add culture medium to reach a final volume of 50 mL.
15. Pellet the cells by centrifugation (300 x g for 5 min).
16. Resuspend the pellet in 10 mL of culture medium and pellet the crypts by centrifugation (80 x g for 3 min).
3. Single Cell Preparation
1. Discard the supernatant of the pelleted crypts and resuspend them in 1 mL trypsin like-enzymes together with 50 µL DNAse (50 µg/mL).
2. Incubate the cells in a water bath at 32 °C for 2 min.
3. Add 10 mL of culture medium. Dissociate the crypts into single cells by harshly pipetting up and down at least 5 times.
4. Filter the solution through a 40 µm strainer (to eliminate clumps and other impurities) and pellet the single cells at 300 x g for 5 min.
4. Flow Cytometry and Plating
1. Prepare 50 mL of 1x Hank's buffered salt solution or HBSS/2% fetal cow serum (FCS) solution and resuspend the pellet in 1 mL for every 106
cells
2. Add to the cell suspension BV421 Lin- (CD31, CD45, TER119) at a concentration of 1:100, and CD24-APC and CD117-PE both at a
concentration of 1:250 antibodies for 30 min.
3. Sort Lgr5+ stem cells and Paneth cells into separate low bind tubes. For details on sorting protocols for Lgr5+ and Paneth cells, please see
Roth et al.7 and Schewe et al.6
1. Centrifuge the sorted cells at 300 x g for 5 min. Resuspend the cells in 100 µL medium with the components described as in 1.3 (see
the Table of Materials).
4. Treat (e.g., by chemical or genetic modification) the Paneth cells (n = 2000) or the Lgr5+ stem cells (n = 2000).
1. To treat cells, use 5 µL of liposome-mediated transfection reagent in a total volume of 100 µL culture medium and small interfering RNA
(siRNA) at a concentration of 100 nM. Incubate for 30 min at 37 °C for siRNA or for the time necessary for the chosen modification.
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5. Wash the cells twice in 500 µL culture medium.
6. Centrifuge at 300 x g for 5 min and resuspend the cells in 10 µL culture medium.
7. Pool the two cellular components (Paneth or Lgr5+ cells) in a 20 µl total volume and centrifuge at 300 x g for 5 min at RT.
8. Co-incubate the Paneth and Lgr5+ cells for 10 min at RT.
9. Remove 10 µL of the supernatant and leave a meniscus of liquid to be sure to not aspirate the cell pellet.
10. Add 30 µL of reconstituted basement membrane to the cells for a total volume of 40 µL, resuspend the cells and plate in a pre-warmed 96
well plate. After 10 min, add 200 µL of complete medium (see the Table of Materials). Change medium every 48 h.
11. Count organoid multiplicity at day 5.
Representative Results
The organoid reconstitution assay allows the separate functional analysis of the essential niche and stem cell components of the intestinal
epithelium, here demonstrated by small interfering RNA (siRNA) of the Apc gene.
To achieve this aim, we first utilized fluorescent activated cell sorting (FACS) to separate 8000 Lgr5+ cells and 6000 Paneth cells from inbred
C57BL6/J mice. In Figure 1a, a flowchart of the ORA assay is depicted. Organoid reconstitution capacity was assessed by incubating Lgr5+ cells
with siRNA oligonucleotides directed against the mRNA of Apc or encompassing a scrambled sequence (SCR) as a control. After treatment, the
same siRNA-treated Lgr5+ cells were either directly plated in organoid medium/reconstituted basement membrane, or incubated with an equal
number of untreated Paneth cells and subsequently plated out. As a control, untreated Lgr5+ cells were plated alone (i.e., without Paneth cells)
to determine the number of organoids derived from untreated Lgr5+ cells. Furthermore, as an additional control, Paneth cells alone were plated
to check for the background of organoid formation derived from the contamination of Paneth-Lgr5 cell doublets sorted in the Paneth cell gate. As
expected, siRNA mediated knockdown of the murine Apc gene in Lgr5+ stem cells (and the resulting activation of the canonical Wnt/β-catenin
signaling pathway) positively affected organoid multiplicity when compared to untreated counterparts or the scrambled control (Figure 1B). The
constitutive Wnt activation also rescued the requirement for Paneth cells, as previously reported1. Furthermore, these organoids appeared as
hollow spheres (spheroids), a well described phenotype for Apc-mutant or Wnt-stimulated organoids (Figure 1C, panel 1), when compared
with the morphology of those obtained from Paneth-Lgr5 cell doublets (Figure 1C, panel 2)8,9. Collectively, these results demonstrate that
reconstituting Paneth cells and Lgr5+ cells can give insight on cell-specific mechanisms within these two cell types; morphological analysis of the
organoids by microscopy can be valuable in this respect since the morphology of the organoids reflects their cell composition (e.g., spheroids are
constituted by Lgr5+ cells only). Another important parameter to be taken into account is the complexity of the organoid (e.g., the number of crypt
budding events).
Figure 1. Effect of siRNA mediated knockdown of Apc in Lgr5+ cells. (A) Flowchart of the experimental procedure. Lgr5EGFP reporter mice
(Lgr5EGFP-IRES-creERT2)1 were employed as a source of Lgr5+ sorted stem cells. Paneth cells were sorted as indicated and previously described6,7.
(B) Organoid multiplicity observed upon reconstitution of Lgr5+ stem cells and Paneth cells. When indicated cells were pretreated with siRNA
oligonucleotides directed against the Apc (siRNA Apc) or scrambled (SCR) control sequence. The asterisks indicate statistically significant
differences (n = 3, *p <0.05 **p <0.001). Error bars refer to SD. (1) Lgr5+ cells, (2) Lgr5+ cells SCR, (3) Lgr5+ cells siRNA Apc, (4) Lgr5+ cells
+ Paneth cells, (5) Lgr5+ cells siRNA Apc + Paneth cells, (6) Paneth cells. (C) Representative images of organoids derived from (1) Lgr5+ cells
siRNA Apc, (2) Lgr5+-Paneth cells. Scale bar = 10 µm. Please click here to view a larger version of this figure.
Discussion
The ORA allows the refined functional analysis of the two essential components of the intestinal stem cell niche, namely Lgr5+ and Paneth
cells. This approach has been previously employed by us and others with slight modifications6,10,11. Here, we present the ORA procedure as a
reproducible and standardized laboratory protocol. Also, we report on the effects of Apc downregulation in Lgr5+ stem cells, as an example of
the possibility of implementing genetic (or biochemical6) modifications to the sorted cellular components. Collectively, the data show that siRNA
mediated knockdown of Apc enhances the stem cell function of Lgr5+ cells, as indicated by the increased organoid multiplicity (Figure 1B).
Several advantages of using intestinal 3D organoid cultures have already been listed in reviews4, including the striking resemblance of their
organization with that of the crypt-villus architecture in vivo, especially when compared to the architecture from standard 2D culture methods with
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immortalized cell lines. However, one of the major limitations of this method is that in most cases, organoid cultures are established from whole
intestinal crypts, a process which does not allow the functional analysis of its individual components and, in particular, of the stem and niche
cells, here represented by Lgr5+ and Paneth cells, respectively.
The ORA overcomes these limitations. Stem and niche cells can be separately sorted from the animal and reconstituted to generate organoids.
As such, this approach allows the functional analysis of these two cellular components by either employing mouse models carrying specific
genetic modifications or exposed to specific stress factors (e.g., DSS and/or specific diets); or by directly modifying the sorted cells genetically
(siRNA, CRISPR-Cas9) or biochemically, before reconstituting them to generate organoids. The multiplicity, morphology, self-renewal capacity,
and extent of differentiation (and eventually the extent of metaplastic changes) of the resulting organoids can be employed as functional read-
outs. In the case of genetic manipulation, such as siRNA, when a morphological effect is not evident, cells should be analyzed one hour after
transfection to validate the knockdown of the mRNA of interest. Paneth and Lgr5+ can also be sorted from mice genetically engineered with
different mutations to study whether different mutations in stem and niche cells lead to altered interactions between these two cell types and a
different organoid formation efficiency and/or morphology.
Critical steps within the protocol are the removal of the villi (step 2.7) and the resuspension of the cells in HBSS/2%FCS (step 4.1). Removal of
the villi is critical to enrich Paneth and Lgr5+ cells located in the lower third of the crypts and to improve the efficiency of sorting. Although FACS
protocols commonly suggest sorting cells in PBS/FCS, the use of HBSS instead of PBS increased and kept cell viability stable throughout the
sorting time. Other important steps are steps 4.7 and 4.8, where physical association of Paneth and Lgr5+ cells allows these lineages to form
doublets that will eventually give rise to organoids.
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secretory precursors were shown to represent infrequently
dividing stem-like cells capable of re-entering the cell cycle
upon tissue insults, thus contributing to the regenerative
response (Buczacki et al., 2013; Roth et al., 2012). Therefore,
we hypothesized that sPLA2s may represent ISC niche factors
with specific functional roles in homeostasis, inflammation, and
cancer.
RESULTS
Pla2g2a ExpressionModulates ISC Function and Paneth
Cell Differentiation
To test the hypothesis that Pla2g2a is an important stem cell
niche factor, we employed the ‘‘mini-gut’’ assay (Sato et al.,
2011) as a readout of stem cell function in small intestinal crypts
from Mom-1-sensitive (Mom1S or Pla2g2a/; C57BL/6J and
129/SW) or Mom-1-resistant (Mom1R or Pla2g2a+/+; FVB/N,
BALB/c, CBA) inbred mouse lines (MacPhee et al., 1995). The
multiplicity of organoids derived from Mom1S strains is signifi-
cantly higher when compared with Mom1R mice (Figure 1A).
However, these inbred strains differ at several loci other than
Pla2g2a, and thus differences in organoid formation cannot be
attributed directly to the Mom-1 locus. Therefore, we employed
a transgenic mouse model in which expression of the Pla2g2a
gene is restored in the C57BL/6J background (Tg-Pla2g2a)
(Cormier et al., 1997) at slightly higher levels (1.5- to 2-fold at
the protein level) compared to Pla2g2a-proficient inbred strains
such as FVB/N (Figure S1, available online). There was a signifi-
cant decrease in organoid formation in both male and female
transgenic mice compared with Pla2g2a/ (C57BL/6J) litter-
mates (Figure 1B), confirming that expression of the Pla2g2a
gene negatively affects the ability of isolated crypts to form intes-
tinal organoids. The overall organoid morphology did not differ
among strains (data not shown).
The Pla2g2a gene is mainly, yet not exclusively, expressed in
the small intestine and in particular by Paneth cells (Figure S1A).
As Pla2g2a inhibits organoid growth, we investigated the histo-
pathology of the digestive tract of Tg-Pla2g2a mice. Notably,
immunohistochemical (IHC) analysis revealed an almost com-
plete absence of lysozyme-positive Paneth cells in the trans-
genic mice (Figure 1C). In addition, the proliferating (Ki67+)
compartment, normally limited to the transient amplifying (TA)
progenitors in control C57BL/6Jmice, was extended to the lower
crypt of Tg-Pla2g2a mice, where post-mitotic Paneth cells are
usually located (Figure 1D). However, granulated Paneth-like
cells were present in the crypt bottom of transgenic animals (Fig-
ure S2A). qRT-PCR (Figure 1E) and IHC (Figure S2B) analysis of
additional lineage-specific markers confirmed the absence of
mature Paneth cells in the Tg-Pla2g2a model. Furthermore,
IHC (Figures S3A and S3B) and fluorescence-activated cell sort-
ing (FACS) (Figures S3C and S3D) analyses of lineage-specific
markers confirmed the accumulation of the Lgr5+/ChgA+ (chro-
mogranin A) secretory (Paneth and goblet cells) precursor line-
age (Buczacki et al., 2013) in transgenic animals. Notably, the
overall FACS pattern obtained from C57BL/6J and Tg-Pla2g2a
mice did not differ with the CD24/SSC marker combination
(data not shown). Thus, the results point to a reduction in fully
mature Paneth cells rather than the complete ablation of this line-
age in the transgenic mice, possibly due to a maturation defect.
Overall, Pla2g2amaymodulate ISC function by inhibiting Paneth
cell differentiation and full maturation.
Intracellular Pla2g2a Inhibits Wnt Signaling by
Increasing Yap1 Phosphorylation
The above experiments were carried out under homeostatic
conditions, i.e., in mice kept under normal conditions and fed
ad libitum. As Pla2g2a encodes the sPLA2-IIA protein whose
expression and secretion are highly enhanced during inflamma-
tion but are thought to be kept at a basal level during homeosta-
sis, we investigated whether the observed inhibitory effects on
intestinal organoid growth are exerted by the intracellular pool
or by the basal secreted fraction of sPLA2-IIA. The organoid
assay was repeated on crypts from FVB (Pla2g2a+/+), C57BL/
6J (Pla2g2a/), and Tg-Pla2g2amice in the presence of the sol-
uble (non-membrane-bound) sPLA2-IIA receptor Pla2r1 to scav-
enge any secreted Pla2g2a protein (Rouault et al., 2007). The
lack of effect on organoid multiplicity (Figure S3E) indicated
that the inhibitory effect exerted by Pla2g2a is likely due to its
intracellular (non-secreted) fraction.
The canonical Wnt signaling plays a role in both ISC mainte-
nance and in Paneth cell maturation (van Es et al., 2005a). As
such, it may underlie the organoid formation and Paneth cell
maturation defects observed in Pla2g2a-expressing transgenic
mice. Therefore, we analyzed the effects of PLA2G2A expres-
sion on Wnt signaling in human colon cancer cell lines with
constitutive pathway activity due to mutations in the APC or
b-catenin genes. Transient expression of PLA2G2A caused sig-
nificant downregulation of Wnt signaling activity in all three lines
(Figure 2A).
To elucidate the mechanisms underlying Pla2g2a-driven inhi-
bition of Wnt signaling, we analyzed previously published intes-
tinal expression profiling studies comparing Tg-Pla2g2a mice to
C57BL/6J controls (Fijneman et al., 2008, 2009) and found upre-
gulation of Yap1 (yes-associated protein 1) in intestinal cells from
Tg-Pla2g2amice (2.63-fold; p value 0.0072). Although Yap1 has
oncogenic and growth-stimulating capacities, it also has unex-
pected growth-suppressive functions; while nuclear Yap1 pro-
motes growth, its phosphorylation by Hippo kinases prevents
nuclear translocation and restricts Wnt signaling (Azzolin et al.,
2014; Barry et al., 2013; Camargo et al., 2007). We FACS purified
Paneth cells from Lgr5–EGFP–ires–CreERT2 reporter mice
(Barker et al., 2007) on Tg-Pla2g2a and C57BL/6J backgrounds,
as previously described (Roth et al., 2012). Yap1 was specifically
upregulated in Paneth cells from Tg-Pla2g2a mice (Figure 2B),
reflecting the Paneth-specific Pla2g2a expression pattern in
those animals (Figure S1B). In contrast, Pla2g2a expression
levels did not differ between Lgr5+ stem cells from control and
transgenic animals. Moreover, Yap1 was expressed at higher
levels in Paneth cells from FVB/N (Pla2g2a+/+) mice (Figure 2B).
This was confirmed by IHC and IF analysis: whereas in wild-
type (C57BL/6J) crypts only the slender Lgr5+ stem cells stain
positive for Yap1, clear Yap1 cytoplasmic staining was observed
in the (immature) Paneth cells from Tg-Pla2g2amice (Figures 2C
and S4C). FACS analysis of wild-type (C57BL/6J) and Tg-
Pla2g2a mice confirmed increased YAP1 phosphorylation in
Paneth cells from the transgenic animals (Figures S4A and
S4B), consistent with decreased organoid formation in these
mice.
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The intestinal stem cell niche provides cues that
actively maintain gut homeostasis. Dysregulation of
these cues may compromise intestinal regeneration
upon tissue insult and/or promote tumor growth.
Here, we identify secreted phospholipases A2
(sPLA2s) as stem cell niche factors with context-
dependent functions in the digestive tract. We
show that group IIA sPLA2, a known genetic modifier
of mouse intestinal tumorigenesis, is expressed by
Paneth cells in the small intestine, while group X
sPLA2 is expressed by Paneth/goblet-like cells in
the colon. During homeostasis, group IIA/X sPLA2s
inhibit Wnt signaling through intracellular activation
of Yap1. However, upon inflammation they are
secreted into the intestinal lumen, where they pro-
mote prostaglandin synthesis and Wnt signaling.
Genetic ablation of both sPLA2s improves recovery
from inflammation but increases colon cancer
susceptibility due to release of their homeostatic
Wnt-inhibitory role. This ‘‘trade-off’’ effect suggests
sPLA2s have important functions as genetic modi-
fiers of inflammation and colon cancer.
INTRODUCTION
In 1993, by taking advantage of an inbred mouse model predis-
posed to multiple intestinal neoplasia (Min), Dove and colla-
borators identified theMom-1 (modifier of Min) locus as a major
modifier of intestinal tumor multiplicity driven by mutations in the
Apc (adenomatous polyposis coli) tumor suppressor gene (Die-
trich et al., 1993). Subsequently, Pla2g2a, encoding the secreted
type IIA phospholipase A2 (sPLA2-IIA), was identified as the
main responsible gene within the Mom-1 locus (MacPhee
et al., 1995). sPLA2-IIA and other sPLA2 members produce
biologically active lipid mediators such as lysophosphatidic
acid (LPA) and arachidonic acid (AA), the latter a substrate for
prostaglandin E2 (PGE2) biosynthesis (Lambeau and Gelb,
2008). Notably, Mom-1-susceptible strains (e.g., C57BL/6J)
carry a single nucleotide insertion in the Pla2g2a gene, resulting
in a null allele, whereas Mom-1-resistant strains (e.g., FVB/N,
BALB/c, CBA) are Pla2g2a proficient (MacPhee et al., 1995).
More definitive evidence for the identity of the Pla2g2a gene as
Mom-1 came from a transgenic mouse overexpressing Pla2g2a
in the C57BL/6J inbred genetic background that, in the presence
of the ApcMin mutation, causes a significant reduction in tumor
multiplicity, though without fully recapitulating the decrease in
tumor multiplicity observed in resistant Mom-1 strains (Cormier
et al., 1997, 2000).
Somatic inactivation of the human APC gene is a rate-limiting
and initiating event in the vast majority of sporadic colon cancer
cases (Fodde et al., 2001). Based on the above mouse studies,
PLA2G2A, i.e., the human ortholog of Mom-1/Pla2g2a, was
thought to represent a modifier of bowel cancer risk in the gen-
eral population. However, studies failed to find either somatic
or germline PLA2G2A alterations in sporadic colon tumors or
hereditary colon cancer patients, respectively (Riggins et al.,
1995; Spirio et al., 1996). This may be due to the specific expres-
sion of the PLA2G2A/Pla2g2a gene in Paneth cells, a secretory
lineage almost exclusively found in the small intestine and only
to a lesser extent in the distal colon (Cormier et al., 2000;Mounier
et al., 2008). Accordingly, Apc mutant mice mainly develop
multiple upper GI (gastrointestinal) adenomas with very infre-
quent colonic lesions. Therefore, other members of the sPLA2
multigene family may act as colon cancer genetic modifiers
in man.
The Paneth-cell-specific expression pattern of Pla2g2a is of
interest in view of the ‘‘niche’’ role played by these secretory cells
in supporting Lgr5+ intestinal stem cells (ISCs) in the intestinal
crypt (Sato et al., 2011). Moreover, both Paneth cells and their
38 Cell Stem Cell 19, 38–51, July 7, 2016 ª 2016 Elsevier Inc.
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secretory precursors were shown to represent infrequently
dividing stem-like cells capable of re-entering the cell cycle
upon tissue insults, thus contributing to the regenerative
response (Buczacki et al., 2013; Roth et al., 2012). Therefore,
we hypothesized that sPLA2s may represent ISC niche factors
with specific functional roles in homeostasis, inflammation, and
cancer.
RESULTS
Pla2g2a ExpressionModulates ISC Function and Paneth
Cell Differentiation
To test the hypothesis that Pla2g2a is an important stem cell
niche factor, we employed the ‘‘mini-gut’’ assay (Sato et al.,
2011) as a readout of stem cell function in small intestinal crypts
from Mom-1-sensitive (Mom1S or Pla2g2a/; C57BL/6J and
129/SW) or Mom-1-resistant (Mom1R or Pla2g2a+/+; FVB/N,
BALB/c, CBA) inbred mouse lines (MacPhee et al., 1995). The
multiplicity of organoids derived from Mom1S strains is signifi-
cantly higher when compared with Mom1R mice (Figure 1A).
However, these inbred strains differ at several loci other than
Pla2g2a, and thus differences in organoid formation cannot be
attributed directly to the Mom-1 locus. Therefore, we employed
a transgenic mouse model in which expression of the Pla2g2a
gene is restored in the C57BL/6J background (Tg-Pla2g2a)
(Cormier et al., 1997) at slightly higher levels (1.5- to 2-fold at
the protein level) compared to Pla2g2a-proficient inbred strains
such as FVB/N (Figure S1, available online). There was a signifi-
cant decrease in organoid formation in both male and female
transgenic mice compared with Pla2g2a/ (C57BL/6J) litter-
mates (Figure 1B), confirming that expression of the Pla2g2a
gene negatively affects the ability of isolated crypts to form intes-
tinal organoids. The overall organoid morphology did not differ
among strains (data not shown).
The Pla2g2a gene is mainly, yet not exclusively, expressed in
the small intestine and in particular by Paneth cells (Figure S1A).
As Pla2g2a inhibits organoid growth, we investigated the histo-
pathology of the digestive tract of Tg-Pla2g2a mice. Notably,
immunohistochemical (IHC) analysis revealed an almost com-
plete absence of lysozyme-positive Paneth cells in the trans-
genic mice (Figure 1C). In addition, the proliferating (Ki67+)
compartment, normally limited to the transient amplifying (TA)
progenitors in control C57BL/6Jmice, was extended to the lower
crypt of Tg-Pla2g2a mice, where post-mitotic Paneth cells are
usually located (Figure 1D). However, granulated Paneth-like
cells were present in the crypt bottom of transgenic animals (Fig-
ure S2A). qRT-PCR (Figure 1E) and IHC (Figure S2B) analysis of
additional lineage-specific markers confirmed the absence of
mature Paneth cells in the Tg-Pla2g2a model. Furthermore,
IHC (Figures S3A and S3B) and fluorescence-activated cell sort-
ing (FACS) (Figures S3C and S3D) analyses of lineage-specific
markers confirmed the accumulation of the Lgr5+/ChgA+ (chro-
mogranin A) secretory (Paneth and goblet cells) precursor line-
age (Buczacki et al., 2013) in transgenic animals. Notably, the
overall FACS pattern obtained from C57BL/6J and Tg-Pla2g2a
mice did not differ with the CD24/SSC marker combination
(data not shown). Thus, the results point to a reduction in fully
mature Paneth cells rather than the complete ablation of this line-
age in the transgenic mice, possibly due to a maturation defect.
Overall, Pla2g2amaymodulate ISC function by inhibiting Paneth
cell differentiation and full maturation.
Intracellular Pla2g2a Inhibits Wnt Signaling by
Increasing Yap1 Phosphorylation
The above experiments were carried out under homeostatic
conditions, i.e., in mice kept under normal conditions and fed
ad libitum. As Pla2g2a encodes the sPLA2-IIA protein whose
expression and secretion are highly enhanced during inflamma-
tion but are thought to be kept at a basal level during homeosta-
sis, we investigated whether the observed inhibitory effects on
intestinal organoid growth are exerted by the intracellular pool
or by the basal secreted fraction of sPLA2-IIA. The organoid
assay was repeated on crypts from FVB (Pla2g2a+/+), C57BL/
6J (Pla2g2a/), and Tg-Pla2g2amice in the presence of the sol-
uble (non-membrane-bound) sPLA2-IIA receptor Pla2r1 to scav-
enge any secreted Pla2g2a protein (Rouault et al., 2007). The
lack of effect on organoid multiplicity (Figure S3E) indicated
that the inhibitory effect exerted by Pla2g2a is likely due to its
intracellular (non-secreted) fraction.
The canonical Wnt signaling plays a role in both ISC mainte-
nance and in Paneth cell maturation (van Es et al., 2005a). As
such, it may underlie the organoid formation and Paneth cell
maturation defects observed in Pla2g2a-expressing transgenic
mice. Therefore, we analyzed the effects of PLA2G2A expres-
sion on Wnt signaling in human colon cancer cell lines with
constitutive pathway activity due to mutations in the APC or
b-catenin genes. Transient expression of PLA2G2A caused sig-
nificant downregulation of Wnt signaling activity in all three lines
(Figure 2A).
To elucidate the mechanisms underlying Pla2g2a-driven inhi-
bition of Wnt signaling, we analyzed previously published intes-
tinal expression profiling studies comparing Tg-Pla2g2a mice to
C57BL/6J controls (Fijneman et al., 2008, 2009) and found upre-
gulation of Yap1 (yes-associated protein 1) in intestinal cells from
Tg-Pla2g2amice (2.63-fold; p value 0.0072). Although Yap1 has
oncogenic and growth-stimulating capacities, it also has unex-
pected growth-suppressive functions; while nuclear Yap1 pro-
motes growth, its phosphorylation by Hippo kinases prevents
nuclear translocation and restricts Wnt signaling (Azzolin et al.,
2014; Barry et al., 2013; Camargo et al., 2007). We FACS purified
Paneth cells from Lgr5–EGFP–ires–CreERT2 reporter mice
(Barker et al., 2007) on Tg-Pla2g2a and C57BL/6J backgrounds,
as previously described (Roth et al., 2012). Yap1 was specifically
upregulated in Paneth cells from Tg-Pla2g2a mice (Figure 2B),
reflecting the Paneth-specific Pla2g2a expression pattern in
those animals (Figure S1B). In contrast, Pla2g2a expression
levels did not differ between Lgr5+ stem cells from control and
transgenic animals. Moreover, Yap1 was expressed at higher
levels in Paneth cells from FVB/N (Pla2g2a+/+) mice (Figure 2B).
This was confirmed by IHC and IF analysis: whereas in wild-
type (C57BL/6J) crypts only the slender Lgr5+ stem cells stain
positive for Yap1, clear Yap1 cytoplasmic staining was observed
in the (immature) Paneth cells from Tg-Pla2g2amice (Figures 2C
and S4C). FACS analysis of wild-type (C57BL/6J) and Tg-
Pla2g2a mice confirmed increased YAP1 phosphorylation in
Paneth cells from the transgenic animals (Figures S4A and
S4B), consistent with decreased organoid formation in these
mice.
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The intestinal stem cell niche provides cues that
actively maintain gut homeostasis. Dysregulation of
these cues may compromise intestinal regeneration
upon tissue insult and/or promote tumor growth.
Here, we identify secreted phospholipases A2
(sPLA2s) as stem cell niche factors with context-
dependent functions in the digestive tract. We
show that group IIA sPLA2, a known genetic modifier
of mouse intestinal tumorigenesis, is expressed by
Paneth cells in the small intestine, while group X
sPLA2 is expressed by Paneth/goblet-like cells in
the colon. During homeostasis, group IIA/X sPLA2s
inhibit Wnt signaling through intracellular activation
of Yap1. However, upon inflammation they are
secreted into the intestinal lumen, where they pro-
mote prostaglandin synthesis and Wnt signaling.
Genetic ablation of both sPLA2s improves recovery
from inflammation but increases colon cancer
susceptibility due to release of their homeostatic
Wnt-inhibitory role. This ‘‘trade-off’’ effect suggests
sPLA2s have important functions as genetic modi-
fiers of inflammation and colon cancer.
INTRODUCTION
In 1993, by taking advantage of an inbred mouse model predis-
posed to multiple intestinal neoplasia (Min), Dove and colla-
borators identified theMom-1 (modifier of Min) locus as a major
modifier of intestinal tumor multiplicity driven by mutations in the
Apc (adenomatous polyposis coli) tumor suppressor gene (Die-
trich et al., 1993). Subsequently, Pla2g2a, encoding the secreted
type IIA phospholipase A2 (sPLA2-IIA), was identified as the
main responsible gene within the Mom-1 locus (MacPhee
et al., 1995). sPLA2-IIA and other sPLA2 members produce
biologically active lipid mediators such as lysophosphatidic
acid (LPA) and arachidonic acid (AA), the latter a substrate for
prostaglandin E2 (PGE2) biosynthesis (Lambeau and Gelb,
2008). Notably, Mom-1-susceptible strains (e.g., C57BL/6J)
carry a single nucleotide insertion in the Pla2g2a gene, resulting
in a null allele, whereas Mom-1-resistant strains (e.g., FVB/N,
BALB/c, CBA) are Pla2g2a proficient (MacPhee et al., 1995).
More definitive evidence for the identity of the Pla2g2a gene as
Mom-1 came from a transgenic mouse overexpressing Pla2g2a
in the C57BL/6J inbred genetic background that, in the presence
of the ApcMin mutation, causes a significant reduction in tumor
multiplicity, though without fully recapitulating the decrease in
tumor multiplicity observed in resistant Mom-1 strains (Cormier
et al., 1997, 2000).
Somatic inactivation of the human APC gene is a rate-limiting
and initiating event in the vast majority of sporadic colon cancer
cases (Fodde et al., 2001). Based on the above mouse studies,
PLA2G2A, i.e., the human ortholog of Mom-1/Pla2g2a, was
thought to represent a modifier of bowel cancer risk in the gen-
eral population. However, studies failed to find either somatic
or germline PLA2G2A alterations in sporadic colon tumors or
hereditary colon cancer patients, respectively (Riggins et al.,
1995; Spirio et al., 1996). This may be due to the specific expres-
sion of the PLA2G2A/Pla2g2a gene in Paneth cells, a secretory
lineage almost exclusively found in the small intestine and only
to a lesser extent in the distal colon (Cormier et al., 2000;Mounier
et al., 2008). Accordingly, Apc mutant mice mainly develop
multiple upper GI (gastrointestinal) adenomas with very infre-
quent colonic lesions. Therefore, other members of the sPLA2
multigene family may act as colon cancer genetic modifiers
in man.
The Paneth-cell-specific expression pattern of Pla2g2a is of
interest in view of the ‘‘niche’’ role played by these secretory cells
in supporting Lgr5+ intestinal stem cells (ISCs) in the intestinal
crypt (Sato et al., 2011). Moreover, both Paneth cells and their
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is required for organoid formation (Sato et al., 2011). Multiple cell
clusters formed and occasionally fused to form larger structures
(Movie S1). However, when Paneth cells from Tg-Pla2g2a mice
were employed, their interactions with the EGFP+ Lgr5+ stem
cells were significantly decreased, as was the corresponding
number of organoids (Movie S2).
The relationship between Pla2g2a and Yap1 was further
confirmed by small interfering RNA (siRNA)-mediated knock-
down in Paneth cells purified from C57BL6/J, Tg-Pla2g2a, and
Pla2g2a-proficient FVB/N animals. Yap1 is expressed at higher
levels in the FVB/N Paneth cells compared with Paneth cells
from Tg-Pla2g2a mice (Figure 2B) and, as expected, with those
from the Pla2g2a-deficient strain C57BL/6J. Accordingly,
siRNA-driven knockdown of Pla2g2a or Yap1 in Paneth cells
from Tg-Pla2g2a and FVB/N mice effectively rescued the in-
hibitory effects of Plag2g2a on organoid formation (Figure 3C).
Similarly, siRNA-driven YAP1 knockdown in human colon
cancer cells fully rescued the Wnt-inhibitory effects of transient
PLA2G2A expression (Figure 3D). Overall, these data indicate
that intracellular Pla2g2a expression inhibits Wnt signaling in
Paneth cells, through increased Yap1 expression and phosphor-
ylation, to negatively regulate the ability of ISCs to form organo-
ids. Consistently, transgenic Pla2g2a expression in the C57BL/
6J inbred genetic background blocks Paneth cell maturation,
leading to the accumulation of secretory precursors (see Graph-
ical Abstract).
Secreted Pla2g2a Enhances ISC Function upon
Inflammation
Pla2g2a expression and secretion is increased upon inflamma-
tion (Lambeau and Gelb, 2008), and its concentration is ex-
pected to increase in the intestinal lumen. To mimic and assess
the effects of secreted Pla2g2a on the ISC niche, the organoid
assays were repeated from C57BL/6J mice with recombinant
Figure 2. Pla2g2a Expression Modulates Wnt Signaling through Yap1 Phosphorylation
(A) TOP-Flash luciferase reporter analysis of Wnt signaling activity in the colon cancer cell lines SW480, HCT116, and HT29 upon transient transfection with a
PLA2G2A expression vector in the presence/absence of Wnt3a conditioned medium (n = 3, *p < 0.05).
(B) Yap1 qRT-PCR analysis in Paneth cells (CD24hiSSChi), secretory precursors (CD24medSSClo), and stem cells (Lgr5+CD24medSSClo) sorted by FACS from
C57BL/6J (Pla2g2a/) and Tg-Pla2g2a mice in the Lgr5EGFP-IRES-creERT2 (Lgr5+) background (left). CD24hiSSChi Paneth cells were also sorted from Pla2g2a+/+
(FVB/N) mice and compared with the corresponding subpopulations sorted from Pla2g2a/ (C57BL/6J) and Tg-Pla2g2a mice (right) (n = 3, **p < 0.001).
(C) Phospho-Yap1 IHC analysis of small intestinal crypts from C57BL/6J (Pla2g2a/; left panel) and Tg-Pla2g2amice (right panel). The black and white arrows
indicate an Lgr5+ stem cell (positive for Yap1) and a Paneth cell (negative for Yap1), respectively.
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We then confirmed the central role of Paneth cells and of Yap1
downstream of Pla2g2a in the regulation of the ISC niche during
homeostasis. Organoid formation was assessed by sorting and
co-incubating Lgr5+ stem cells from control (C57BL/6J;
Pla2g2a/) mice with Paneth cells from Tg-Pla2g2a mice, and
vice versa (Figure 3A). A substantial decrease in organoid
numbers was observed only when Pla2g2a-expressing Paneth
cells from transgenic mice were mixed with control Lgr5+ stem
cells (Figure 3B), demonstrating that inhibitory effects of Pla2g2a
expression on organoid formation are largely mediated by the
immature Paneth cells. Live cell time-lapse imaging of the re-as-
sociation of sorted single Lgr5+ stem cells (EGFP+; green) and
single Paneth cells from wild-type C57BL/6J mice confirmed
that physical contact between the stem cells and Paneth cells
Figure 1. Pla2g2a Expression Modulates ISC Function and Paneth Cell Differentiation
(A) Organoid assays performed with crypts from indicatedMom-1-sensitive orMom-1-resistant strains. Differences are statistically significant (p < 0.001) except
for TgPla2g2a versus CBA/J and FVB/N versus BALB/c.
(B) Organoid assays performed on C57BL/6J (Pla2g2a/) and Tg-Pla2g2a male and female mice (n = 5, *p < 0.001).
(C) Lysozyme IHC analysis of duodenal sections of C57BL/6J (Pla2g2a/) and Tg-Pla2g2a mice.
(D) Ki67 IHC analysis of small intestinal crypts (duodenum and ileum) from Pla2g2a/ (C57BL/6J) and Tg-Pla2g2a mice.
(E) Heatmap representation qRT-PCR expression analysis of Paneth- and stem-cell-specific genes from FACS-purified CD24/SSC lineages.
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is required for organoid formation (Sato et al., 2011). Multiple cell
clusters formed and occasionally fused to form larger structures
(Movie S1). However, when Paneth cells from Tg-Pla2g2a mice
were employed, their interactions with the EGFP+ Lgr5+ stem
cells were significantly decreased, as was the corresponding
number of organoids (Movie S2).
The relationship between Pla2g2a and Yap1 was further
confirmed by small interfering RNA (siRNA)-mediated knock-
down in Paneth cells purified from C57BL6/J, Tg-Pla2g2a, and
Pla2g2a-proficient FVB/N animals. Yap1 is expressed at higher
levels in the FVB/N Paneth cells compared with Paneth cells
from Tg-Pla2g2a mice (Figure 2B) and, as expected, with those
from the Pla2g2a-deficient strain C57BL/6J. Accordingly,
siRNA-driven knockdown of Pla2g2a or Yap1 in Paneth cells
from Tg-Pla2g2a and FVB/N mice effectively rescued the in-
hibitory effects of Plag2g2a on organoid formation (Figure 3C).
Similarly, siRNA-driven YAP1 knockdown in human colon
cancer cells fully rescued the Wnt-inhibitory effects of transient
PLA2G2A expression (Figure 3D). Overall, these data indicate
that intracellular Pla2g2a expression inhibits Wnt signaling in
Paneth cells, through increased Yap1 expression and phosphor-
ylation, to negatively regulate the ability of ISCs to form organo-
ids. Consistently, transgenic Pla2g2a expression in the C57BL/
6J inbred genetic background blocks Paneth cell maturation,
leading to the accumulation of secretory precursors (see Graph-
ical Abstract).
Secreted Pla2g2a Enhances ISC Function upon
Inflammation
Pla2g2a expression and secretion is increased upon inflamma-
tion (Lambeau and Gelb, 2008), and its concentration is ex-
pected to increase in the intestinal lumen. To mimic and assess
the effects of secreted Pla2g2a on the ISC niche, the organoid
assays were repeated from C57BL/6J mice with recombinant
Figure 2. Pla2g2a Expression Modulates Wnt Signaling through Yap1 Phosphorylation
(A) TOP-Flash luciferase reporter analysis of Wnt signaling activity in the colon cancer cell lines SW480, HCT116, and HT29 upon transient transfection with a
PLA2G2A expression vector in the presence/absence of Wnt3a conditioned medium (n = 3, *p < 0.05).
(B) Yap1 qRT-PCR analysis in Paneth cells (CD24hiSSChi), secretory precursors (CD24medSSClo), and stem cells (Lgr5+CD24medSSClo) sorted by FACS from
C57BL/6J (Pla2g2a/) and Tg-Pla2g2a mice in the Lgr5EGFP-IRES-creERT2 (Lgr5+) background (left). CD24hiSSChi Paneth cells were also sorted from Pla2g2a+/+
(FVB/N) mice and compared with the corresponding subpopulations sorted from Pla2g2a/ (C57BL/6J) and Tg-Pla2g2a mice (right) (n = 3, **p < 0.001).
(C) Phospho-Yap1 IHC analysis of small intestinal crypts from C57BL/6J (Pla2g2a/; left panel) and Tg-Pla2g2amice (right panel). The black and white arrows
indicate an Lgr5+ stem cell (positive for Yap1) and a Paneth cell (negative for Yap1), respectively.
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We then confirmed the central role of Paneth cells and of Yap1
downstream of Pla2g2a in the regulation of the ISC niche during
homeostasis. Organoid formation was assessed by sorting and
co-incubating Lgr5+ stem cells from control (C57BL/6J;
Pla2g2a/) mice with Paneth cells from Tg-Pla2g2a mice, and
vice versa (Figure 3A). A substantial decrease in organoid
numbers was observed only when Pla2g2a-expressing Paneth
cells from transgenic mice were mixed with control Lgr5+ stem
cells (Figure 3B), demonstrating that inhibitory effects of Pla2g2a
expression on organoid formation are largely mediated by the
immature Paneth cells. Live cell time-lapse imaging of the re-as-
sociation of sorted single Lgr5+ stem cells (EGFP+; green) and
single Paneth cells from wild-type C57BL/6J mice confirmed
that physical contact between the stem cells and Paneth cells
Figure 1. Pla2g2a Expression Modulates ISC Function and Paneth Cell Differentiation
(A) Organoid assays performed with crypts from indicatedMom-1-sensitive orMom-1-resistant strains. Differences are statistically significant (p < 0.001) except
for TgPla2g2a versus CBA/J and FVB/N versus BALB/c.
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Figure 4. Secreted Pla2g2a Enhances ISC Function through PGE2 Synthesis and Wnt Signaling upon Inflammation
(A) C57BL/6J organoid formation in the absence/presence of recombinant Pla2g2a and soluble Pla2r1 receptor (n = 5, *p < 0.001).
(B) Quantified organoid formation following DSS treatment of C57BL/6J (Pla2g2a/), Tg-Pla2g2a, and FVB/N (Pla2g2a+/+) mice, in the absence/presence of
soluble Pla2r1 (n = 3, *p < 0.001; **p < 0.05).
(C) Results of organoid assays performed on Pla2g2a/ (C57BL/6J) mice in the presence of agonists (AA, PGE2) and antagonists (NSAIDs; ketoprofen and
diclofenac), the latter in the presence of recombinant Pla2g2a (n = 5, *p < 0.001).
(D) Results of organoid assays from C57BL/6J versus Pla2r1/ mice in the absence/presence of recombinant Pla2g2a (n = 5, *p < 0.001).
(E) qRT-PCR expression analysis of Pla2r1 in sorted Lgr5+, Paneth, and p16 (Paneth-like) cells of the small (SI) and large (LI) intestine. Control qRT-PCR analyses
were performed to validate the quality and identity of the sorted stem (Lgr5), Paneth (Lyz), and p16 (Pla2g10) cells.
(F) Left panel (2–9): organoid numbers following reconstitution of Paneth cells (PCs) (2–5) or Lgr5+ stem cells (SCs) (6–9) sorted from the small intestine of Lgr5-
reporter C57BL/6J (B6) mice pretreatedwith recombinant Pla2g2a.When indicated, sorted cells were also treatedwith siRNA oligonucleotides specific for Pla2r1
andCox2, or scrambled sequences (SCR) (n = 3, *p < 0.05; **p < 0.001). (1) B6-PCs +B6-SCs (negative control; no rec. Pla2g2a), (2) B6-PCs +B6-SCs, (3) B6-PCs
[siRNA-SCR] + B6-SCs, (4) B6-PCs [siRNA-Pla2R1] + B6-SCs, (5) B6-PCs [siRNA-Cox2] + B6-SCs, (6) B6-PCs + B6-SCs, (7) B6-PCs + B6-SCs [siRNA-SCR], (8)
B6-PCs +B6-SCs [siRNA-Pla2R1], and (9) B6-PCs +B6-SCs [siRNA-Cox2]. Right panel (10–12): organoid numbers upon reconstitution of B6-PCswith B6-SCs in
(legend continued on next page)
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Pla2g2a protein added to the culture medium. A >2-fold increase
(p < 0.001) was observed in organoid formation upon addition of
recombinant sPLA2-IIA even at low concentrations (i.e., in the
nM range; Figure 4A). Repeating the experiment in the presence
of soluble Pla2r1 receptor, which sequesters the recombinant
sPLA2-IIA protein with high affinity (Rouault et al., 2007),
completely prevented these stimulatory effects (Figure 4A).
We then utilized an in vivo model of inflammation to confirm
increased Pla2g2a secretion exerts a positive effect on ISC func-
tion. Inflammation was induced in C57BL/6J (Pla2g2a/), FVB/
N (Pla2g2a+/+), and Tg-Pla2g2a mice by adding 3% dextran so-
dium sulfate (DSS) to their drinking water for a week. This results
in loose stools, fecal bleeding, infiltration of the mucosa with
granulocytes, and significant body weight loss (Wirtz et al.,
2007). The DSS treatment causes an inflammatory response
throughout the entire GI tract (pan-gastroenteritis) (Yazbeck
et al., 2011) and is therefore suited to study the role of Pla2g2a
secretion in the small intestine. Notably, the overall disease ac-
tivity index (DAI) (Cooper et al., 1993) following DSS treatment,
here employed as a general indicator of the detrimental effects
of inflammation, was moderately improved in Tg-Pla2g2a
compared to C57BL/6J mice (DAI = 5.2 and 8.1, respectively;
Table S1). The subtle nature of this effect was confirmed
by the observation that histologic parameters (i.e., CD3- and
Figure 3. Reconstitution Organoid Assays Highlight the Role of Pla2g2a in Inhibiting Wnt Signaling through Yap1
(A) Flowchart of the reconstitution organoid assay. Single-cell suspensions were obtained from small intestinal crypts isolated from C57BL/6J (Pla2g2a/) and
Tg-Pla2g2a mice previously bred with Lgr5-EGFP reporter animals (Lgr5EGFP-IRES-creERT2). Purified Lgr5+ stem cells (Lgr5+CD24medSSClo) and Paneth cells
(CD24hiSSChi) were mixed and plated in matrigel for organoid growth.
(B) Results of the reconstitution organoid assay with Paneth cells (PCs) and Lgr5+ stem cells (SCs) from C57BL/6J (B6) and Tg-Pla2g2a (Tg) mice previously bred
with Lgr5-EGFP reporter animals (Lgr5EGFP-IRES-creERT2) (n = 3, *p < 0.05; **p < 0.001).
(C) Organoid formation following reconstitution of Lgr5+stem cells (SCs) and Paneth cells (PCs) sorted from Pla2g2a/ (B6), Tg-Pla2g2a (Tg), and FVB/N (FVB)
mice. When indicated, PCs were pretreated with siRNA oligonucleotides directed against Pla2g2a, Yap1, or a ‘‘scrambled’’ (SCR) control sequence (n = 3,
*p < 0.05; **p < 0.001). (1) B6-PCs + B6-SCs, (2) Tg-PCs + Tg-SCs, (3) Tg-PCs [siRNA-Pla2g2a] + B6-SCs, (4) Tg-PCs [siRNA-Yap1] + B6-SCs, (5) Tg-PCs [siRNA-
SCR] + B6-SCs, (6) Tg-PCs, (7) B6-PCs + B6-SCs, (8) FVB-PCs + B6-SCs, (9) FVB-PCs [siRNA-Pla2g2a] + B6-SCs, (10) FVB-PCs [siRNA-Yap1] + B6-SCs, (11)
FVB-PCs [siRNA-SCR] + B6-SCs, and (12) FVB-PCs.
(D) TOP-Flash reporter analysis of Wnt signaling activity in the colon cancer cell line SW480 upon transient transfection with a PLA2G2A expression vector in the
presence/absence of siRNA-driven YAP1 downregulation (n = 3, *p < 0.05).
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Figure 4. Secreted Pla2g2a Enhances ISC Function through PGE2 Synthesis and Wnt Signaling upon Inflammation
(A) C57BL/6J organoid formation in the absence/presence of recombinant Pla2g2a and soluble Pla2r1 receptor (n = 5, *p < 0.001).
(B) Quantified organoid formation following DSS treatment of C57BL/6J (Pla2g2a/), Tg-Pla2g2a, and FVB/N (Pla2g2a+/+) mice, in the absence/presence of
soluble Pla2r1 (n = 3, *p < 0.001; **p < 0.05).
(C) Results of organoid assays performed on Pla2g2a/ (C57BL/6J) mice in the presence of agonists (AA, PGE2) and antagonists (NSAIDs; ketoprofen and
diclofenac), the latter in the presence of recombinant Pla2g2a (n = 5, *p < 0.001).
(D) Results of organoid assays from C57BL/6J versus Pla2r1/ mice in the absence/presence of recombinant Pla2g2a (n = 5, *p < 0.001).
(E) qRT-PCR expression analysis of Pla2r1 in sorted Lgr5+, Paneth, and p16 (Paneth-like) cells of the small (SI) and large (LI) intestine. Control qRT-PCR analyses
were performed to validate the quality and identity of the sorted stem (Lgr5), Paneth (Lyz), and p16 (Pla2g10) cells.
(F) Left panel (2–9): organoid numbers following reconstitution of Paneth cells (PCs) (2–5) or Lgr5+ stem cells (SCs) (6–9) sorted from the small intestine of Lgr5-
reporter C57BL/6J (B6) mice pretreatedwith recombinant Pla2g2a.When indicated, sorted cells were also treatedwith siRNA oligonucleotides specific for Pla2r1
andCox2, or scrambled sequences (SCR) (n = 3, *p < 0.05; **p < 0.001). (1) B6-PCs +B6-SCs (negative control; no rec. Pla2g2a), (2) B6-PCs +B6-SCs, (3) B6-PCs
[siRNA-SCR] + B6-SCs, (4) B6-PCs [siRNA-Pla2R1] + B6-SCs, (5) B6-PCs [siRNA-Cox2] + B6-SCs, (6) B6-PCs + B6-SCs, (7) B6-PCs + B6-SCs [siRNA-SCR], (8)
B6-PCs +B6-SCs [siRNA-Pla2R1], and (9) B6-PCs +B6-SCs [siRNA-Cox2]. Right panel (10–12): organoid numbers upon reconstitution of B6-PCswith B6-SCs in
(legend continued on next page)
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Pla2g2a protein added to the culture medium. A >2-fold increase
(p < 0.001) was observed in organoid formation upon addition of
recombinant sPLA2-IIA even at low concentrations (i.e., in the
nM range; Figure 4A). Repeating the experiment in the presence
of soluble Pla2r1 receptor, which sequesters the recombinant
sPLA2-IIA protein with high affinity (Rouault et al., 2007),
completely prevented these stimulatory effects (Figure 4A).
We then utilized an in vivo model of inflammation to confirm
increased Pla2g2a secretion exerts a positive effect on ISC func-
tion. Inflammation was induced in C57BL/6J (Pla2g2a/), FVB/
N (Pla2g2a+/+), and Tg-Pla2g2a mice by adding 3% dextran so-
dium sulfate (DSS) to their drinking water for a week. This results
in loose stools, fecal bleeding, infiltration of the mucosa with
granulocytes, and significant body weight loss (Wirtz et al.,
2007). The DSS treatment causes an inflammatory response
throughout the entire GI tract (pan-gastroenteritis) (Yazbeck
et al., 2011) and is therefore suited to study the role of Pla2g2a
secretion in the small intestine. Notably, the overall disease ac-
tivity index (DAI) (Cooper et al., 1993) following DSS treatment,
here employed as a general indicator of the detrimental effects
of inflammation, was moderately improved in Tg-Pla2g2a
compared to C57BL/6J mice (DAI = 5.2 and 8.1, respectively;
Table S1). The subtle nature of this effect was confirmed
by the observation that histologic parameters (i.e., CD3- and
Figure 3. Reconstitution Organoid Assays Highlight the Role of Pla2g2a in Inhibiting Wnt Signaling through Yap1
(A) Flowchart of the reconstitution organoid assay. Single-cell suspensions were obtained from small intestinal crypts isolated from C57BL/6J (Pla2g2a/) and
Tg-Pla2g2a mice previously bred with Lgr5-EGFP reporter animals (Lgr5EGFP-IRES-creERT2). Purified Lgr5+ stem cells (Lgr5+CD24medSSClo) and Paneth cells
(CD24hiSSChi) were mixed and plated in matrigel for organoid growth.
(B) Results of the reconstitution organoid assay with Paneth cells (PCs) and Lgr5+ stem cells (SCs) from C57BL/6J (B6) and Tg-Pla2g2a (Tg) mice previously bred
with Lgr5-EGFP reporter animals (Lgr5EGFP-IRES-creERT2) (n = 3, *p < 0.05; **p < 0.001).
(C) Organoid formation following reconstitution of Lgr5+stem cells (SCs) and Paneth cells (PCs) sorted from Pla2g2a/ (B6), Tg-Pla2g2a (Tg), and FVB/N (FVB)
mice. When indicated, PCs were pretreated with siRNA oligonucleotides directed against Pla2g2a, Yap1, or a ‘‘scrambled’’ (SCR) control sequence (n = 3,
*p < 0.05; **p < 0.001). (1) B6-PCs + B6-SCs, (2) Tg-PCs + Tg-SCs, (3) Tg-PCs [siRNA-Pla2g2a] + B6-SCs, (4) Tg-PCs [siRNA-Yap1] + B6-SCs, (5) Tg-PCs [siRNA-
SCR] + B6-SCs, (6) Tg-PCs, (7) B6-PCs + B6-SCs, (8) FVB-PCs + B6-SCs, (9) FVB-PCs [siRNA-Pla2g2a] + B6-SCs, (10) FVB-PCs [siRNA-Yap1] + B6-SCs, (11)
FVB-PCs [siRNA-SCR] + B6-SCs, and (12) FVB-PCs.
(D) TOP-Flash reporter analysis of Wnt signaling activity in the colon cancer cell line SW480 upon transient transfection with a PLA2G2A expression vector in the
presence/absence of siRNA-driven YAP1 downregulation (n = 3, *p < 0.05).
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C h A P t e r  3
Paneth- (Mmp7, Dll1, Dll4, Ephb3) and goblet-cell-specific
genes (Muc2, Spdef, Spink4) (Figure 5D). Notably, another mem-
ber of the sPLA2 family, namely Pla2g10 encoding the mouse
group X secreted phospholipase A2 (sPLA2-X or mGX-sPLA2),
was expressed at a significantly higher level in p16 than in the
other populations (Figure 5D). Accordingly, previous reports indi-
cated that sPLA2-X is expressed in the colon (Mounier et al.,
2008).
Pla2g10 Has Opposing Roles in Regulating Wnt
Signaling and ISC Function in the Colon during
Homeostasis and Inflammation
We then assessedwhetherPla2g10 controls stem cell function in
the colon. We performed organoid assays from colonic crypts
derived from Pla2g10/ knockout mice in the C57BL/6J back-
ground (therefore null for Pla2g2a and Pla2g10) (Shridas et al.,
2010) and Pla2g10+/+ controls. Genetic ablation of Pla2g10
significantly increased the number of colon organoids (Fig-
ure 6A). We then assessed whether the negative effect of
Figure 5. Pla2g10 Is Expressed by the Pan-
eth-like Secretory Cell Lineage in theMouse
Colon
(A) CD24/cKit/SSC FACS sorting strategy em-
ployed for colonic epithelial cells from Lgr5-EGFP
reporter animals (Lgr5EGFP-IRES-creERT2). Upper
panel, whole colon; lower panel, GFP+ (Lgr5+)
fraction. Sorting gates were defined as follows:
p11 (CD24med/cKitlo), p15 (CD24med/cKitmed), p16
(CD24hi/cKithi), and p18 (CD24med/cKithi).
(B) Organoid formation assay upon reconstitution
of 1,000 cells from the p15/16/18 gates (after
depletion of GFP-positive doublets by side
scatter) with 1,000 Lgr5+ stem cells (p11) (n = 3,
*p < 0.001).
(C) Confocal microscopy images of doublets
constituted by smaller Lgr5+ (GFP+) stem cells and
larger Lgr5-negative and c-Kit+ (red) cells found
in p16.
(D) Heatmap representation of the results of the
qRT-PCR expression analysis of sorted p16, p15,
and p11 cells for Paneth- and goblet-specific
genes.
Pla2g10 expression on colonic stem cell
proliferation resulted from Wnt signaling
inhibition, similarly to Pla2g2a in the small
intestine. Transient PLA2G10 expression
inhibited TOPflash Wnt reporter activity
in colon cancer lines with constitutive
Wnt activation (Figure 6B). Consistently,
stable PLA2G10 expression in colon can-
cer cells significantly reduced CSC multi-
plicity as shown by ‘‘megacolony’’ forma-
tion (Yeung et al., 2010) (Figure S7B).
Plag2g10 expression in p16 cells medi-
ates these inhibitory effects. Pre-treating
p16 cells (c-Kit+/CD24hi) with Pla2g10
siRNA before reconstituting them with
Lgr5+ stem cells (p11; CD24med/cKitlo)
from the colonic epithelium of Lgr5-
EGFP reporter mice effectively increased colon organoid forma-
tion (Figure 6C), confirming the results obtained with the
Pla2g10-deficient mice. Similar to the small intestine, siRNA-
mediated Yap1 downregulation rescued the capacity of p16 cells
from C57BL/6J mice to form colon organoids when recon-
stituted with Lgr5+ stem cells (Figure 6C) and suppressed the
inhibitory effect of PLA2G10 expression on Wnt in human colon
cancer cells (Figure 6D). Hence, under homeostatic conditions
Pla2g10 negatively regulates Wnt signaling and stem cell prolif-
eration in the colon via Yap1, analogous to Pla2g2a in the small
intestine.
The parallels between Pla2g2a and Pla2g10 in regulating stem
cell function extend beyond homeostasis. Addition of recombi-
nant sPLA2-X protein in organoid reconstitution assays to mimic
the effects of its secretion significantly enhanced organoid
formation (Figure 7A); this effect was negated by addition of sol-
uble Pla2r1. The catalytic mGX sPLA2 mutant H48Q also
enhanced organoid multiplicity (Figure 7A), indicating that the ef-
fects of sPLA2-X are mediated primarily via Pla2r1, which binds
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MUC1-positive cells, presence of infiltrating cells and ulcers, and
destruction of tissue architecture) did not differ between the two
genotypes (data not shown). We also confirmed a substantial
increase in Pla2g2a secretion following DSS-induced inflamma-
tion by ELISA on stool samples from Tg-Pla2g2a and C57BL/6J
mice (Figure S5A, left).
Consistently, a striking increase in organoid multiplicity was
observed upon DSS-induced inflammation from the Pla2g2a-
proficient strains (Tg-Pla2g2a and FVB/N mice) when compared
to Pla2g2a-deficient C57BL/6J mice (Figure 4B). Notably, both
Tg-Pla2g2a and FVB/N were characterized by a low organoid-
forming capacity under homeostatic conditions (Figures 1A
and 1B). The soluble Pla2r1 scavenger inhibited this increase,
confirming that Pla2g2a secretion underlies this measure of
enhanced ISC function (Figure 4B). This conclusion was
confirmed by treating organoids with the pro-inflammatory cyto-
kine interferon-gamma (IFN-g) to trigger Paneth cell degranula-
tion and release of Pla2g2a into the culture medium (Farin
et al., 2014), which significantly increased organoid multiplicity
from Tg-Pla2g2a, but not C57BL/6J, mice.
sPLA2-IIA proteins play important roles in prostaglandin syn-
thesis. sPLA2 proteins hydrolyze phospholipids to produce AA
that is converted by cyclooxygenases (Cox1 and Cox2) into
prostaglandin E2 (PGE2) (Lambeau and Gelb, 2008). Accord-
ingly, a >100-fold increase in PGE2 synthesis was observed in
intestinal organoids from C57BL/6J (Pla2g2a/) upon addition
of recombinant Pla2g2a to the culture medium (Figure S5C).
To test whether the observed positive effect exerted by
secreted Pla2g2a on ISC function is due to increased PGE2 pro-
duction, we repeated the organoid assays in the presence of
prostaglandin biosynthesis agonists (AA, PGE2) and antagonists
(NSAIDs; ketoprofen and diclofenac). Both AA and PGE2 had
positive effects on organoid multiplicity similar to recombinant
Pla2g2a, whereas either NSAID inhibited the Pla2g2a-dependent
increase in number of organoids obtained from C57BL/6J ani-
mals (Figure 4C). Additionally, changes in organoid morphology
into enterospheres, spherical structures primarily composed of
stem cells and that lack budding and branching structures (Stelz-
ner et al., 2012), were noted upon addition of Pla2g2a, AA, and
PGE2, and in organoids obtained by DSS-treated mice (Fig-
ure S5D). Conversion of organoids to enterospheres is regulated
by Wnt signaling (Mustata et al., 2013). Consistent with these re-
sults and previous reports of synergism between PGE2 and the
canonical Wnt pathway in hematopoietic stem cells (Goessling
et al., 2009) and colon carcinoma cells (Castellone et al., 2005;
Shao et al., 2005), PGE2 enhanced Wnt activity in SW480 and
HCT116 colon cancer cell lines (Figure S5E).
To elucidate how exogenous Pla2g2a triggers PGE2 biosyn-
thesis, we tested the organoid-forming capacity of Pla2g2a
receptor type 1 (Pla2r1) knockout mice in the presence/absence
of recombinant Pla2g2a. While no change in organoid number
was seen between wild-type (C57BL/6J) and Pla2r1/ mice in
the absence of exogenous Pla2g2a, the latter did not respond
to recombinant Pla2g2a (Figure 4D). Hence, Pla2r1 mediates
the positive effects of exogenous Pla2g2a on ISC function. We
then determined that within the intestine, Pla2r1 expression
was exclusively detected in Paneth cells (Figure 4E). To fun-
ctionally validate this observation, we performed organoid
reconstitution assays with Paneth cells pretreated with siRNA ol-
igonucleotides against Pla2r1. Knockdown of Pla2r1 in Paneth
cells, though not in Lgr5+ stem cells, abolished the positive effect
of recombinant Pla2g2a on organoid multiplicity (Figure 4F, left).
The cytosolic phospholipase A2 group IVa (Pla2g4a or
cPLA2a) is activated by Pla2r1 to catalyze AA biosynthesis (Lam-
beau and Gelb, 2008). The specific cPLA2a inhibitor pyrrophe-
none suppressed the increase in organoid multiplicity observed
by adding exogenous Pla2g2a (Figure 4G, left); also, organoids
grown from Pla2g4a knockout mice (Bonventre et al., 1997)
were insensitive to the stimulatory effects of exogenous Pla2g2a
(Figure 4G, right). Additional reconstitution assays with sorted
Paneth cells treated with PGE2 (Figure 4F, right) and anti-Cox2
siRNA oligonucleotides (Figure 4F, left) confirmed that prosta-
glandin biosynthesis plays a central role in mediating effects of
secreted Pla2g2a on ISC function. In sum, these results show
that secreted Pla2g2a positively regulates ISC proliferation
through the Pla2r1 receptor, which activates Pla2g4a/cPLA2a.
This triggers the release of AA, which is then converted by
Cox1/2 into PGE2 to synergistically activate the canonical Wnt
pathway.
Pla2g10 Is Expressed by the Paneth-like Secretory Cell
Lineage in the Mouse Colon
Similarly to Paneth cells in supporting Lgr5+ ISCs in the small in-
testine, we hypothesized that a secretory cell lineage with similar
niche functions may be present in the colon and could physically
associate with Lgr5+ CBCs to promote organoid formation.
A c-Kit+ subpopulation of secretory epithelial cells from the colon
was recently shown to promote organoid formation from Lgr5+
ISCs (Rothenberg et al., 2012). We performed FACS analysis
of the colonic epithelium from Lgr5-EGFP reporter mice with
CD24 and c-Kit markers and defined four distinct sorting gates
(p11, CD24med/cKitlo; p15, CD24med/cKitmed; p16, CD24hi/cKithi;
p18, CD24med/cKithi) (Figure 5A). Within these gates, Lgr5+ cells
were present either as single cells (mostly in p11) or in physical
association (as doublets or triplets) with potential niche cells.
Reconstitution organoid assays were then performed by incu-
bating colonic Lgr5+ stem cells (p11; Lgr5+/CD24med/cKitlo) with
the same number of (GFP) single cells from each of the p15,
p16, and p18 subpopulations. Lgr5+ doublets and triplets were
excluded by sorting, as previously described (Roth et al.,
2012). The p16 subpopulation (c-Kit+/CD24hi) unequivocally
promotes organoid formation compared with all other subpopu-
lations, each of which gave rise to no or very few organoids
(Figure 5B). Confocal microscopy confirmed that only the p16
subpopulation contained doublets and triplets of smaller Lgr5+
stem cells and larger Lgr5-negative cells (these clusters
were subsequently excluded during sorting; Figures 5C
and S6). Sorted p16 cells expressed a mixed signature of
the presence of 1 mM PGE2 for 30 min. (10) Both B6-SCs and B6-PCs pretreated with PGE2, (11) only PCs pretreated with PGE2, and (12) only PCs pretreated
with PGE2.
(G) Organoid assays from C57BL/6J (Pla2g2a/) mice in the presence/absence of pyrrophenone (PP) and recombinant Pla2g2a (left panel), and from C57BL/6J
versus Pla2g4a/ in the absence/presence of recombinant Pla2g2a (right panel) (n = 5, *p < 0.001).
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Paneth- (Mmp7, Dll1, Dll4, Ephb3) and goblet-cell-specific
genes (Muc2, Spdef, Spink4) (Figure 5D). Notably, another mem-
ber of the sPLA2 family, namely Pla2g10 encoding the mouse
group X secreted phospholipase A2 (sPLA2-X or mGX-sPLA2),
was expressed at a significantly higher level in p16 than in the
other populations (Figure 5D). Accordingly, previous reports indi-
cated that sPLA2-X is expressed in the colon (Mounier et al.,
2008).
Pla2g10 Has Opposing Roles in Regulating Wnt
Signaling and ISC Function in the Colon during
Homeostasis and Inflammation
We then assessedwhetherPla2g10 controls stem cell function in
the colon. We performed organoid assays from colonic crypts
derived from Pla2g10/ knockout mice in the C57BL/6J back-
ground (therefore null for Pla2g2a and Pla2g10) (Shridas et al.,
2010) and Pla2g10+/+ controls. Genetic ablation of Pla2g10
significantly increased the number of colon organoids (Fig-
ure 6A). We then assessed whether the negative effect of
Figure 5. Pla2g10 Is Expressed by the Pan-
eth-like Secretory Cell Lineage in theMouse
Colon
(A) CD24/cKit/SSC FACS sorting strategy em-
ployed for colonic epithelial cells from Lgr5-EGFP
reporter animals (Lgr5EGFP-IRES-creERT2). Upper
panel, whole colon; lower panel, GFP+ (Lgr5+)
fraction. Sorting gates were defined as follows:
p11 (CD24med/cKitlo), p15 (CD24med/cKitmed), p16
(CD24hi/cKithi), and p18 (CD24med/cKithi).
(B) Organoid formation assay upon reconstitution
of 1,000 cells from the p15/16/18 gates (after
depletion of GFP-positive doublets by side
scatter) with 1,000 Lgr5+ stem cells (p11) (n = 3,
*p < 0.001).
(C) Confocal microscopy images of doublets
constituted by smaller Lgr5+ (GFP+) stem cells and
larger Lgr5-negative and c-Kit+ (red) cells found
in p16.
(D) Heatmap representation of the results of the
qRT-PCR expression analysis of sorted p16, p15,
and p11 cells for Paneth- and goblet-specific
genes.
Pla2g10 expression on colonic stem cell
proliferation resulted from Wnt signaling
inhibition, similarly to Pla2g2a in the small
intestine. Transient PLA2G10 expression
inhibited TOPflash Wnt reporter activity
in colon cancer lines with constitutive
Wnt activation (Figure 6B). Consistently,
stable PLA2G10 expression in colon can-
cer cells significantly reduced CSC multi-
plicity as shown by ‘‘megacolony’’ forma-
tion (Yeung et al., 2010) (Figure S7B).
Plag2g10 expression in p16 cells medi-
ates these inhibitory effects. Pre-treating
p16 cells (c-Kit+/CD24hi) with Pla2g10
siRNA before reconstituting them with
Lgr5+ stem cells (p11; CD24med/cKitlo)
from the colonic epithelium of Lgr5-
EGFP reporter mice effectively increased colon organoid forma-
tion (Figure 6C), confirming the results obtained with the
Pla2g10-deficient mice. Similar to the small intestine, siRNA-
mediated Yap1 downregulation rescued the capacity of p16 cells
from C57BL/6J mice to form colon organoids when recon-
stituted with Lgr5+ stem cells (Figure 6C) and suppressed the
inhibitory effect of PLA2G10 expression on Wnt in human colon
cancer cells (Figure 6D). Hence, under homeostatic conditions
Pla2g10 negatively regulates Wnt signaling and stem cell prolif-
eration in the colon via Yap1, analogous to Pla2g2a in the small
intestine.
The parallels between Pla2g2a and Pla2g10 in regulating stem
cell function extend beyond homeostasis. Addition of recombi-
nant sPLA2-X protein in organoid reconstitution assays to mimic
the effects of its secretion significantly enhanced organoid
formation (Figure 7A); this effect was negated by addition of sol-
uble Pla2r1. The catalytic mGX sPLA2 mutant H48Q also
enhanced organoid multiplicity (Figure 7A), indicating that the ef-
fects of sPLA2-X are mediated primarily via Pla2r1, which binds
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MUC1-positive cells, presence of infiltrating cells and ulcers, and
destruction of tissue architecture) did not differ between the two
genotypes (data not shown). We also confirmed a substantial
increase in Pla2g2a secretion following DSS-induced inflamma-
tion by ELISA on stool samples from Tg-Pla2g2a and C57BL/6J
mice (Figure S5A, left).
Consistently, a striking increase in organoid multiplicity was
observed upon DSS-induced inflammation from the Pla2g2a-
proficient strains (Tg-Pla2g2a and FVB/N mice) when compared
to Pla2g2a-deficient C57BL/6J mice (Figure 4B). Notably, both
Tg-Pla2g2a and FVB/N were characterized by a low organoid-
forming capacity under homeostatic conditions (Figures 1A
and 1B). The soluble Pla2r1 scavenger inhibited this increase,
confirming that Pla2g2a secretion underlies this measure of
enhanced ISC function (Figure 4B). This conclusion was
confirmed by treating organoids with the pro-inflammatory cyto-
kine interferon-gamma (IFN-g) to trigger Paneth cell degranula-
tion and release of Pla2g2a into the culture medium (Farin
et al., 2014), which significantly increased organoid multiplicity
from Tg-Pla2g2a, but not C57BL/6J, mice.
sPLA2-IIA proteins play important roles in prostaglandin syn-
thesis. sPLA2 proteins hydrolyze phospholipids to produce AA
that is converted by cyclooxygenases (Cox1 and Cox2) into
prostaglandin E2 (PGE2) (Lambeau and Gelb, 2008). Accord-
ingly, a >100-fold increase in PGE2 synthesis was observed in
intestinal organoids from C57BL/6J (Pla2g2a/) upon addition
of recombinant Pla2g2a to the culture medium (Figure S5C).
To test whether the observed positive effect exerted by
secreted Pla2g2a on ISC function is due to increased PGE2 pro-
duction, we repeated the organoid assays in the presence of
prostaglandin biosynthesis agonists (AA, PGE2) and antagonists
(NSAIDs; ketoprofen and diclofenac). Both AA and PGE2 had
positive effects on organoid multiplicity similar to recombinant
Pla2g2a, whereas either NSAID inhibited the Pla2g2a-dependent
increase in number of organoids obtained from C57BL/6J ani-
mals (Figure 4C). Additionally, changes in organoid morphology
into enterospheres, spherical structures primarily composed of
stem cells and that lack budding and branching structures (Stelz-
ner et al., 2012), were noted upon addition of Pla2g2a, AA, and
PGE2, and in organoids obtained by DSS-treated mice (Fig-
ure S5D). Conversion of organoids to enterospheres is regulated
by Wnt signaling (Mustata et al., 2013). Consistent with these re-
sults and previous reports of synergism between PGE2 and the
canonical Wnt pathway in hematopoietic stem cells (Goessling
et al., 2009) and colon carcinoma cells (Castellone et al., 2005;
Shao et al., 2005), PGE2 enhanced Wnt activity in SW480 and
HCT116 colon cancer cell lines (Figure S5E).
To elucidate how exogenous Pla2g2a triggers PGE2 biosyn-
thesis, we tested the organoid-forming capacity of Pla2g2a
receptor type 1 (Pla2r1) knockout mice in the presence/absence
of recombinant Pla2g2a. While no change in organoid number
was seen between wild-type (C57BL/6J) and Pla2r1/ mice in
the absence of exogenous Pla2g2a, the latter did not respond
to recombinant Pla2g2a (Figure 4D). Hence, Pla2r1 mediates
the positive effects of exogenous Pla2g2a on ISC function. We
then determined that within the intestine, Pla2r1 expression
was exclusively detected in Paneth cells (Figure 4E). To fun-
ctionally validate this observation, we performed organoid
reconstitution assays with Paneth cells pretreated with siRNA ol-
igonucleotides against Pla2r1. Knockdown of Pla2r1 in Paneth
cells, though not in Lgr5+ stem cells, abolished the positive effect
of recombinant Pla2g2a on organoid multiplicity (Figure 4F, left).
The cytosolic phospholipase A2 group IVa (Pla2g4a or
cPLA2a) is activated by Pla2r1 to catalyze AA biosynthesis (Lam-
beau and Gelb, 2008). The specific cPLA2a inhibitor pyrrophe-
none suppressed the increase in organoid multiplicity observed
by adding exogenous Pla2g2a (Figure 4G, left); also, organoids
grown from Pla2g4a knockout mice (Bonventre et al., 1997)
were insensitive to the stimulatory effects of exogenous Pla2g2a
(Figure 4G, right). Additional reconstitution assays with sorted
Paneth cells treated with PGE2 (Figure 4F, right) and anti-Cox2
siRNA oligonucleotides (Figure 4F, left) confirmed that prosta-
glandin biosynthesis plays a central role in mediating effects of
secreted Pla2g2a on ISC function. In sum, these results show
that secreted Pla2g2a positively regulates ISC proliferation
through the Pla2r1 receptor, which activates Pla2g4a/cPLA2a.
This triggers the release of AA, which is then converted by
Cox1/2 into PGE2 to synergistically activate the canonical Wnt
pathway.
Pla2g10 Is Expressed by the Paneth-like Secretory Cell
Lineage in the Mouse Colon
Similarly to Paneth cells in supporting Lgr5+ ISCs in the small in-
testine, we hypothesized that a secretory cell lineage with similar
niche functions may be present in the colon and could physically
associate with Lgr5+ CBCs to promote organoid formation.
A c-Kit+ subpopulation of secretory epithelial cells from the colon
was recently shown to promote organoid formation from Lgr5+
ISCs (Rothenberg et al., 2012). We performed FACS analysis
of the colonic epithelium from Lgr5-EGFP reporter mice with
CD24 and c-Kit markers and defined four distinct sorting gates
(p11, CD24med/cKitlo; p15, CD24med/cKitmed; p16, CD24hi/cKithi;
p18, CD24med/cKithi) (Figure 5A). Within these gates, Lgr5+ cells
were present either as single cells (mostly in p11) or in physical
association (as doublets or triplets) with potential niche cells.
Reconstitution organoid assays were then performed by incu-
bating colonic Lgr5+ stem cells (p11; Lgr5+/CD24med/cKitlo) with
the same number of (GFP) single cells from each of the p15,
p16, and p18 subpopulations. Lgr5+ doublets and triplets were
excluded by sorting, as previously described (Roth et al.,
2012). The p16 subpopulation (c-Kit+/CD24hi) unequivocally
promotes organoid formation compared with all other subpopu-
lations, each of which gave rise to no or very few organoids
(Figure 5B). Confocal microscopy confirmed that only the p16
subpopulation contained doublets and triplets of smaller Lgr5+
stem cells and larger Lgr5-negative cells (these clusters
were subsequently excluded during sorting; Figures 5C
and S6). Sorted p16 cells expressed a mixed signature of
the presence of 1 mM PGE2 for 30 min. (10) Both B6-SCs and B6-PCs pretreated with PGE2, (11) only PCs pretreated with PGE2, and (12) only PCs pretreated
with PGE2.
(G) Organoid assays from C57BL/6J (Pla2g2a/) mice in the presence/absence of pyrrophenone (PP) and recombinant Pla2g2a (left panel), and from C57BL/6J
versus Pla2g4a/ in the absence/presence of recombinant Pla2g2a (right panel) (n = 5, *p < 0.001).
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increased when compared with C57BL/6J (Pla2g2a//
Pla2g10+/+) mice (Figure 7D). In the same set of experiments,
addition of the recombinant Pla2r1 soluble receptor to the cul-
ture medium reduced organoid multiplicity from C57BL/6J
mice, whereas it had, as expected, no effect on organoids
from Pla2g2a//Pla2g10/ mice (Figure 7D). This indicates
that the increase in organoid numbers observed in double
knockout (DKO) mice upon inflammation cannot be replicated
in DSS-treated Pla2g2a//Pla2g10+/+ animals by scavenging
the secreted group X PLA2 with the soluble Pla2r1 receptor.
To further investigate the role of the secreted phospholipases
in response to inflammation, we repeated the DSS treatment of
Pla2g2a//Pla2g10/ and C57BL/6J (Pla2g2a//Pla2g10+/+)
mice as described above, followed by administration of
Figure 7. Pla2g2a and Pla2g10 Are Genetic Modifiers of IBD and Colon Cancer
(A) Results of colon organoid assay of C57BL/6J (Pla2g2a//Pla2g10+/+) and Pla2g10-knockout (Pla2g2a//Pla2g10/) mice in the presence/absence
of recombinant mGX sPLA2 (both wild-type and the H48Q catalytic mutant proteins were employed), and of the recombinant (soluble) Pla2r1 receptor (n = 3,
*p < 0.001; **p < 0.05).
(B) Results of colon organoid assays performed on C57BL/6J mice in the presence of recombinant mGX sPLA2 alone or in combination with an antibody directed
against the mouse Pla2r1 receptor (Rouault et al., 2007), pyrrophenone, a specific cPLA2a inhibitor (Lambeau and Gelb, 2008), and NSAIDs (ketoprofen and
diclofenac) (n = 3, *p < 0.001).
(C) Quantification of the response to DSS-induced inflammation in mice of the four Pla2g2a/Pl2g10 genotypes as measured by percentage of weight loss
(compared with starting weight). See also Table S1 for more details.
(D) Results of colon organoid assay of C57BL/6J (Pla2g2a//Pla2g10+/+) andPla2g10-knockout (Pla2g2a//Pla2g10/) mice upon DSS-driven inflammation in
the presence/absence of the soluble Pla2r1 receptor (n = 3, *p < 0.001).
(E) Quantification of the response to DSS-induced inflammation and varespladib administration (fromday 8 onward) inmice of the four Pla2g2a/Pl2g10 genotypes
as measured by percentage of weight loss (compared with starting weight). Varespladib treatment of C57BL/6J animals prevented their recovery, and the
mice had to be euthanized at day 10. See also Table S2 for more details.
(F) Incidence of colonic tumors in Pla2g2a//Pla2g10+/+ (C57BL/6J), Pla2g2a//Pla2g10/+, and Pla2g2a//Pla2g10/ mice upon AOM-DSS treatment
(n = 10, *p < 0.001).
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sPLA2-X with high affinity in the mouse colon (Rouault et al.,
2007). As observed for Pla2g2a, PGE2-driven Wnt stimulation
contributes to this stimulatory effect, supported by the signifi-
cant increase in prostaglandin level in the culture medium of
colonic organoids from C57BL/6J mice upon addition of recom-
binant sPLA2-X (Figure S5C). As expected, this increase was
entirely suppressed by the addition of NSAIDs (ketoprofen and
diclofenac, inhibitors of cyclooxygenase activity) to the culture
medium together with the recombinant Pla2g2a (Figure S5C).
Accordingly, the positive effects on organoid formation upon
addition of recombinant Pla2g10 were inhibited by an antibody
directed against mouse Pla2r1 (Rouault et al., 2007), the two
NSAIDs, and the cPLA2a inhibitor pyrrophenone (Lambeau
and Gelb, 2008), thus confirming that the pathway through which
the secreted Pla2g10 stimulates PGE2 synthesis is analogous to
that observed for secreted Pla2g2a (Figure 7B). As it was
observed for Paneth cells in the small intestine, Pla2r1 expres-
sion was exclusively found in p16 and not in Lgr5+ stem cells
of the colon (Figure 4E). Moreover, knockdown of Pla2r1 in the
same p16 cells, though not in Lgr5+ cells, abolishes the positive
effect brought about by the recombinant Pla2g10 on organoid
multiplicity in reconstitution assays (Figure S7A). Additional
reconstitution assays performed with sorted p16 cells treated
with PGE2 and with siRNAs directed against Cox2 confirmed
the central role of the prostaglandin biosynthesis pathway in
underlining the positive effect of secreted Pla2g10 on colonic
stem cell function (Figure S7A). In vivo validation for these obser-
vations was provided by the significantly increased organoid for-
Figure 6. Pla2g10, Analogous to Pla2g2a in
the Small Intestine, Has Opposing Roles in
Regulating Wnt and ISC Function in the Co-
lon during Homeostasis and Inflammation
(A) Colon organoid assay of C57BL/6J
(Pla2g2a//Pla2g10+/+) and Pla2g10-knockout
(Pla2g2a//Pla2g10/) mice (n = 3, *p < 0.001).
(B) TOP-Flash reporter assay of Wnt activity in
colon cancer cell lines SW480 and HCT116 upon
transient transfection with a PLA2G10 expression
plasmid (n = 3, *p < 0.001).
(C) Organoid formation following reconstitution of
colonic Lgr5+ stem cells (SCs) with Pla2g10-pro-
ficient (B6) and Pla2g10- deficient (Pla2g10KO)
Paneth-like cells (p16). When indicated, p16 cells
were pretreated with siRNAs against Pla2g10,
Yap1, or a ‘‘scrambled’’ (SCR) control sequence
(n = 3, *p < 0.05; **p < 0.001). (1) B6-p16, (2) B6-
p16 + B6-SCs, (3) B6-p16 [siRNA-SCR] + B6-SCs,
(4) B6-p16 [siRNA-Pla2g10] + B6-SCs, (5) B6-p16
[siRNA-Yap1] + B6-SCs, (6) Pla2g10KO-p16, (7)
Pla2g10KO-p16 + B6-SCs, (8) Pla2g10KO-p16
[siRNA-SCR] + B6-SCs, (9) Pla2g10KO-p16
[siRNA-Pla2g10] + B6-SCs, and (10) Pla2g10KO-
p16 [siRNA-Yap1] + B6-SCs.
(D) TOP-Flash Wnt reporter assay in the colon
cancer cell line SW480 upon transient transfection
with a PLA2G10-expression plasmid and siRNA-
driven YAP1 downregulation (n = 3, *p < 0.05).
mation capacity upon DSS treatment of
Pla2g10 knockout mice when compared
with C57BL/6J (Pla2g10+/+) (Figure 7D).
Accordingly, Pla2g10 is secreted upon inflammation, as shown
by TR-FIAs analysis of stool samples from DSS-treated
C57BL/6J mice (Eerola et al., 2006) (Figure S5A, right).
Overall, these results confirm that the previously shown oppo-
site roles of Pla2g2a as intracellular and secreted stem cell niche
factor in Paneth cells of the small intestine are conserved by the
Pla2g10 gene in p16 (Paneth-like) secretory cells of the colon.
Pla2g2a and Pla2g10 Are Genetic Modifiers of IBD and
Colon Cancer: The ‘‘Trade-Off’’ Effect
In view of the C57BL/6J (Pla2g2a/) inbred background of the
Pla2g10/mice, a more thorough genetic analysis was needed
to address the distinct roles of the two phospholipases as mod-
ifiers of intestinal bowel inflammation and colon cancer. To this
aim, we first administered 3% DSS in the drinking water for
a week to mice of all four Pla2 genotypes (Pla2g2a//
Pla2g10+/+ [C57BL/6J], Tg-Pla2g2a/Pla2g10+/+ [Tg-Pla2g2a],
Tg-Pla2g2a/Pla2g10/, and Pla2g2a//Pla2g10/). The DAI
(Table S1) (Cooper et al., 1993) and in particular the loss of
weight (Figure 7C) show that genetic ablation ofPla2g10 resulted
in an improved response to the DSS-induced colitis both in the
presence or absence of a functional Pla2g2a allele. As also
observed in the small intestine, immune-histopathologic param-
eters in the colon (number of colonic ulcers, presence of inflam-
matory cells) did not show any major difference among the four
genotypes (data not shown).
Supporting these data, the organoid formation capacity upon
DSS treatment of Pla2g2a//Pla2g10/mice was significantly
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increased when compared with C57BL/6J (Pla2g2a//
Pla2g10+/+) mice (Figure 7D). In the same set of experiments,
addition of the recombinant Pla2r1 soluble receptor to the cul-
ture medium reduced organoid multiplicity from C57BL/6J
mice, whereas it had, as expected, no effect on organoids
from Pla2g2a//Pla2g10/ mice (Figure 7D). This indicates
that the increase in organoid numbers observed in double
knockout (DKO) mice upon inflammation cannot be replicated
in DSS-treated Pla2g2a//Pla2g10+/+ animals by scavenging
the secreted group X PLA2 with the soluble Pla2r1 receptor.
To further investigate the role of the secreted phospholipases
in response to inflammation, we repeated the DSS treatment of
Pla2g2a//Pla2g10/ and C57BL/6J (Pla2g2a//Pla2g10+/+)
mice as described above, followed by administration of
Figure 7. Pla2g2a and Pla2g10 Are Genetic Modifiers of IBD and Colon Cancer
(A) Results of colon organoid assay of C57BL/6J (Pla2g2a//Pla2g10+/+) and Pla2g10-knockout (Pla2g2a//Pla2g10/) mice in the presence/absence
of recombinant mGX sPLA2 (both wild-type and the H48Q catalytic mutant proteins were employed), and of the recombinant (soluble) Pla2r1 receptor (n = 3,
*p < 0.001; **p < 0.05).
(B) Results of colon organoid assays performed on C57BL/6J mice in the presence of recombinant mGX sPLA2 alone or in combination with an antibody directed
against the mouse Pla2r1 receptor (Rouault et al., 2007), pyrrophenone, a specific cPLA2a inhibitor (Lambeau and Gelb, 2008), and NSAIDs (ketoprofen and
diclofenac) (n = 3, *p < 0.001).
(C) Quantification of the response to DSS-induced inflammation in mice of the four Pla2g2a/Pl2g10 genotypes as measured by percentage of weight loss
(compared with starting weight). See also Table S1 for more details.
(D) Results of colon organoid assay of C57BL/6J (Pla2g2a//Pla2g10+/+) andPla2g10-knockout (Pla2g2a//Pla2g10/) mice upon DSS-driven inflammation in
the presence/absence of the soluble Pla2r1 receptor (n = 3, *p < 0.001).
(E) Quantification of the response to DSS-induced inflammation and varespladib administration (fromday 8 onward) inmice of the four Pla2g2a/Pl2g10 genotypes
as measured by percentage of weight loss (compared with starting weight). Varespladib treatment of C57BL/6J animals prevented their recovery, and the
mice had to be euthanized at day 10. See also Table S2 for more details.
(F) Incidence of colonic tumors in Pla2g2a//Pla2g10+/+ (C57BL/6J), Pla2g2a//Pla2g10/+, and Pla2g2a//Pla2g10/ mice upon AOM-DSS treatment
(n = 10, *p < 0.001).
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sPLA2-X with high affinity in the mouse colon (Rouault et al.,
2007). As observed for Pla2g2a, PGE2-driven Wnt stimulation
contributes to this stimulatory effect, supported by the signifi-
cant increase in prostaglandin level in the culture medium of
colonic organoids from C57BL/6J mice upon addition of recom-
binant sPLA2-X (Figure S5C). As expected, this increase was
entirely suppressed by the addition of NSAIDs (ketoprofen and
diclofenac, inhibitors of cyclooxygenase activity) to the culture
medium together with the recombinant Pla2g2a (Figure S5C).
Accordingly, the positive effects on organoid formation upon
addition of recombinant Pla2g10 were inhibited by an antibody
directed against mouse Pla2r1 (Rouault et al., 2007), the two
NSAIDs, and the cPLA2a inhibitor pyrrophenone (Lambeau
and Gelb, 2008), thus confirming that the pathway through which
the secreted Pla2g10 stimulates PGE2 synthesis is analogous to
that observed for secreted Pla2g2a (Figure 7B). As it was
observed for Paneth cells in the small intestine, Pla2r1 expres-
sion was exclusively found in p16 and not in Lgr5+ stem cells
of the colon (Figure 4E). Moreover, knockdown of Pla2r1 in the
same p16 cells, though not in Lgr5+ cells, abolishes the positive
effect brought about by the recombinant Pla2g10 on organoid
multiplicity in reconstitution assays (Figure S7A). Additional
reconstitution assays performed with sorted p16 cells treated
with PGE2 and with siRNAs directed against Cox2 confirmed
the central role of the prostaglandin biosynthesis pathway in
underlining the positive effect of secreted Pla2g10 on colonic
stem cell function (Figure S7A). In vivo validation for these obser-
vations was provided by the significantly increased organoid for-
Figure 6. Pla2g10, Analogous to Pla2g2a in
the Small Intestine, Has Opposing Roles in
Regulating Wnt and ISC Function in the Co-
lon during Homeostasis and Inflammation
(A) Colon organoid assay of C57BL/6J
(Pla2g2a//Pla2g10+/+) and Pla2g10-knockout
(Pla2g2a//Pla2g10/) mice (n = 3, *p < 0.001).
(B) TOP-Flash reporter assay of Wnt activity in
colon cancer cell lines SW480 and HCT116 upon
transient transfection with a PLA2G10 expression
plasmid (n = 3, *p < 0.001).
(C) Organoid formation following reconstitution of
colonic Lgr5+ stem cells (SCs) with Pla2g10-pro-
ficient (B6) and Pla2g10- deficient (Pla2g10KO)
Paneth-like cells (p16). When indicated, p16 cells
were pretreated with siRNAs against Pla2g10,
Yap1, or a ‘‘scrambled’’ (SCR) control sequence
(n = 3, *p < 0.05; **p < 0.001). (1) B6-p16, (2) B6-
p16 + B6-SCs, (3) B6-p16 [siRNA-SCR] + B6-SCs,
(4) B6-p16 [siRNA-Pla2g10] + B6-SCs, (5) B6-p16
[siRNA-Yap1] + B6-SCs, (6) Pla2g10KO-p16, (7)
Pla2g10KO-p16 + B6-SCs, (8) Pla2g10KO-p16
[siRNA-SCR] + B6-SCs, (9) Pla2g10KO-p16
[siRNA-Pla2g10] + B6-SCs, and (10) Pla2g10KO-
p16 [siRNA-Yap1] + B6-SCs.
(D) TOP-Flash Wnt reporter assay in the colon
cancer cell line SW480 upon transient transfection
with a PLA2G10-expression plasmid and siRNA-
driven YAP1 downregulation (n = 3, *p < 0.05).
mation capacity upon DSS treatment of
Pla2g10 knockout mice when compared
with C57BL/6J (Pla2g10+/+) (Figure 7D).
Accordingly, Pla2g10 is secreted upon inflammation, as shown
by TR-FIAs analysis of stool samples from DSS-treated
C57BL/6J mice (Eerola et al., 2006) (Figure S5A, right).
Overall, these results confirm that the previously shown oppo-
site roles of Pla2g2a as intracellular and secreted stem cell niche
factor in Paneth cells of the small intestine are conserved by the
Pla2g10 gene in p16 (Paneth-like) secretory cells of the colon.
Pla2g2a and Pla2g10 Are Genetic Modifiers of IBD and
Colon Cancer: The ‘‘Trade-Off’’ Effect
In view of the C57BL/6J (Pla2g2a/) inbred background of the
Pla2g10/mice, a more thorough genetic analysis was needed
to address the distinct roles of the two phospholipases as mod-
ifiers of intestinal bowel inflammation and colon cancer. To this
aim, we first administered 3% DSS in the drinking water for
a week to mice of all four Pla2 genotypes (Pla2g2a//
Pla2g10+/+ [C57BL/6J], Tg-Pla2g2a/Pla2g10+/+ [Tg-Pla2g2a],
Tg-Pla2g2a/Pla2g10/, and Pla2g2a//Pla2g10/). The DAI
(Table S1) (Cooper et al., 1993) and in particular the loss of
weight (Figure 7C) show that genetic ablation ofPla2g10 resulted
in an improved response to the DSS-induced colitis both in the
presence or absence of a functional Pla2g2a allele. As also
observed in the small intestine, immune-histopathologic param-
eters in the colon (number of colonic ulcers, presence of inflam-
matory cells) did not show any major difference among the four
genotypes (data not shown).
Supporting these data, the organoid formation capacity upon
DSS treatment of Pla2g2a//Pla2g10/mice was significantly
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health status of these animals (Figure 7E; Table S2). Hence,
scavenging of group X sPLA2 (in the absence of sPLA2-IIA) fails
to reproduce the improved response to the inflammatory insult
observed in DKO mice. This suggests that the underlying cause
of the protective effect to the detrimental effects of DSS
observed in DKO mice may reside in the functional role that
both phospholipases play in the ISC niche during homeostasis
when they exert a regulatory function on niche cells by inhibit-
ing Wnt. Genetic ablation of Pla2g10 and Pla2g2a relieves this
intracellular inhibitory effect, thus enhancing Wnt and positively
affecting ISC function and tissue regeneration. Accordingly, the
expression of known Wnt targets in sorted p16 (Paneth-like)
and total colon cells from mice of all four genotypes was as-
sayed. As shown in Figure S7C, during homeostasis specific
Wnt targets (i.e., Axin2, Jun, Klf4, Efnb2, Sox9) are upregulated
in Paneth-like cells of the colon in a gradient from Pla2g10/
Pla2g2a-proficient mice to the DKO animals. This effect was
not seen when whole crypts were analyzed (Figure S7C). The
observed increase in Wnt activity upon genetic ablation of
both genes is also reflected by the highest organoid formation
efficiency obtained from the colon of DKO mice both in homeo-
stasis (Figure 6A) and upon inflammation (Figure 7D). These
data support the upregulation of Wnt signaling in niche cells
of the colon upon Pla2g10 and Pla2g2a genetic ablation and
provide a plausible explanation for their improved response to
acute inflammation.
Among the Wnt targets found to be upregulated in colonic
Paneth-like cells of DKO mice, Sox9 is noteworthy as it encodes
for an established transcription factor in Paneth cell differentia-
tion (Bastide et al., 2007; Mori-Akiyama et al., 2007). Moreover,
Sox9 expression was also associated with the appearance of
ectopic Paneth cells in the colon upon inducible Apc loss and
constitutive Wnt activation (Feng et al., 2013). Hence, SOX9
upregulation is likely to underlie Paneth cell metaplasia in IBD pa-
tients with improved response to the inflammatory insult (Pater-
son and Watson, 1961). Increased Wnt signaling in colonic p16
cells triggers Sox9 upregulation and the consequent maturation
toward the Paneth cell lineage. Metaplastic Paneth cells provide
additional niche support and thereby improve the regenerative
response to inflammation.
Whereas the observed Wnt activation, elicited by the genetic
ablation of both Pla2g2a and Pla2g10, can explain the improved
regenerative response to the detrimental effects of inflammation,
it is also likely to enhance susceptibility to colon cancer. Indeed,
Pla2g2a//Pla2g10/mice revealed a striking multifocal colon
cancer phenotype upon AOM/DSS treatment. To assess
whether the increased colon cancer susceptibility of the DKO
mice was dependent on inflammation, we bred them with
Apc1638N/+, a model characterized by a mild upper GI tumor
phenotype but no colon tumors (Fodde et al., 1994). Notwith-
standing the limited number of animals here analyzed
(Apc1638N/+/Pla2g2a//Pla2g10/+, n = 5, 28 weeks old;
Apc1638N/+/Pla2g2a//Pla2g10/, n = 3, 22 weeks old;
Apc1638N/+/Pla2g2a//Pla2g10+/+, n = 3, 28 weeks old), hetero-
and homozygous Pla2g10mutant mice were shown to develop a
significantly increased multiplicity of aberrant crypt foci (average
per mouse was 1.8 and 4.0, respectively, versus 0.7 in controls)
and tumors (average per mouse was 1.6 and 3.7, respectively,
versus 0 in controls) in the colon. Hence, the predisposition to
colon cancer conferred by Pla2g10 seems to be independent
of inflammation.
Overall, although hypomorphic alleles at the PLA2G2A and
PLA2G10 genes and at other loci encoding for members of the
same biochemical pathways may protect the individual from
the detrimental effects of inflammation of the bowel, the trade-
off of this initial beneficial effect may lie in an increased suscep-
tibility to colon cancer. In the near future, it would be of interest to
establish whether Paneth cell metaplasia in IBD patients is
associated with improved response to inflammation in com-
bination with increased cancer risk. In conclusion, the observed
‘‘yin-yang’’ mode of action of two sPLA2s in intestinal homeosta-
sis and inflammation can have profound consequences for an
individual’s response and susceptibility to inflammation and to
both sporadic (i.e., non-inflammatory) and IBD-related colon
cancer. Finally, in view of the abundance of sPLA2s in several
mammalian tissues, it will be of interest to assess whether their
newly identified role as key ISC niche factors in health and dis-
ease holds true for a broader spectrum of organs.
EXPERIMENTAL PROCEDURES
Organoid Assays
To form organoids ex vivo, two distinct sources of cells were employed,
namely whole crypts and single-cell suspensions from small intestine or colon.
Whole crypt cultures were performed as previously described (Sato et al.,
2009).
All organoid assays were performed in several biological replicates (i.e., with
independent animals of the same genotype and/or experimental conditions)
defined by ‘‘n,’’ whereas three technical replicates were implemented for
each biological replicate. Organoids were counted at day 5 in most of the
experiments unless stated otherwise.
AOM/DSS-Induced Colon Carcinogenesis
To induce colon cancer in the context of inflammation, a modification of the
well-established AOM/DSS protocol was employed (Neufert et al., 2007). In
short, mice were administered a single azoxymethane (AOM) injection (intra-
peritoneal; 10 mg/kg), followed by 1 week with the inflammatory agent DSS
(MP Biomedicals) in the drinking water (2.5%). Mice were then euthanized
16 weeks after AOM injection or at the first appearance of signs of discomfort.
All procedures were performed in agreement with local animal welfare laws
and guidelines.
DAI Scores and Varespladib Treatment
To establish DAI scores upon DSS-induced inflammation, we employed the
method originally described by Cooper et al. (1993), with minor modifications.
Mice were administered 3% DSS in the drinking water for a week, during which
they were monitored for a number of parameters including stool consistency,
blood loss, appearance, and percent weight loss. For the treatment with
varespladib, mice were first administered 3% DSS for 1 week, followed by
varespladib treatment at day 8 in the drinking water (60 mM). The vehicle inwhich
the varespladib isdissolved is 5%DMSO,5%ETOH, and30%PEG300 inwater.
sPLA2 Quantification
Time-resolved fluoroimmunoassays (TR-FIAs) for Pla2g2a were performed as
described previously with minor modifications (Eerola et al., 2006).
More comprehensive Experimental Procedures can be found in the Supple-
mental Experimental Procedures.
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varespladib, a non-permeable inhibitor of group IIA, V, and X
sPLA2 (Smart et al., 2006). As shown in Figure 7E and Table
S2, loss of body weight and the overall DAI scores were signifi-
cantly improved in DKO mice when compared with the C57BL/
6J controls independently of varespladib or vector administra-
tion. However, while vehicle-treated C57BL/6J animals started
recovering body weight from day 8 onward, treatment with var-
espladib prevented their recovery and led to severe deterioration
(i.e., increased loss of weight, diarrhea, gross fecal bleeding, and
lethargic state) of these mice, which had to be euthanized at day
10 (Figure 7E). Hence, group X sPLA2 inhibition in the absence of
sPLA2-IIA prevents recovery from acute inflammation, whereas
null mutations at both Pla2g2a and Pla2g10 genes improve
the overall response to the inflammatory insult, analogous to
the effect of Pla2r1 on organoid multiplicity after DSS treatment.
As presented above, several reports failed to demonstrate that
the human PLA2G2A gene represents a major modifier of colon
cancer in man (Riggins et al., 1995; Spirio et al., 1996). In view of
these reports, we asked whether the combined genetic ablation
of both Pla2g2a and Pla2g10 confers susceptibility to colon can-
cer. To this aim, we applied the well-established AOM-DSS pro-
tocol to elicit colon tumors in Pla2g2a//Pla2g10+/ and
Pla2g2a//Pla2g10/ mice when compared with C57BL/6J
(Pla2g2a//Pla2g10+/+) controls (Neufert et al., 2007; Tanaka
et al., 2003). Notably, the C57BL/6J strain has been reported
to be resistant to this protocol (Suzuki et al., 2006). Upon a single
AOM injection followed by 1 week with 3% DSS in the drinking
water, Pla2g2a//Pla2g10+/ and Pla2g2a//Pla2g10/ ani-
mals developed a significantly increased number of colonic
tumors when compared with Pla2g2a//Pla2g10+/+ littermates
(Figure 7F). Histological and IHC analysis of the colonic tumors
obtained in Pla2g10/mice revealed carcinoma in situ features
with b-catenin nuclear translocation (data not shown), as also
shown in other AOM-DSS rodent models of colon carcinogen-
esis. However, no histopathological differences were observed
between tumors found in Pla2g10/ and those arising in
Pla2g10+/ and Pla2g10+/+ mice (data not shown). Hence, the
combined deficiency of Pla2g2a and Pla2g10 increases suscep-
tibility to colon cancer in the context of DSS-induced colitis.
Hence, it appears that while complete genetic depletion of
both Pla2g2a and Pla2g10 protects against the detrimental ef-
fects of the DSS-induced intestinal inflammation, the trade-off
for this protective effect is the pronouncedly increased predispo-
sition to multifocal colon cancers.
DISCUSSION
Collectively, the data presented in our study show that the
Pla2g2a and Pla2g10 genes, encoding for the group IIA and
group X sPLA2s, play regulatory roles as stem cell niche factors
in both the small intestine (in Paneth cells) and in the large
bowel (in secretory Paneth-like cells of the colon). Notably, their
stem cell regulatory functions are context dependent: both
inhibit Wnt signaling from within the intracellular compartment
during homeostasis, thus controlling maturation and the
stem-cell-supporting function of these secretory lineages.
Upon inflammation, however, they are secreted into the intesti-
nal lumen and stimulate Wnt in autocrine fashion through PGE2
biosynthesis, thus contributing to the regenerative response
(Zhang et al., 2015) (see Graphical Abstract). It should be noted
that although Wnt has been the major object of our investiga-
tions, it is likely that other signaling pathways play important
roles downstream of the A2 phospholipases. For example,
the observed cell-cell defect (see Movie S1) is likely to result
from the decreased expression of the Notch ligands Dll1 and
Dll4 in Paneth cells from Tg-Pla2g2a mice (Figure 1E) as it
has been shown that Lgr5+ CBCs require Notch signals, which
are governed by direct cell-cell contacts (Fre et al., 2005; van
Es et al., 2005b).
Based on the above, the human PLA2G2A and PLA2G10
genes and other members of the here-identified pathways are
likely to represent important genetic modifiers of inflammatory
bowel disease (IBD) and colon cancer in man. In a recently pub-
lished GWAS association study of IBD (Liu et al., 2015), 38 risk
loci were identified, including three genes, namely PTGS2
(COX2), PLA2G4A, and PLA2R1, which are integral members
of the prostaglandin biosynthesis pathway through which
sPLA2s positively affect ISC function during inflammation. In
the context of inflammation, group IIA and X sPLA2 are secreted
into the intestinal lumen, where they promote PGE2 synthesis
through interaction with the Pla2r1 receptor, activation of
cPLA2a (Pla2g4a), and AA synthesis from membrane phospho-
lipids. AA represents the main substrate of Cox2 for production
of PGE2. As previously shown and here confirmed, prostaglandin
exerts stimulatory effects on Wnt signaling (Castellone et al.,
2005; Goessling et al., 2009; Shao et al., 2005). Accordingly,
inhibition of the prostaglandin-degrading enzyme 15-PGDH
(15-hydroxyprostaglandin dehydrogenase) increases regenera-
tive capacity in a broad spectrum of tissues, including bone
marrow and the colon (Zhang et al., 2015).
Based on the model arising from the above data, expression
of the group IIA and X secreted phospholipases is expected to
improve the overall response to inflammation, whereas null or
hypomorphic alleles at these genes are predicted to increase
susceptibility to the detrimental effects of IBD. This was in
part confirmed in the TgPla2g2a mice compared to the
Pla2g2a-deficient C57BL/6J inbred strain. In the presence of
a functional Pla2g10 gene, Pla2g2a secretion upon DSS-treat-
ment improves stem cell function and the overall response to
the deleterious effects of inflammation (Table S1). Surprisingly,
the most improved response to DSS-induced inflammation
was observed in Pla2g2a//Pla2g10/mice, i.e., in the
absence of the secreted group IIA and X phospholipases (Fig-
ure 7C; Table S1).
Two distinct results obtained here may point to a likely
explanation for this apparently contradictory observation. First,
addition of the Pla2r1 soluble receptor to the culture medium
negatively affected organoid multiplicity from DSS-treated
C57BL/6J mice (Figure 7D). This shows that the high organoid
multiplicity observed in DKO mice upon inflammation cannot be
replicated by scavenging the secreted Pla2g10 in DSS-treated
C57BL/6J (Pla2g2a//Pla2g10+/+) mice. This ex vivo result was
then confirmed in vivo by administrating varespladib, a non-
permeable inhibitor of both Pla2g2a and Pla2g10 (Smart
et al., 2006), to C57BL/6J mice after DSS administration.
Whereas vehicle-treated C57BL/6J animals started recovering
only a few days after DSS treatment, varespladib administration
prevented recovery and severely compromised the overall
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health status of these animals (Figure 7E; Table S2). Hence,
scavenging of group X sPLA2 (in the absence of sPLA2-IIA) fails
to reproduce the improved response to the inflammatory insult
observed in DKO mice. This suggests that the underlying cause
of the protective effect to the detrimental effects of DSS
observed in DKO mice may reside in the functional role that
both phospholipases play in the ISC niche during homeostasis
when they exert a regulatory function on niche cells by inhibit-
ing Wnt. Genetic ablation of Pla2g10 and Pla2g2a relieves this
intracellular inhibitory effect, thus enhancing Wnt and positively
affecting ISC function and tissue regeneration. Accordingly, the
expression of known Wnt targets in sorted p16 (Paneth-like)
and total colon cells from mice of all four genotypes was as-
sayed. As shown in Figure S7C, during homeostasis specific
Wnt targets (i.e., Axin2, Jun, Klf4, Efnb2, Sox9) are upregulated
in Paneth-like cells of the colon in a gradient from Pla2g10/
Pla2g2a-proficient mice to the DKO animals. This effect was
not seen when whole crypts were analyzed (Figure S7C). The
observed increase in Wnt activity upon genetic ablation of
both genes is also reflected by the highest organoid formation
efficiency obtained from the colon of DKO mice both in homeo-
stasis (Figure 6A) and upon inflammation (Figure 7D). These
data support the upregulation of Wnt signaling in niche cells
of the colon upon Pla2g10 and Pla2g2a genetic ablation and
provide a plausible explanation for their improved response to
acute inflammation.
Among the Wnt targets found to be upregulated in colonic
Paneth-like cells of DKO mice, Sox9 is noteworthy as it encodes
for an established transcription factor in Paneth cell differentia-
tion (Bastide et al., 2007; Mori-Akiyama et al., 2007). Moreover,
Sox9 expression was also associated with the appearance of
ectopic Paneth cells in the colon upon inducible Apc loss and
constitutive Wnt activation (Feng et al., 2013). Hence, SOX9
upregulation is likely to underlie Paneth cell metaplasia in IBD pa-
tients with improved response to the inflammatory insult (Pater-
son and Watson, 1961). Increased Wnt signaling in colonic p16
cells triggers Sox9 upregulation and the consequent maturation
toward the Paneth cell lineage. Metaplastic Paneth cells provide
additional niche support and thereby improve the regenerative
response to inflammation.
Whereas the observed Wnt activation, elicited by the genetic
ablation of both Pla2g2a and Pla2g10, can explain the improved
regenerative response to the detrimental effects of inflammation,
it is also likely to enhance susceptibility to colon cancer. Indeed,
Pla2g2a//Pla2g10/mice revealed a striking multifocal colon
cancer phenotype upon AOM/DSS treatment. To assess
whether the increased colon cancer susceptibility of the DKO
mice was dependent on inflammation, we bred them with
Apc1638N/+, a model characterized by a mild upper GI tumor
phenotype but no colon tumors (Fodde et al., 1994). Notwith-
standing the limited number of animals here analyzed
(Apc1638N/+/Pla2g2a//Pla2g10/+, n = 5, 28 weeks old;
Apc1638N/+/Pla2g2a//Pla2g10/, n = 3, 22 weeks old;
Apc1638N/+/Pla2g2a//Pla2g10+/+, n = 3, 28 weeks old), hetero-
and homozygous Pla2g10mutant mice were shown to develop a
significantly increased multiplicity of aberrant crypt foci (average
per mouse was 1.8 and 4.0, respectively, versus 0.7 in controls)
and tumors (average per mouse was 1.6 and 3.7, respectively,
versus 0 in controls) in the colon. Hence, the predisposition to
colon cancer conferred by Pla2g10 seems to be independent
of inflammation.
Overall, although hypomorphic alleles at the PLA2G2A and
PLA2G10 genes and at other loci encoding for members of the
same biochemical pathways may protect the individual from
the detrimental effects of inflammation of the bowel, the trade-
off of this initial beneficial effect may lie in an increased suscep-
tibility to colon cancer. In the near future, it would be of interest to
establish whether Paneth cell metaplasia in IBD patients is
associated with improved response to inflammation in com-
bination with increased cancer risk. In conclusion, the observed
‘‘yin-yang’’ mode of action of two sPLA2s in intestinal homeosta-
sis and inflammation can have profound consequences for an
individual’s response and susceptibility to inflammation and to
both sporadic (i.e., non-inflammatory) and IBD-related colon
cancer. Finally, in view of the abundance of sPLA2s in several
mammalian tissues, it will be of interest to assess whether their
newly identified role as key ISC niche factors in health and dis-
ease holds true for a broader spectrum of organs.
EXPERIMENTAL PROCEDURES
Organoid Assays
To form organoids ex vivo, two distinct sources of cells were employed,
namely whole crypts and single-cell suspensions from small intestine or colon.
Whole crypt cultures were performed as previously described (Sato et al.,
2009).
All organoid assays were performed in several biological replicates (i.e., with
independent animals of the same genotype and/or experimental conditions)
defined by ‘‘n,’’ whereas three technical replicates were implemented for
each biological replicate. Organoids were counted at day 5 in most of the
experiments unless stated otherwise.
AOM/DSS-Induced Colon Carcinogenesis
To induce colon cancer in the context of inflammation, a modification of the
well-established AOM/DSS protocol was employed (Neufert et al., 2007). In
short, mice were administered a single azoxymethane (AOM) injection (intra-
peritoneal; 10 mg/kg), followed by 1 week with the inflammatory agent DSS
(MP Biomedicals) in the drinking water (2.5%). Mice were then euthanized
16 weeks after AOM injection or at the first appearance of signs of discomfort.
All procedures were performed in agreement with local animal welfare laws
and guidelines.
DAI Scores and Varespladib Treatment
To establish DAI scores upon DSS-induced inflammation, we employed the
method originally described by Cooper et al. (1993), with minor modifications.
Mice were administered 3% DSS in the drinking water for a week, during which
they were monitored for a number of parameters including stool consistency,
blood loss, appearance, and percent weight loss. For the treatment with
varespladib, mice were first administered 3% DSS for 1 week, followed by
varespladib treatment at day 8 in the drinking water (60 mM). The vehicle inwhich
the varespladib isdissolved is 5%DMSO,5%ETOH, and30%PEG300 inwater.
sPLA2 Quantification
Time-resolved fluoroimmunoassays (TR-FIAs) for Pla2g2a were performed as
described previously with minor modifications (Eerola et al., 2006).
More comprehensive Experimental Procedures can be found in the Supple-
mental Experimental Procedures.
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varespladib, a non-permeable inhibitor of group IIA, V, and X
sPLA2 (Smart et al., 2006). As shown in Figure 7E and Table
S2, loss of body weight and the overall DAI scores were signifi-
cantly improved in DKO mice when compared with the C57BL/
6J controls independently of varespladib or vector administra-
tion. However, while vehicle-treated C57BL/6J animals started
recovering body weight from day 8 onward, treatment with var-
espladib prevented their recovery and led to severe deterioration
(i.e., increased loss of weight, diarrhea, gross fecal bleeding, and
lethargic state) of these mice, which had to be euthanized at day
10 (Figure 7E). Hence, group X sPLA2 inhibition in the absence of
sPLA2-IIA prevents recovery from acute inflammation, whereas
null mutations at both Pla2g2a and Pla2g10 genes improve
the overall response to the inflammatory insult, analogous to
the effect of Pla2r1 on organoid multiplicity after DSS treatment.
As presented above, several reports failed to demonstrate that
the human PLA2G2A gene represents a major modifier of colon
cancer in man (Riggins et al., 1995; Spirio et al., 1996). In view of
these reports, we asked whether the combined genetic ablation
of both Pla2g2a and Pla2g10 confers susceptibility to colon can-
cer. To this aim, we applied the well-established AOM-DSS pro-
tocol to elicit colon tumors in Pla2g2a//Pla2g10+/ and
Pla2g2a//Pla2g10/ mice when compared with C57BL/6J
(Pla2g2a//Pla2g10+/+) controls (Neufert et al., 2007; Tanaka
et al., 2003). Notably, the C57BL/6J strain has been reported
to be resistant to this protocol (Suzuki et al., 2006). Upon a single
AOM injection followed by 1 week with 3% DSS in the drinking
water, Pla2g2a//Pla2g10+/ and Pla2g2a//Pla2g10/ ani-
mals developed a significantly increased number of colonic
tumors when compared with Pla2g2a//Pla2g10+/+ littermates
(Figure 7F). Histological and IHC analysis of the colonic tumors
obtained in Pla2g10/mice revealed carcinoma in situ features
with b-catenin nuclear translocation (data not shown), as also
shown in other AOM-DSS rodent models of colon carcinogen-
esis. However, no histopathological differences were observed
between tumors found in Pla2g10/ and those arising in
Pla2g10+/ and Pla2g10+/+ mice (data not shown). Hence, the
combined deficiency of Pla2g2a and Pla2g10 increases suscep-
tibility to colon cancer in the context of DSS-induced colitis.
Hence, it appears that while complete genetic depletion of
both Pla2g2a and Pla2g10 protects against the detrimental ef-
fects of the DSS-induced intestinal inflammation, the trade-off
for this protective effect is the pronouncedly increased predispo-
sition to multifocal colon cancers.
DISCUSSION
Collectively, the data presented in our study show that the
Pla2g2a and Pla2g10 genes, encoding for the group IIA and
group X sPLA2s, play regulatory roles as stem cell niche factors
in both the small intestine (in Paneth cells) and in the large
bowel (in secretory Paneth-like cells of the colon). Notably, their
stem cell regulatory functions are context dependent: both
inhibit Wnt signaling from within the intracellular compartment
during homeostasis, thus controlling maturation and the
stem-cell-supporting function of these secretory lineages.
Upon inflammation, however, they are secreted into the intesti-
nal lumen and stimulate Wnt in autocrine fashion through PGE2
biosynthesis, thus contributing to the regenerative response
(Zhang et al., 2015) (see Graphical Abstract). It should be noted
that although Wnt has been the major object of our investiga-
tions, it is likely that other signaling pathways play important
roles downstream of the A2 phospholipases. For example,
the observed cell-cell defect (see Movie S1) is likely to result
from the decreased expression of the Notch ligands Dll1 and
Dll4 in Paneth cells from Tg-Pla2g2a mice (Figure 1E) as it
has been shown that Lgr5+ CBCs require Notch signals, which
are governed by direct cell-cell contacts (Fre et al., 2005; van
Es et al., 2005b).
Based on the above, the human PLA2G2A and PLA2G10
genes and other members of the here-identified pathways are
likely to represent important genetic modifiers of inflammatory
bowel disease (IBD) and colon cancer in man. In a recently pub-
lished GWAS association study of IBD (Liu et al., 2015), 38 risk
loci were identified, including three genes, namely PTGS2
(COX2), PLA2G4A, and PLA2R1, which are integral members
of the prostaglandin biosynthesis pathway through which
sPLA2s positively affect ISC function during inflammation. In
the context of inflammation, group IIA and X sPLA2 are secreted
into the intestinal lumen, where they promote PGE2 synthesis
through interaction with the Pla2r1 receptor, activation of
cPLA2a (Pla2g4a), and AA synthesis from membrane phospho-
lipids. AA represents the main substrate of Cox2 for production
of PGE2. As previously shown and here confirmed, prostaglandin
exerts stimulatory effects on Wnt signaling (Castellone et al.,
2005; Goessling et al., 2009; Shao et al., 2005). Accordingly,
inhibition of the prostaglandin-degrading enzyme 15-PGDH
(15-hydroxyprostaglandin dehydrogenase) increases regenera-
tive capacity in a broad spectrum of tissues, including bone
marrow and the colon (Zhang et al., 2015).
Based on the model arising from the above data, expression
of the group IIA and X secreted phospholipases is expected to
improve the overall response to inflammation, whereas null or
hypomorphic alleles at these genes are predicted to increase
susceptibility to the detrimental effects of IBD. This was in
part confirmed in the TgPla2g2a mice compared to the
Pla2g2a-deficient C57BL/6J inbred strain. In the presence of
a functional Pla2g10 gene, Pla2g2a secretion upon DSS-treat-
ment improves stem cell function and the overall response to
the deleterious effects of inflammation (Table S1). Surprisingly,
the most improved response to DSS-induced inflammation
was observed in Pla2g2a//Pla2g10/mice, i.e., in the
absence of the secreted group IIA and X phospholipases (Fig-
ure 7C; Table S1).
Two distinct results obtained here may point to a likely
explanation for this apparently contradictory observation. First,
addition of the Pla2r1 soluble receptor to the culture medium
negatively affected organoid multiplicity from DSS-treated
C57BL/6J mice (Figure 7D). This shows that the high organoid
multiplicity observed in DKO mice upon inflammation cannot be
replicated by scavenging the secreted Pla2g10 in DSS-treated
C57BL/6J (Pla2g2a//Pla2g10+/+) mice. This ex vivo result was
then confirmed in vivo by administrating varespladib, a non-
permeable inhibitor of both Pla2g2a and Pla2g10 (Smart
et al., 2006), to C57BL/6J mice after DSS administration.
Whereas vehicle-treated C57BL/6J animals started recovering
only a few days after DSS treatment, varespladib administration
prevented recovery and severely compromised the overall
48 Cell Stem Cell 19, 38–51, July 7, 2016
66
C h A P t e r  3
Neufert, C., Becker, C., and Neurath, M.F. (2007). An induciblemousemodel of
colon carcinogenesis for the analysis of sporadic and inflammation-driven
tumor progression. Nat. Protoc. 2, 1998–2004.
Paterson, J.C., and Watson, S.H. (1961). Paneth cell metaplasia in ulcerative
colitis. Am. J. Pathol. 38, 243–249.
Riggins, G.J., Markowitz, S., Wilson, J.K., Vogelstein, B., and Kinzler, K.W.
(1995). Absence of secretory phospholipase A2 gene alterations in human
colorectal cancer. Cancer Res. 55, 5184–5186.
Roth, S., Franken, P., Sacchetti, A., Kremer, A., Anderson, K., Sansom, O., and
Fodde, R. (2012). Paneth cells in intestinal homeostasis and tissue injury. PLoS
ONE 7, e38965.
Rothenberg, M.E., Nusse, Y., Kalisky, T., Lee, J.J., Dalerba, P., Scheeren, F.,
Lobo, N., Kulkarni, S., Sim, S., Qian, D., et al. (2012). Identification of a cKit(+)
colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice.
Gastroenterology 142, 1195–1205.e6.
Rouault, M., Le Calvez, C., Boilard, E., Surrel, F., Singer, A., Ghomashchi, F.,
Bezzine, S., Scarzello, S., Bollinger, J., Gelb, M.H., and Lambeau, G. (2007).
Recombinant production and properties of binding of the full set of mouse
secreted phospholipases A2 to the mouse M-type receptor. Biochemistry
46, 1647–1662.
Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange,
D.E., van Es, J.H., Abo, A., Kujala, P., Peters, P.J., and Clevers, H. (2009).
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesen-
chymal niche. Nature 459, 262–265.
Sato, T., van Es, J.H., Snippert, H.J., Stange, D.E., Vries, R.G., van den Born,
M., Barker, N., Shroyer, N.F., van de Wetering, M., and Clevers, H. (2011).
Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts.
Nature 469, 415–418.
Shao, J., Jung, C., Liu, C., and Sheng, H. (2005). Prostaglandin E2 Stimulates
the beta-catenin/T cell factor-dependent transcription in colon cancer. J. Biol.
Chem. 280, 26565–26572.
Shridas, P., Bailey, W.M., Boyanovsky, B.B., Oslund, R.C., Gelb, M.H., and
Webb, N.R. (2010). Group X secretory phospholipase A2 regulates the expres-
sion of steroidogenic acute regulatory protein (StAR) in mouse adrenal glands.
J. Biol. Chem. 285, 20031–20039.
Smart, B.P., Oslund, R.C., Walsh, L.A., and Gelb, M.H. (2006). The first potent
inhibitor of mammalian group X secreted phospholipase A2: elucidation of
sites for enhanced binding. J. Med. Chem. 49, 2858–2860.
Spirio, L.N., Kutchera, W., Winstead, M.V., Pearson, B., Kaplan, C.,
Robertson, M., Lawrence, E., Burt, R.W., Tischfield, J.A., Leppert, M.F.,
et al. (1996). Three secretory phospholipase A(2) genes that map to human
chromosome 1P35-36 are not mutated in individuals with attenuated adeno-
matous polyposis coli. Cancer Res. 56, 955–958.
Stelzner, M., Helmrath, M., Dunn, J.C., Henning, S.J., Houchen, C.W., Kuo, C.,
Lynch, J., Li, L., Magness, S.T., Martin, M.G., et al.; NIH Intestinal Stem Cell
Consortium (2012). A nomenclature for intestinal in vitro cultures. Am. J.
Physiol. Gastrointest. Liver Physiol. 302, G1359–G1363.
Suzuki, R., Kohno, H., Sugie, S., Nakagama, H., and Tanaka, T. (2006). Strain
differences in the susceptibility to azoxymethane and dextran sodium sulfate-
induced colon carcinogenesis in mice. Carcinogenesis 27, 162–169.
Tanaka, T., Kohno, H., Suzuki, R., Yamada, Y., Sugie, S., and Mori, H. (2003).
A novel inflammation-related mouse colon carcinogenesis model induced by
azoxymethane and dextran sodium sulfate. Cancer Sci. 94, 965–973.
van Es, J.H., Jay, P., Gregorieff, A., van Gijn, M.E., Jonkheer, S., Hatzis, P.,
Thiele, A., van den Born, M., Begthel, H., Brabletz, T., et al. (2005a). Wnt signal-
ling induces maturation of Paneth cells in intestinal crypts. Nat. Cell Biol. 7,
381–386.
van Es, J.H., van Gijn, M.E., Riccio, O., van den Born, M., Vooijs, M., Begthel,
H., Cozijnsen,M., Robine, S.,Winton, D.J., Radtke, F., andClevers, H. (2005b).
Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts
and adenomas into goblet cells. Nature 435, 959–963.
Wirtz, S., Neufert, C., Weigmann, B., and Neurath, M.F. (2007). Chemically
induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541–546.
Yazbeck, R., Howarth, G.S., Butler, R.N., Geier, M.S., and Abbott, C.A. (2011).
Biochemical and histological changes in the small intestine of mice with
dextran sulfate sodium colitis. J. Cell. Physiol. 226, 3219–3224.
Yeung, T.M., Gandhi, S.C., Wilding, J.L., Muschel, R., and Bodmer, W.F.
(2010). Cancer stem cells from colorectal cancer-derived cell lines. Proc.
Natl. Acad. Sci. USA 107, 3722–3727.
Zhang, Y., Desai, A., Yang, S.Y., Bae, K.B., Antczak, M.I., Fink, S.P., Tiwari, S.,
Willis, J.E., Williams, N.S., Dawson, D.M., et al. (2015). Tissue regeneration.
Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue
regeneration. Science 348, aaa2340.
Cell Stem Cell 19, 38–51, July 7, 2016 51
AUTHOR CONTRIBUTIONS
Experimental contributions were as follows: organoid assays (M. Schewe and
P.F.F.); qRT-PCR analysis (M. Schewe and R.B.); siRNA and TOP-Flash as-
says (M. Schewe); colon cancer cell line culture and transfections (M. Schewe);
immunohistochemistry (P.F.F.); FACS analysis and sorting (A.S.); western blot
analysis (M. Schmitt); mouse colony management, AOM/DSS treatments, and
phenotypic analysis (M. Schewe and R.J.); transgenic mice (R.T.C., P.M.S.,
M.G., C.P., G.L., and N.R.W.); recombinant proteins (C.P., M.G., and G.L.);
ELISA assays (L.J. and C.P.); and live imaging of organoid formation
(M.E.vR. and M. Schewe). The project was conceived by R.F. and M. Schewe
with substantial contributions from R.T.C. and G.L. The manuscript was writ-
ten by R.F. with substantial contributions fromM. Schewe, G.L., and R.T.C. All
authors contributed to the final version of the manuscript.
ACKNOWLEDGMENTS
The authors are grateful to Mr. Frank van der Panne for his help with the
artwork, and to Dr. Len Augenlicht, Dr. Hans Clevers, and Dr. Pekka Katajisto
for critical reading of the manuscript. This study wasmade possible by funding
from the Dutch Cancer Society (KWF; EMCR 2012-5473) and from the
Netherlands Institute of Regenerative Medicine (NIRM; http://www.
regeneratieve-geneeskunde.nl/) to R.F., and from CNRS and the Fondation
ARC pour la Recherche sur le Cancer to G.L.
Received: August 31, 2015
Revised: February 10, 2016
Accepted: May 19, 2016
Published: June 9, 2016
REFERENCES
Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin,
S., Frasson, C., Basso, G., Guzzardo, V., et al. (2014). YAP/TAZ incorporation
in the b-catenin destruction complex orchestrates the Wnt response. Cell 158,
157–170.
Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen,
M., Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., and Clevers, H.
(2007). Identification of stem cells in small intestine and colon by marker
gene Lgr5. Nature 449, 1003–1007.
Barry, E.R., Morikawa, T., Butler, B.L., Shrestha, K., de la Rosa, R., Yan, K.S.,
Fuchs, C.S., Magness, S.T., Smits, R., Ogino, S., et al. (2013). Restriction of in-
testinal stem cell expansion and the regenerative response by YAP. Nature
493, 106–110.
Bastide, P., Darido, C., Pannequin, J., Kist, R., Robine, S., Marty-Double, C.,
Bibeau, F., Scherer, G., Joubert, D., Hollande, F., et al. (2007). Sox9 regulates
cell proliferation and is required for Paneth cell differentiation in the intestinal
epithelium. J. Cell Biol. 178, 635–648.
Bonventre, J.V., Huang, Z., Taheri, M.R., O’Leary, E., Li, E., Moskowitz, M.A.,
and Sapirstein, A. (1997). Reduced fertility and postischaemic brain injury in
mice deficient in cytosolic phospholipase A2. Nature 390, 622–625.
Buczacki, S.J., Zecchini, H.I., Nicholson, A.M., Russell, R., Vermeulen, L.,
Kemp, R., andWinton, D.J. (2013). Intestinal label-retaining cells are secretory
precursors expressing Lgr5. Nature 495, 65–69.
Camargo, F.D., Gokhale, S., Johnnidis, J.B., Fu, D., Bell, G.W., Jaenisch, R.,
and Brummelkamp, T.R. (2007). YAP1 increases organ size and expands un-
differentiated progenitor cells. Curr. Biol. 17, 2054–2060.
Castellone, M.D., Teramoto, H., Williams, B.O., Druey, K.M., and Gutkind, J.S.
(2005). Prostaglandin E2 promotes colon cancer cell growth through a
Gs-axin-beta-catenin signaling axis. Science 310, 1504–1510.
Cooper, H.S., Murthy, S.N., Shah, R.S., and Sedergran, D.J. (1993).
Clinicopathologic study of dextran sulfate sodium experimental murine colitis.
Lab. Invest. 69, 238–249.
Cormier, R.T., Hong, K.H., Halberg, R.B., Hawkins, T.L., Richardson, P.,
Mulherkar, R., Dove, W.F., and Lander, E.S. (1997). Secretory phospholipase
Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet. 17, 88–91.
Cormier, R.T., Bilger, A., Lillich, A.J., Halberg, R.B., Hong, K.H., Gould, K.A.,
Borenstein, N., Lander, E.S., and Dove, W.F. (2000). The Mom1AKR intestinal
tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64.
Oncogene 19, 3182–3192.
Dietrich, W.F., Lander, E.S., Smith, J.S., Moser, A.R., Gould, K.A., Luongo, C.,
Borenstein, N., and Dove, W. (1993). Genetic identification of Mom-1, a major
modifier locus affectingMin-induced intestinal neoplasia in themouse. Cell 75,
631–639.
Eerola, L.I., Surrel, F., Nevalainen, T.J., Gelb, M.H., Lambeau, G., and Laine,
V.J. (2006). Analysis of expression of secreted phospholipases A2 in mouse
tissues at protein and mRNA levels. Biochim. Biophys. Acta 1761, 745–756.
Farin, H.F., Karthaus, W.R., Kujala, P., Rakhshandehroo, M., Schwank, G.,
Vries, R.G., Kalkhoven, E., Nieuwenhuis, E.E., and Clevers, H. (2014).
Paneth cell extrusion and release of antimicrobial products is directly
controlled by immune cell-derived IFN-g. J. Exp. Med. 211, 1393–1405.
Feng, Y., Sentani, K., Wiese, A., Sands, E., Green, M., Bommer, G.T., Cho,
K.R., and Fearon, E.R. (2013). Sox9 induction, ectopic Paneth cells, and
mitotic spindle axis defects in mouse colon adenomatous epithelium arising
from conditional biallelic Apc inactivation. Am. J. Pathol. 183, 493–503.
Fijneman, R.J., Peham, J.R., van deWiel, M.A., Meijer, G.A., Matise, I., Velcich,
A., and Cormier, R.T. (2008). Expression of Pla2g2a prevents carcinogenesis in
Muc2-deficient mice. Cancer Sci. 99, 2113–2119.
Fijneman, R.J., Bade, L.K., Peham, J.R., van de Wiel, M.A., van Hinsbergh,
V.W., Meijer, G.A., O’Sullivan, M.G., and Cormier, R.T. (2009). Pla2g2a
attenuates colon tumorigenesis in azoxymethane-treated C57BL/6 mice;
expression studies reveal Pla2g2a target genes and pathways. Cell. Oncol.
31, 345–356.
Fodde, R., Edelmann, W., Yang, K., van Leeuwen, C., Carlson, C., Renault, B.,
Breukel, C., Alt, E., Lipkin, M., Khan, P.M., et al. (1994). A targeted chain-termi-
nation mutation in the mouse Apc gene results in multiple intestinal tumors.
Proc. Natl. Acad. Sci. USA 91, 8969–8973.
Fodde, R., Smits, R., and Clevers, H. (2001). APC, signal transduction and
genetic instability in colorectal cancer. Nat. Rev. Cancer 1, 55–67.
Fre, S., Huyghe, M., Mourikis, P., Robine, S., Louvard, D., and Artavanis-
Tsakonas, S. (2005). Notch signals control the fate of immature progenitor cells
in the intestine. Nature 435, 964–968.
Goessling, W., North, T.E., Loewer, S., Lord, A.M., Lee, S., Stoick-Cooper,
C.L., Weidinger, G., Puder, M., Daley, G.Q., Moon, R.T., and Zon, L.I. (2009).
Genetic interaction of PGE2 andWnt signaling regulates developmental spec-
ification of stem cells and regeneration. Cell 136, 1136–1147.
Lambeau, G., and Gelb, M.H. (2008). Biochemistry and physiology of mamma-
lian secreted phospholipases A2. Annu. Rev. Biochem. 77, 495–520.
Liu, J.Z., van Sommeren, S., Huang, H., Ng, S.C., Alberts, R., Takahashi, A.,
Ripke, S., Lee, J.C., Jostins, L., Shah, T., et al.; International Multiple
Sclerosis Genetics Consortium; International IBD Genetics Consortium
(2015). Association analyses identify 38 susceptibility loci for inflammatory
bowel disease and highlight shared genetic risk across populations. Nat.
Genet. 47, 979–986.
MacPhee, M., Chepenik, K.P., Liddell, R.A., Nelson, K.K., Siracusa, L.D., and
Buchberg, A.M. (1995). The secretory phospholipase A2 gene is a candidate
for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.
Cell 81, 957–966.
Mori-Akiyama, Y., van den Born, M., van Es, J.H., Hamilton, S.R., Adams, H.P.,
Zhang, J., Clevers, H., and de Crombrugghe, B. (2007). SOX9 is required for
the differentiation of paneth cells in the intestinal epithelium.
Gastroenterology 133, 539–546.
Mounier, C.M., Wendum, D., Greenspan, E., Fle´jou, J.F., Rosenberg, D.W.,
and Lambeau, G. (2008). Distinct expression pattern of the full set of secreted
phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a
biomarker candidate. Br. J. Cancer 98, 587–595.
Mustata, R.C., Vasile, G., Fernandez-Vallone, V., Strollo, S., Lefort, A., Libert,
F., Monteyne, D., Pe´rez-Morga, D., Vassart, G., and Garcia, M.I. (2013).
Identification of Lgr5-independent spheroid-generating progenitors of the
mouse fetal intestinal epithelium. Cell Rep. 5, 421–432.
50 Cell Stem Cell 19, 38–51, July 7, 2016
67
Neufert, C., Becker, C., and Neurath, M.F. (2007). An induciblemousemodel of
colon carcinogenesis for the analysis of sporadic and inflammation-driven
tumor progression. Nat. Protoc. 2, 1998–2004.
Paterson, J.C., and Watson, S.H. (1961). Paneth cell metaplasia in ulcerative
colitis. Am. J. Pathol. 38, 243–249.
Riggins, G.J., Markowitz, S., Wilson, J.K., Vogelstein, B., and Kinzler, K.W.
(1995). Absence of secretory phospholipase A2 gene alterations in human
colorectal cancer. Cancer Res. 55, 5184–5186.
Roth, S., Franken, P., Sacchetti, A., Kremer, A., Anderson, K., Sansom, O., and
Fodde, R. (2012). Paneth cells in intestinal homeostasis and tissue injury. PLoS
ONE 7, e38965.
Rothenberg, M.E., Nusse, Y., Kalisky, T., Lee, J.J., Dalerba, P., Scheeren, F.,
Lobo, N., Kulkarni, S., Sim, S., Qian, D., et al. (2012). Identification of a cKit(+)
colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice.
Gastroenterology 142, 1195–1205.e6.
Rouault, M., Le Calvez, C., Boilard, E., Surrel, F., Singer, A., Ghomashchi, F.,
Bezzine, S., Scarzello, S., Bollinger, J., Gelb, M.H., and Lambeau, G. (2007).
Recombinant production and properties of binding of the full set of mouse
secreted phospholipases A2 to the mouse M-type receptor. Biochemistry
46, 1647–1662.
Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange,
D.E., van Es, J.H., Abo, A., Kujala, P., Peters, P.J., and Clevers, H. (2009).
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesen-
chymal niche. Nature 459, 262–265.
Sato, T., van Es, J.H., Snippert, H.J., Stange, D.E., Vries, R.G., van den Born,
M., Barker, N., Shroyer, N.F., van de Wetering, M., and Clevers, H. (2011).
Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts.
Nature 469, 415–418.
Shao, J., Jung, C., Liu, C., and Sheng, H. (2005). Prostaglandin E2 Stimulates
the beta-catenin/T cell factor-dependent transcription in colon cancer. J. Biol.
Chem. 280, 26565–26572.
Shridas, P., Bailey, W.M., Boyanovsky, B.B., Oslund, R.C., Gelb, M.H., and
Webb, N.R. (2010). Group X secretory phospholipase A2 regulates the expres-
sion of steroidogenic acute regulatory protein (StAR) in mouse adrenal glands.
J. Biol. Chem. 285, 20031–20039.
Smart, B.P., Oslund, R.C., Walsh, L.A., and Gelb, M.H. (2006). The first potent
inhibitor of mammalian group X secreted phospholipase A2: elucidation of
sites for enhanced binding. J. Med. Chem. 49, 2858–2860.
Spirio, L.N., Kutchera, W., Winstead, M.V., Pearson, B., Kaplan, C.,
Robertson, M., Lawrence, E., Burt, R.W., Tischfield, J.A., Leppert, M.F.,
et al. (1996). Three secretory phospholipase A(2) genes that map to human
chromosome 1P35-36 are not mutated in individuals with attenuated adeno-
matous polyposis coli. Cancer Res. 56, 955–958.
Stelzner, M., Helmrath, M., Dunn, J.C., Henning, S.J., Houchen, C.W., Kuo, C.,
Lynch, J., Li, L., Magness, S.T., Martin, M.G., et al.; NIH Intestinal Stem Cell
Consortium (2012). A nomenclature for intestinal in vitro cultures. Am. J.
Physiol. Gastrointest. Liver Physiol. 302, G1359–G1363.
Suzuki, R., Kohno, H., Sugie, S., Nakagama, H., and Tanaka, T. (2006). Strain
differences in the susceptibility to azoxymethane and dextran sodium sulfate-
induced colon carcinogenesis in mice. Carcinogenesis 27, 162–169.
Tanaka, T., Kohno, H., Suzuki, R., Yamada, Y., Sugie, S., and Mori, H. (2003).
A novel inflammation-related mouse colon carcinogenesis model induced by
azoxymethane and dextran sodium sulfate. Cancer Sci. 94, 965–973.
van Es, J.H., Jay, P., Gregorieff, A., van Gijn, M.E., Jonkheer, S., Hatzis, P.,
Thiele, A., van den Born, M., Begthel, H., Brabletz, T., et al. (2005a). Wnt signal-
ling induces maturation of Paneth cells in intestinal crypts. Nat. Cell Biol. 7,
381–386.
van Es, J.H., van Gijn, M.E., Riccio, O., van den Born, M., Vooijs, M., Begthel,
H., Cozijnsen,M., Robine, S.,Winton, D.J., Radtke, F., andClevers, H. (2005b).
Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts
and adenomas into goblet cells. Nature 435, 959–963.
Wirtz, S., Neufert, C., Weigmann, B., and Neurath, M.F. (2007). Chemically
induced mouse models of intestinal inflammation. Nat. Protoc. 2, 541–546.
Yazbeck, R., Howarth, G.S., Butler, R.N., Geier, M.S., and Abbott, C.A. (2011).
Biochemical and histological changes in the small intestine of mice with
dextran sulfate sodium colitis. J. Cell. Physiol. 226, 3219–3224.
Yeung, T.M., Gandhi, S.C., Wilding, J.L., Muschel, R., and Bodmer, W.F.
(2010). Cancer stem cells from colorectal cancer-derived cell lines. Proc.
Natl. Acad. Sci. USA 107, 3722–3727.
Zhang, Y., Desai, A., Yang, S.Y., Bae, K.B., Antczak, M.I., Fink, S.P., Tiwari, S.,
Willis, J.E., Williams, N.S., Dawson, D.M., et al. (2015). Tissue regeneration.
Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue
regeneration. Science 348, aaa2340.
Cell Stem Cell 19, 38–51, July 7, 2016 51
AUTHOR CONTRIBUTIONS
Experimental contributions were as follows: organoid assays (M. Schewe and
P.F.F.); qRT-PCR analysis (M. Schewe and R.B.); siRNA and TOP-Flash as-
says (M. Schewe); colon cancer cell line culture and transfections (M. Schewe);
immunohistochemistry (P.F.F.); FACS analysis and sorting (A.S.); western blot
analysis (M. Schmitt); mouse colony management, AOM/DSS treatments, and
phenotypic analysis (M. Schewe and R.J.); transgenic mice (R.T.C., P.M.S.,
M.G., C.P., G.L., and N.R.W.); recombinant proteins (C.P., M.G., and G.L.);
ELISA assays (L.J. and C.P.); and live imaging of organoid formation
(M.E.vR. and M. Schewe). The project was conceived by R.F. and M. Schewe
with substantial contributions from R.T.C. and G.L. The manuscript was writ-
ten by R.F. with substantial contributions fromM. Schewe, G.L., and R.T.C. All
authors contributed to the final version of the manuscript.
ACKNOWLEDGMENTS
The authors are grateful to Mr. Frank van der Panne for his help with the
artwork, and to Dr. Len Augenlicht, Dr. Hans Clevers, and Dr. Pekka Katajisto
for critical reading of the manuscript. This study wasmade possible by funding
from the Dutch Cancer Society (KWF; EMCR 2012-5473) and from the
Netherlands Institute of Regenerative Medicine (NIRM; http://www.
regeneratieve-geneeskunde.nl/) to R.F., and from CNRS and the Fondation
ARC pour la Recherche sur le Cancer to G.L.
Received: August 31, 2015
Revised: February 10, 2016
Accepted: May 19, 2016
Published: June 9, 2016
REFERENCES
Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin,
S., Frasson, C., Basso, G., Guzzardo, V., et al. (2014). YAP/TAZ incorporation
in the b-catenin destruction complex orchestrates the Wnt response. Cell 158,
157–170.
Barker, N., van Es, J.H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen,
M., Haegebarth, A., Korving, J., Begthel, H., Peters, P.J., and Clevers, H.
(2007). Identification of stem cells in small intestine and colon by marker
gene Lgr5. Nature 449, 1003–1007.
Barry, E.R., Morikawa, T., Butler, B.L., Shrestha, K., de la Rosa, R., Yan, K.S.,
Fuchs, C.S., Magness, S.T., Smits, R., Ogino, S., et al. (2013). Restriction of in-
testinal stem cell expansion and the regenerative response by YAP. Nature
493, 106–110.
Bastide, P., Darido, C., Pannequin, J., Kist, R., Robine, S., Marty-Double, C.,
Bibeau, F., Scherer, G., Joubert, D., Hollande, F., et al. (2007). Sox9 regulates
cell proliferation and is required for Paneth cell differentiation in the intestinal
epithelium. J. Cell Biol. 178, 635–648.
Bonventre, J.V., Huang, Z., Taheri, M.R., O’Leary, E., Li, E., Moskowitz, M.A.,
and Sapirstein, A. (1997). Reduced fertility and postischaemic brain injury in
mice deficient in cytosolic phospholipase A2. Nature 390, 622–625.
Buczacki, S.J., Zecchini, H.I., Nicholson, A.M., Russell, R., Vermeulen, L.,
Kemp, R., andWinton, D.J. (2013). Intestinal label-retaining cells are secretory
precursors expressing Lgr5. Nature 495, 65–69.
Camargo, F.D., Gokhale, S., Johnnidis, J.B., Fu, D., Bell, G.W., Jaenisch, R.,
and Brummelkamp, T.R. (2007). YAP1 increases organ size and expands un-
differentiated progenitor cells. Curr. Biol. 17, 2054–2060.
Castellone, M.D., Teramoto, H., Williams, B.O., Druey, K.M., and Gutkind, J.S.
(2005). Prostaglandin E2 promotes colon cancer cell growth through a
Gs-axin-beta-catenin signaling axis. Science 310, 1504–1510.
Cooper, H.S., Murthy, S.N., Shah, R.S., and Sedergran, D.J. (1993).
Clinicopathologic study of dextran sulfate sodium experimental murine colitis.
Lab. Invest. 69, 238–249.
Cormier, R.T., Hong, K.H., Halberg, R.B., Hawkins, T.L., Richardson, P.,
Mulherkar, R., Dove, W.F., and Lander, E.S. (1997). Secretory phospholipase
Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet. 17, 88–91.
Cormier, R.T., Bilger, A., Lillich, A.J., Halberg, R.B., Hong, K.H., Gould, K.A.,
Borenstein, N., Lander, E.S., and Dove, W.F. (2000). The Mom1AKR intestinal
tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64.
Oncogene 19, 3182–3192.
Dietrich, W.F., Lander, E.S., Smith, J.S., Moser, A.R., Gould, K.A., Luongo, C.,
Borenstein, N., and Dove, W. (1993). Genetic identification of Mom-1, a major
modifier locus affectingMin-induced intestinal neoplasia in themouse. Cell 75,
631–639.
Eerola, L.I., Surrel, F., Nevalainen, T.J., Gelb, M.H., Lambeau, G., and Laine,
V.J. (2006). Analysis of expression of secreted phospholipases A2 in mouse
tissues at protein and mRNA levels. Biochim. Biophys. Acta 1761, 745–756.
Farin, H.F., Karthaus, W.R., Kujala, P., Rakhshandehroo, M., Schwank, G.,
Vries, R.G., Kalkhoven, E., Nieuwenhuis, E.E., and Clevers, H. (2014).
Paneth cell extrusion and release of antimicrobial products is directly
controlled by immune cell-derived IFN-g. J. Exp. Med. 211, 1393–1405.
Feng, Y., Sentani, K., Wiese, A., Sands, E., Green, M., Bommer, G.T., Cho,
K.R., and Fearon, E.R. (2013). Sox9 induction, ectopic Paneth cells, and
mitotic spindle axis defects in mouse colon adenomatous epithelium arising
from conditional biallelic Apc inactivation. Am. J. Pathol. 183, 493–503.
Fijneman, R.J., Peham, J.R., van deWiel, M.A., Meijer, G.A., Matise, I., Velcich,
A., and Cormier, R.T. (2008). Expression of Pla2g2a prevents carcinogenesis in
Muc2-deficient mice. Cancer Sci. 99, 2113–2119.
Fijneman, R.J., Bade, L.K., Peham, J.R., van de Wiel, M.A., van Hinsbergh,
V.W., Meijer, G.A., O’Sullivan, M.G., and Cormier, R.T. (2009). Pla2g2a
attenuates colon tumorigenesis in azoxymethane-treated C57BL/6 mice;
expression studies reveal Pla2g2a target genes and pathways. Cell. Oncol.
31, 345–356.
Fodde, R., Edelmann, W., Yang, K., van Leeuwen, C., Carlson, C., Renault, B.,
Breukel, C., Alt, E., Lipkin, M., Khan, P.M., et al. (1994). A targeted chain-termi-
nation mutation in the mouse Apc gene results in multiple intestinal tumors.
Proc. Natl. Acad. Sci. USA 91, 8969–8973.
Fodde, R., Smits, R., and Clevers, H. (2001). APC, signal transduction and
genetic instability in colorectal cancer. Nat. Rev. Cancer 1, 55–67.
Fre, S., Huyghe, M., Mourikis, P., Robine, S., Louvard, D., and Artavanis-
Tsakonas, S. (2005). Notch signals control the fate of immature progenitor cells
in the intestine. Nature 435, 964–968.
Goessling, W., North, T.E., Loewer, S., Lord, A.M., Lee, S., Stoick-Cooper,
C.L., Weidinger, G., Puder, M., Daley, G.Q., Moon, R.T., and Zon, L.I. (2009).
Genetic interaction of PGE2 andWnt signaling regulates developmental spec-
ification of stem cells and regeneration. Cell 136, 1136–1147.
Lambeau, G., and Gelb, M.H. (2008). Biochemistry and physiology of mamma-
lian secreted phospholipases A2. Annu. Rev. Biochem. 77, 495–520.
Liu, J.Z., van Sommeren, S., Huang, H., Ng, S.C., Alberts, R., Takahashi, A.,
Ripke, S., Lee, J.C., Jostins, L., Shah, T., et al.; International Multiple
Sclerosis Genetics Consortium; International IBD Genetics Consortium
(2015). Association analyses identify 38 susceptibility loci for inflammatory
bowel disease and highlight shared genetic risk across populations. Nat.
Genet. 47, 979–986.
MacPhee, M., Chepenik, K.P., Liddell, R.A., Nelson, K.K., Siracusa, L.D., and
Buchberg, A.M. (1995). The secretory phospholipase A2 gene is a candidate
for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.
Cell 81, 957–966.
Mori-Akiyama, Y., van den Born, M., van Es, J.H., Hamilton, S.R., Adams, H.P.,
Zhang, J., Clevers, H., and de Crombrugghe, B. (2007). SOX9 is required for
the differentiation of paneth cells in the intestinal epithelium.
Gastroenterology 133, 539–546.
Mounier, C.M., Wendum, D., Greenspan, E., Fle´jou, J.F., Rosenberg, D.W.,
and Lambeau, G. (2008). Distinct expression pattern of the full set of secreted
phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a
biomarker candidate. Br. J. Cancer 98, 587–595.
Mustata, R.C., Vasile, G., Fernandez-Vallone, V., Strollo, S., Lefort, A., Libert,
F., Monteyne, D., Pe´rez-Morga, D., Vassart, G., and Garcia, M.I. (2013).
Identification of Lgr5-independent spheroid-generating progenitors of the
mouse fetal intestinal epithelium. Cell Rep. 5, 421–432.
50 Cell Stem Cell 19, 38–51, July 7, 2016

ChAPter 4
 Interplay between metabolic 
identities in the intestinal crypt 
 supports stem cell function
Nature. 543, 424-427 (2017).

4 2 4  |  N A T U R E  |  V O L  5 4 3  |  1 6  m A R c h  2 0 1 7
LETTER
doi:10.1038/nature21673
Interplay between metabolic identities in the 
intestinal crypt supports stem cell function
maria J. Rodríguez-colman1, matthias Schewe2, maaike meerlo1, Edwin Stigter1, Johan Gerrits3, mia Pras-Raves3, 
Andrea Sacchetti2, marten hornsveld1, Koen c. Oost1, hugo J. Snippert1, Nanda Verhoeven-Duif3, Riccardo Fodde2 & 
Boudewijn m.T. Burgering1
The small intestinal epithelium self-renews every four or five days. 
Intestinal stem cells (Lgr5+ crypt base columnar cells (CBCs)) 
sustain this renewal and reside between terminally differentiated 
Paneth cells at the bottom of the intestinal crypt1. Whereas the 
signalling requirements for maintaining stem cell function and 
crypt homeostasis have been well studied, little is known about how 
metabolism contributes to epithelial homeostasis. Here we show 
that freshly isolated Lgr5+ CBCs and Paneth cells from the mouse 
small intestine display different metabolic programs. Compared 
to Paneth cells, Lgr5+ CBCs display high mitochondrial activity. 
Inhibition of mitochondrial activity in Lgr5+ CBCs or inhibition 
of glycolysis in Paneth cells strongly affects stem cell function, as 
indicated by impaired organoid formation. In addition, Paneth 
cells support stem cell function by providing lactate to sustain the 
enhanced mitochondrial oxidative phosphorylation in the Lgr5+ 
CBCs. Mechanistically, we show that oxidative phosphorylation 
stimulates p38 MAPK activation by mitochondrial reactive oxygen 
species signalling, thereby establishing the mature crypt phenotype. 
Together, our results reveal a critical role for the metabolic identity 
of Lgr5+ CBCs and Paneth cells in supporting optimal stem cell 
function, and we identify mitochondria and reactive oxygen species 
signalling as a driving force of cellular differentiation.
In the small intestine, crypts of Lieberkühn encircle each intestinal 
villus. At the base of these crypts the Lgr5+ crypt base columnar stem 
cells reside and generate transit amplifying progenitors, which migrate 
upwards and differentiate into enterocytes, tuft, goblet or enteroendo-
crine cells1. Paneth cells support stem cell function of Lgr5+ CBCs by 
supplying essential factors (WNT, Delta-like 1 and epidermal growth 
factor). Cell metabolism has been implicated in stem cell maintenance 
and differentiation in some adult stem cell populations2–5. Recently, 
calorie restriction has been shown to increase Lgr5+ CBCs and Paneth 
cell numbers6, but otherwise the role of metabolism in the intestinal 
crypt homeostasis remains unknown. We analysed the metabolome 
of Lgr5+ CBCs, Paneth cells and the remaining population of cells 
(CD24−Lgr5−) isolated from the small intestine of Lgr5–GFP mice. 
Principal component analysis (PCA) of liquid chromatography– 
tandem mass spectrometry (LC-MS/MS)-based metabolomics shows 
clear clustering of the metabolic profiles based on cell identity (Fig. 1a, 
Extended Data Fig. 1a). The pyruvate/lactate ratio, a measure of the 
relative contribution to cellular bioenergetics of mitochondrial 
 respiration versus glycolysis, differed between populations,  indicating 
increased mitochondrial activity in Lgr5+ CBCs (Fig. 1b). Small 
 intestinal organoids recapitulate in vitro many aspects of the intestine, 
including crypt structure and the interaction between Paneth cells 
and stem cells (reviewed in refs 7, 8). Live imaging of mitochondria 
and mitochondrial membrane potential (MMP), indicates increased 
mitochondrial activity in Lgr5+ CBCs when compared to the  adjacent 
Paneth cells (Fig. 1c, d, Extended Data Fig. 1b, c). Additionally, 
organoids enriched with Lgr5+ CBCs9 showed a 20% increase in 
 respiration, supporting the notion that Lgr5+ CBCs display increased 
mitochondrial activity (Extended Data Fig. 1d, e). Mitochondrial-
derived reactive oxygen species (ROS) can contribute to cellular redox 
stress. Therefore, we analysed the level of mitochondrial superoxide 
and cytosolic ROS in organoids. Although mitochondrial superoxide 
is higher in Lgr5+ CBCs compared to Paneth cells, cytoplasmic ROS 
levels do not differ between Paneth cells and CBCs (Extended Data 
Fig. 1f, g), indicating that higher mitochondrial activity does not 
 necessarily result in increased redox stress in Lgr5+ CBCs.
In standard medium (ENR; containing epidermal growth factor, 
noggin, and R-spondin 1) organoids grow as mini-guts with defined 
crypt domains. However, the addition of Wnt3a-conditioned medium 
(WENR) results in spherical organoids that lack differentiated cell types 
and homogeneously proliferate10 (Fig. 2a, b). This differs from mini-gut 
organoids where proliferation is restricted to Lgr5+ CBCs and transit 
amplifying cells (Fig. 2b, Extended Data Fig. 2a). Stem cell markers Lgr5 
and Olfm4 are downregulated in spherical organoids (Fig. 2a, Extended 
1Molecular Cancer Research, Center Molecular Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584CG Utrecht, The Netherlands. 2Department of Pathology, Erasmus MC 


















































































Figure 1 | Metabolic compartmentalization in the crypt. a, Lgr5+  
CBCs, Paneth cells (PCs) and Lgr5−CD24− cells populations were 
obtained by FACS followed by LC-MS/MS metabolomics and PCA 
(n = 3; cells sorted from two mice were pooled for each independent 
measurement) b, Pyruvate/lactate ratio. c, JC-1 staining of mitochondria 
(green) and mitochondria with high MMP (red) in an organoid crypt. 
*Indicates CBCs located between Paneth cells. DIC, differential 
interference contrast. d, Quantification of JC-1 in CBCs (20) and Paneth 
cells (10) from 3 different organoids (one representative experiment of 3 
independent ones). Graphs show mean and s.d. Two-tailed t-test (b) and  
Mann–Whitney test (d), * * * * P < 0.0001.
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Data Fig. 2b), whereas the expression of embryonic stem cell markers 
(Trop2 and Spp1) is increased (Fig. 2a). Remarkably, spherical WENR 
organoids resemble embryonic small intestine organoids, as both grow 
as homogenous proliferative spheres that lack differentiated cells and 
share a similar gene expression signature, which is distinct from adult 
Lgr5+ CBCs11. Embryonic organoids can differentiate  spontaneously 
(intestinalization) and become mini-gut organoids11,12. WENR 
 organoids can reproduce this process; by removal of Wnt3a from 
the medium after splitting, Paneth cells and Lgr5+ CBCs emerge in 
budding structures and crypt formation is restored10,13,14 (Extended 
Data Fig. 2b, c). Thus, switching spherical organoids from WENR to 
ENR medium establishes a model to study differentiation preceding 
crypt formation.
Spherical WENR organoids display enhanced glycolytic  metabolism 
when compared to mini-guts (Fig. 2c, Extended Data Fig. 2d, e). 
Accordingly, spherical organoids showed a decreased pyruvate/ 
lactate ratio (Extended Data Fig. 2f). Inhibition of pyruvate dehydro-
genase kinase 1 by dichloroacetate (DCA), and hence inhibition of 
 glycolysis15,16 (Extended Data Fig. 2g), resulted in reduced proliferation 
(Fig. 2d, Extended Data Fig. 2h). Inhibition of proliferation probably 
precedes the onset of differentiation. Indeed, glycolytic perturbation 
by addition of DCA or 2-deoxy-d-glucose enhanced the number of 
crypts per organoid and the expression of the Paneth cell markers 
Lyz1 and Lyz2 (Fig. 2e, Extended Data Fig. 2i–k). ATP production 
relies on mitochondrial oxidative phosphorylation (OXPHOS) when 
 glycolysis is perturbed, therefore we analysed OXPHOS contribution 
to  differentiation. Galactose, through the Leloir pathway, activates 
OXPHOS17,18. Substitution of glucose with galactose enhanced crypt 
formation (Extended Data Fig. 2l), suggesting that mitochondrial 
activation drives differentiation. In addition, mitochondrial copy 
number increased during differentiation (Extended Data Fig. 3a). 
Phenotypically, crypt formation in organoids is initiated through an 
increase in cell density, forming a bud-like structure, and mitochondrial 
activity appears increased within the initiating crypt (Fig. 3a, Extended 
Data Fig. 3b). Inhibition of mitochondrial OXPHOS by blocking the 
electron transport chain complex I or IV or ATP synthase reduced crypt 
formation (Extended Data Fig. 3c, d). Notably, Wnt3a enhanced the 
effect of blocking the electron transport chain (Extended Data Fig. 3e). 
Together, these results indicate that mitochondrial electron transport 
chain activity is required for crypt formation initiation. Increased 
OXPHOS activity may lead to ROS generation with consequent 
 alteration of the cellular redox state. Glutathione is the main  cellular 
anti-oxidant and its oxidized/reduced state in mitochondria can 
be  analysed by the genetically encoded sensor mtGrx1–roGFP19 
 (mitochondrial encoded glutaredoxin1 fused to reduction– oxidation 
 sensitive GFP) in organoids (Extended Data Fig. 3f). Spherical 
 organoids display throughout a homogeneous redox ratio, but 
 following  initiation of differentiation, redox state in budding areas is 
altered (Fig. 3b, Extended Data Fig. 3g). Thus, increased mitochon-
drial  activity results in mitochondrial redox changes and consequent 
ROS signalling that may initiate differentiation and crypt formation. 
Indeed, exogenous antioxidants, mitoTEMPO, and to a lesser extent 
EUK-134, inhibited crypt formation and Paneth cell marker expres-
sion (Extended Data Fig. 3h, i). Furthermore, low concentrations of 
 paraquat, to mimic mitochondrial ROS signalling, enhanced expression 
of Paneth cell markers, but did not result in a significant increase of 
the numbers of crypts (Extended Data Fig. 3j, k), suggesting that other 
functions of mitochondria (that is, ATP, metabolic intermediates) also 
contribute to crypt formation.
p38 MAP kinases respond to cellular redox changes20,21. In 
 organoids, mitochondrial-derived ROS signals activate p38 and its 
activity also increases during differentiation (Extended Data Fig. 4a, b, 
Supplementary Fig. 1). To measure p38 activation at the cellular level, 
we employed the genetically encoded sensor p38KTRClover22. We 
validated p38KTRClover in organoids (Extended Data Fig. 4c) and 
confirmed that mitochondrial ROS activates p38 (Fig. 4a). Notably, 
during differentiation, p38 activity increased at budding sites and 
was active in in emerging Lyz-positive cells (Paneth cells) and CBCs 
(Fig. 4b, c). p38 activity is sustained during crypt maturation and 
in mature crypts, where it becomes less active towards the villi 
domain (Fig. 4c). Further, immunohistochemistry of mouse intestine 
 corroborates these results and also shows increased phospho-p38 at 







































































































































Figure 2 | Characterization of WENR organoids. a, Gene expression in 
WENR organoids was determined by quantitative PCR and represented as 
ratio relative to ENR organoids. Plotted values statistically differ from ENR 
condition (n = 5; two-tailed t-test P < 0.05). b, Representative images of 
immunostained mini-gut (ENR) and spherical organoids (WENR). Paneth 
cells and proliferative cells were detected with WGA and Ki67 antibody, 
respectively (n = 3). c, Glycolytic capacity was determined by glycolysis 
stress test (Seahorse). d, WENR organoids were treated with DCA and the 
perimeter was measured with ImageJ. e, Crypt formation by inhibition of 
glycolysis was analysed by differentiation assay adding DCA. Results show 
one representative experiment of n = 5 (e) and n = 3 (c, d). Mean and s.d. 
are plotted. Two-tailed t-test, * P < 0.05, * * * P < 0.001.
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Figure 3 | Mitochondrial OXPHOS and ROS signalling drive differentiation and crypt formation. a, Representative confocal image of mitochondria 
and high MMP mitochondria of JC-1-stained organoids in transition to differentiation. b, Representative images of mitochondrial redox state analysed in 
mtGrx1–roGFP organoids. Images represent oxidized/reduced roGFP. One representative experiment of n = 3 are shown.
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Extended Data Fig. 4d). Inhibition of p38 activity reduced differen-
tiation and crypt formation (Extended Data Fig. 4e, f) and thereby 
phenocopied mitochondrial ROS scavenging. Together, our results 
show that mitochondrial OXPHOS activity drives differentiation and 
crypt formation by a mechanism that involves p38 activation through 
mitochondrial ROS signalling.
Lastly, we addressed the role of metabolism in the maintenance of 
stem cell function. We therefore employed the organoid reconstitution 
assay, in which isolated Lgr5+ CBCs were combined with Paneth cells to 
produce self-renewing organoids. This assay serves as a proxy for stem 
and niche cell function6,10,23,24. To test the relevance of metabolic com-
partmentalization between Lgr5+ CBCs and Paneth cells, we treated 
either cell population with metabolic inhibitors that showed expected 
efficacy and did not affect cell viability (Extended Data 5a, b). Notably, 
Paneth cells pre-treated with inhibitors of glycolysis or glucose and 
lactate transporters were inefficient in supporting organoid formation 
upon reconstitution with Lgr5+ CBCs, whereas upon treatment with 
OXPHOS inhibitors, Paneth cells retained their niche-supporting func-
tion (Fig. 5b). Conversely, treatment of Lgr5+ CBCs with OXPHOS 
inhibitors clearly reduced organoid reconstitution, whereas the other 
inhibitors showed a mild effect (Fig. 5a). These results show that the 
glycolytic phenotype in Paneth cells and increased OXPHOS in Lgr5+ 
CBCs are required in supporting both niche and stem cell function.
Lactate is the end product of glycolysis and can be back converted 
into pyruvate and fuel OXPHOS. We hypothesized that lactate  produced 
by Paneth cells could provide the respiratory substrate to sustain 
OXPHOS in Lgr5+ CBCs. Wnt ligands can substitute for Paneth cells 
in  supporting ex vivo Lgr5+ CBCs to form organoids6,10,23. We there-
fore repeated reconstitution assays, replacing Paneth cell function with 
Wnt3a and either glucose or lactate. Indeed, lactate strongly enhanced 
the ability of Lgr5+ CBCs to establish organoids (Fig. 5c). Thus, besides 
Wnt3a, glycolysis towards lactate in Paneth cells establishes the stem 
cell niche. Next, we analysed the effects of replacing lactate by  pyruvate, 
inhibition of pyruvate transport into mitochondria, and inhibition 
of ROS and p38 signalling. Our results indicate that in Lgr5+ CBCs, 
lactate is converted into pyruvate to fuel mitochondrial OXPHOS, 
 leading to ROS signalling and activation of p38 and differentiation 
(Fig. 5d, e, Extended Data Fig. 5c–g). Together, our results reveal the 
existence of metabolic compartmentalization in the intestinal crypt 
in which Paneth cells support Lgr5+ CBC oxidative metabolism, 
 constituting a metabolic niche that provides optimal stem cell  function 
(Fig. 5f).
Several studies have indicated a role for metabolism in stem cell 
 function, but a clear understanding has been lacking2–5. Here, we 
report that a metabolic transition towards mitochondrial OXPHOS 
is required to drive differentiation in an organoid model  representing 
the development of the intestinal crypt in vivo. Importantly, this 
 metabolic  transition towards OXPHOS and consequent p38  activation 
is maintained in adult Lgr5+ CBCs and ultimately regulates stem cell 
function by self-renewal and differentiation capacity. In agreement 
with our results, deregulation of mitochondrial COX1 in Drosophila 
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Figure 4 | p38 activity drives differentiation and crypt formation. 
a, b, Representative images of p38 activity as determined by confocal 
microscopy of p38KTRClover organoids by calculating the Hoechst/
p38KTRClover ratio (n = 5). c, Detailed visualization of p38 activity at 
different stages of crypt formation on p38KTRClover organoids (n = 5).  































































































































































































































Figure 5 | Metabolic regulation of Lgr5+ CBC stem cell function.  
a, b, OXPHOS in Lgr5+ CBCs (a) and glycolysis in Paneth cells (b) are 
required for stem cell function. Organoid reconstitution efficiency was 
determined in Lgr5+ CBCs or Paneth cells were treated with glycolysis 
(orange) or OXPHOS inhibitors (green) before combining and plating 
on matrigel (n = 3). c, Single Lgr5+ CBCs were plated in ENR medium 
supplemented as indicated and organoid reconstitution efficiency was 
determined (n = 6). d, e, Organoid reconstitution efficiency was assessed 
by plating single Lgr5+ CBCs in medium supplemented with 100 ng Wnt3a 
and the indicated compounds (n = 6). Ctrl, control; mT, mitoTEMPO; PH, 
PH-797804; SB, SB203580; UK, UK-5099. Average and s.d. are shown. 
Two-tailed t-test, * P < 0.05, * * P < 0.01, * * * P < 0.001, NS, not significant. 
f, Schematic representation of the main findings in this work. p-p38, 
phospho-p38.
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melanogaster leads to loss of CBCs and decreased number of crypts25. 
Also, conditional p38α -knockout mice show altered epithelial 
 homeostasis in colon and small intestine26. Studies on ROS and stem 
cell fate have focused mostly on ROS as a causal mechanism for DNA 
damage rather than on its role in signalling (discussed in ref. 27). 
However, mitochondrial-derived ROS does not inevitably result in 
increased DNA damage28,29, and our results indicate that increased 
OXPHOS in Lgr5+ CBCs generates ROS signalling rather than stress. 
Interestingly, gene expression profiling suggests that there is similarity 
between  normal Lgr5+ CBCs and colon cancer stem cells25, and this 
could also be true of their metabolism. Indeed, increased mitochon-
drial metabolism in cancer stem cells has been previously reported30. 
Thus, whereas the bulk of cancer cells adopt a ‘Warburg metabolism’, 
the minor population of cancer stem cells may rely on OXPHOS. 
Therefore, targeting mitochondria may provide therapeutic benefit in 
eradicating cancer stem cells, as opposed to other strategies that target 
the bulk of a tumour.
Online Content Methods, along with any additional Extended Data display items and 
Source Data, are available in the online version of the paper; references unique to 
these sections appear only in the online paper.
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Data reporting. No statistical methods were used to predetermine sample size. 
The experiments were not randomized and the investigators were not blinded to 
allocation during experiments and outcome assessment.
Organoid culture. Small intestinal organoids were derived from isolated crypts 
collected from the entire length of the small intestine of wild-type, LGR5–GFP or 
DTR–LGR5–GFP mice as described ref. in 14. The basic culture medium (ENR) 
contained advanced DMEM/F12 supplemented with penicillin/streptomycin, 
10 mM HEPES, 1×  Glutamax, 1×  B27 (all from Life Technologies) and 1 mM 
N-acetylcysteine (Sigma) that was supplemented with murine recombinant 
epidermal growth factor (Peprotech), R-spondin1-CM (5% v/v) and noggin-CM 
(10% v/v). WENR medium was prepared with ENR medium supplemented with 
R-spondin1-CM (20% v/v) and 50% Wnt3a-CM (conditioned medium) (v/v). 
A mycoplasma-free status was confirmed routinely.
Lentiviral infection. mtGrx1–roGFP in pLPCX redox sensor was cloned into a 
lentiviral vector under the control of Hef1 promoter and with puromycin  resistance 
cassette. pLentiPGK Puro DEST p38KTRClover was purchased in Addgene. 
p38KTRClover30 facilitates tracking of p38 activity by live imaging of nuclear 
(inactive) and cytoplasmic (active) localization of the GFP sensor. mtGrx1–
roGFP in pLPCX was a gift of T. Dick (Cancer Research Center, Heidelberg, 
Germany). The genetically encoded sensor mtGrx1–roGFP allows for ratiometric 
 quantification in mitochondria of oxidized/reduced glutathione by excitation with 
405 and 488 nm, respectively, and emission in the green channel26. Both genetic 
encoded sensors were introduced in organoids by lentiviral infection according 
to ref. 31.
Differentiation assay. Organoids were grown in WENR medium until crypts 
were no longer visible (approximately 7 days per one passage). WENR spherical 
organoids were split up and plated in either WENR or ENR medium. Galactose 
and glucose media were prepared using advanced F12 glucose free medium and 
 supplemented with either galactose or glucose to a final concentration of 15 mM 
and used as regular F12 to prepare ENR medium. Compounds were added along 
with the medium directly after plating, with the exception of EUK134, mitoTEMPO, 
paraquat and antimycinA, which were added 14–16 h after plating. EUK134 
mimics catalase and superoxide dismutase activity and, in this way, scavenges ROS 
in the cytosol, and mitoTEMPO is a scavenger of mitochondrial superoxide32. DCA 
concentration was 15 mM. Pictures were taken after 48 or 72 h after treatment. All 
compounds were purchased from Sigma. The number of organoids and crypts 
were blindly counted with the cell counter (ImageJ plugin) and crypt formation 
was scored as the number of crypts divided by the number of organoids per picture. 
For each condition, a minimum of six pictures with approximately 6–10 organoids 
per picture were counted (see Extended Data Fig. 2j for an example). Statistical 
analyses were performed using Graphpad Prism 6. For crypt formation assays, an 
independent experiment (n) refers to independent splitting, plating and treatment 
of organoids performed on different days.
DNA and RNA extraction and qPCR. Organoids were washed once with cold 
PBS and collected in RLT buffer. RNA was extracted with the RNeasy kit (Qiagen), 
with on-column DNase treatment (Qiagen), according to the manufacturer’s 
instructions. RNA was reverse-transcribed with oligodT primers and the CBCript 
cDNA synthesis kit (Biorad). For DNA extraction, organoids were washed once 
with cold PBS and DNA was extracted with the QIAamp DNA Micro Kit (Qiagen). 
DNA was used as a template to amplify nuclear and mitochondria- encoded genes. 
In both cases, qPCR was performed with FastStart SYBR Green Master mix 
(Roche). Relative gene expression was calculated using the Ct method by nor-
malization to HNRNPA1 and CycA. Statistics were done with Graphpad Prism 6. 
Primer sequences: Glut1 forward (5′-GCAGTTCGGCTATAACACT-3′), Glut1 
reverse (5′-GGTGGTTCCATGTTTGATTG-3′ ); Hk1 forward (5′-AAGGATGA 
CCAAGTCAAAAAGATTG-3′), Hk1 reverse (5′-CGGGAGAGGCCATTCT 
TCATC-3′); Mct1 forward (5′-GATGGACCTCATTGGACCCC-3′), Mct1 reverse 
(5′-GAGGCGGCCTAAAAGTGGT-3′); Hnrnpa1 forward (5′-TGACA 
GCTATAACAACGGAG-3′), Hnrnpa1  reverse (5′-AAAGTTTCCT 
CCCTTCATCG-3′); Pbgd forward (5′-CCTCGACTCTGCTTCGTCTG-3′), 
Pbgd reverse (5′-CACAGACCACAAATCCATGA-3′); Tuba1a forward (5′-AGG 
AT TATGAGGAGGT TGGT-3 ′ ) ,  Tuba1a  for ward (5 ′-ATAAACA 
TCCCTGTGGAAGC-3′); Ppia forward (5′-ACTGAATGGCTGGATGGCAA-3′), 
Ppia reverse (5′-CAAAACGCTCCATGGCTTCC-3′); Lyz1 forward (5′-CGT 
TGTGAGTTGGCCAGAA-3′); Lyz1 reverse (5′-GCTAAACACACC 
CAGTCAGC-3′); Lyz2 forward 2 (5′-TGAACGTTGTGAGTTTGCCA-3′), Lyz2 
reverse (5′-TGAGCTAAACACACCCAGTCG-3′); Ki67 forward (5′-CCTT 
TGCTGTCCCCGAAGA-3 ′ ) ,  Ki67  reverse (5 ′-GGCT TCTCATC 
TGTTGCTTCCT-3′); Slc2a forward (GLUT2) (5′-ATCGCTCCAAC 
CACACTCAG-3′), Slc2a reverse (5′-GCTGAGGCCAGCAATCTGAC-3′); 
Olfm4 forward (5′-TGAAGGAGATGCAAAAACTGG-3′), Olfm4 reverse 
(5′-CTCCAGCTTCTCTACCAAGAGG-3′); Me2  forward (5′-AGG 
CGTCCGGGGAGAG-3′), Me2 reverse (5′-ATGAGTGGCTTGCCCTTCTC-3′); 
Alpi forward (5′-AACTCACCTCATGGGCCTCTT-3′), Alpi reverse (5′-GGGTT 
TCGGT TGGCATCATA-3 ′) ;  Lct  for ward (5 ′-CGTCTGCT TCCT 
ATCAGGTTGAA-3′), Lct reverse (5′-GTGGGAAAATGTGTCCCAGATACT-3′); 
Lgr5 forward (5′-GTTCAAGATGAGCGGGACCT-3′), Lgr5 reverse (5′-ATAGG 
TGCTCACAGGGCTTG-3′); Pkm forward (5′-ATGCAGCACCTGA 
TAGCTCG-3′), Pkm reverse (5′-AGGTCTGTGGAGTGACTGGA-3′). Sequences 
of primers for Ascl2, Cd44, Chga, Si, LZP, Lgr4, Trop2, Spp1 and CCND1 were 
obtained from ref. 11.
Protein lysates and western blot. Organoids were washed once with cold PBS 
and collected in cell recovery solution (Corning) according to the manufacturer’s 
instructions. Total proteins were collected by direct lysis of organoids in Laemli 
sample buffer. Proteins were run in SDS–PAGE and transferred to Polyscreen 
PVDF transfer membranes (PerkinElmer). Antibodies used in this work: anti-
GAPDH (Millipore), P38 antibody (Biolabs 9212); phospho-p38 (Cell Signaling 
CS9215); GAPDH (Millipore MAB374); Ki67 (Abcam ab15580); lysozyme 
(DAKO A0099), phospho-p38 MAPK (Thr180/Tyr182) (9211S, Cell Signaling), 
phospho-p38 MAPK (Thr180/Tyr182) (4511S, Cell Signaling).
Immunostaining, live imaging in organoids and immunohistochemistry. 
Organoids were plated in 4-well round Cellview plates. Samples were fixed with 
4% paraformaldehyde (PFA) for 45 minutes at 4 °C. After fixation organoids 
were washed with cold PBS and permeabilized with PBS buffer containing 10% 
DMSO, 2% Triton and 10 g l−1 BSA. Antibody incubation was performed in the 
same buffer; anti-Ki67 (Abcam), rabbit anti-lysozyme (Dako). Fluorescence was 
detected using anti-rabbit Alexa Fluor 488 antibody. Paneth cells were also stained 
with wheat germ agglutinin (WGA) and DNA was stained with Hoechst (both 
Molecular Probes). Images were captured using a SP8 confocal microscope (Leica 
Microsystems). For live imaging, organoids were stained with the following probes; 
JC-1 (T3168), MitoTracker Deep Red FM (M22426), Tetramethylrhodamine 
(TMRM, T668), CellRox (C10448), MitoSOX (M36008). JC-1 dye accumulates in 
mitochondria; it exists as a monomer at low concentrations and yields green fluo-
rescence. The dye forms J-aggregates at high mitochonrial membrane potential and 
the emission shifts to red. The ratio of green to red fluorescence is dependent only 
on the membrane. All probes were applied following manufacturer recommenda-
tions and were purchased from Thermo Fisher. Imaging of mtGrx1–roGFP (Fig. 3b, 
Extended Data Fig. 3g) was performed in 3 independent experiments and 17 orga-
noids were analysed. Data analysis was performed according to ref. 33. Imaging 
of p38KTRClover (Fig. 4) was performed in 4 independent experiments and 
24 organoids were analysed. Additionally, p38KTRClover organoids were treated 
with 1 mM mitoTEMPO overnight or 7.5 mM parquat for 90 min (Fig. 4a) 
and then imaged. Experiments were performed twice with 2 technical replicates in 
each and 30 organoids were analysed. The ratios Hoechst/Clover was  considered 
as a  measurement of p38 activity and is represented in Real Glow scale (ImageJ). 
ImageJ was used for all imaging analysis. For immunohistochemistry, fresh 
mouse intestine of one mouse was fixed in 4% formaldehyde for 24 h followed 
by dehydration in 70% ethanol and embedding in paraffin. Rehydrated slides 
were blocked for endogenous peroxidase activity in phosphate buffer (pH 5.8) 
containing 1.5% hydrogen peroxide. For antigen retrieval, samples were cooked 
for 20 min in 10 mM citrate buffer (pH 6) in a microwave. Primary and secondary 
horseradish- peroxidase-conjugated antibodies were incubated overnight or 1 h at 
4 °C, respectively. Staining of slides was performed using diaminobenzidine and 
haematoxylin. For imaging, independent experiments (n) refer to the number of 
independent stainings performed and imaged on different days.
Metabolomics. Cells were sorted by FACS from intestinal crypts of mice6. To 
reach the minimal amount for analysis, cells sorted from two mice were pooled 
for each independent measurement, so 6 mice were used for n = 3. LC/MS was 
performed on the 3 independent samples and each sample was measured 3 times. 
Direct infusion mass spectrometry (DI-MS) metabolomics was performed on the 
3 independent samples with 3 technical replicates measured 3 times each leading 
to a total of 9 measurements per group. Cells were sorted by FACS and collected 
directly in ice-cold methanol. After homogenization, the extracts were diluted 
in water and internal standards in methanol for DI-MS. Direct infusion was 
 performed using chip-based infusion (400 nozzles, nominal internal Ø 5 μ m) on 
the TriVersa NanoMate (Advion). High resolution mass spectrometry (140,000) 
was performed using a Q-ExactivePlus (Thermo Scientific GmbH) using a scan 
range of m/z 70 to 600 in positive and negative modes. Besides mass calibration 
of the instrument, internal lock masses were used for high mass accuracy. Cells 
were collected in biological triplicates. Cell extracts were diluted (1:1 v/v) using 
70 μ l  stable isotopes solution in methanol (NSK-A-amino acids and NSK-B-free 
 carnitine and acylcarnitine reference standards (Cambridge Isotope Laboratories). 
After  dilution with 60 μ l 0.3% formic acid, samples were filtered using a precon-
ditioned (with methanol) 96-well filter plate (Acro prep, 0.2 μ m GHP, NTRL, 
1 ml well; Pall Corporation). The sample filtrate was collected using cleaned 
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
76
C h A P t e r  4
Letter reSeArCH
96-well plate (Advion). A volume of 13 μ l was infused into the DI-HRMS  system 
in  triplicate (technical replicates). RAW data files were converted to mzXML 
format using MSConvert34. The data were processed using an in-house- developed 
untargeted metabolomics pipeline written in the R programming language 
(http://www.r-project.org). First, the mzXML files were converted to readable 
 format by the XCMS package35. For every sample, peak finding was performed and 
peaks with the same m/z (within 0.5 × full width at half maximum) were grouped 
over different samples. Peak groups that were not present in three out of three 
 technical replicates in at least one biological sample were discarded. The  intensities 
of the technical replicates were averaged. Peak groups were identified using all 
entries in the HMDB, including their most likely adducts (Na+, K+, NH4+ in 
positive mode and Cl− and formate in negative mode) and isotopes, using an 
 accuracy of 3 p.p.m. or better. For LC-MS/MS analysis, 200 μ l of the methanol 
extract was evaporated to dryness after the addition of internal standards. The 
residue was dissolved in 100 μ l 10% acetonitrile in ultrapure water of which 
5 μ l was injected for analysis. Analysis was conducted with a Thermo Scientific 
Acella UHPLC system and an Acquity BEH C-8 column (1 × 150 mm, 1.7 μ m). 
The  column outlet was coupled to a Thermo Scientific Orbitrap XL equipped 
with an electrospray ion source operated in either negative or positive mode. 
The system was operated at a flow rate of 150 μ l min−1 and 40 °C. The mobile 
phases  consisted of 6.5 mM ammonium carbonate pH 8 (solvent A), and 6.5 mM 
 ammonium  carbonate in methanol (solvent B) in negative mode. For positive mode 
analysis the solvents were 0.1% formic acid in ultrapure water and 0.1% formic 
acid in methanol, respectively. A 10-min linear gradient of 0–100% B was started 
3 min after the injection of the sample. The system was kept at 100% B for the next 
4 min, after which the system returned to its starting situation. Total  runtime was 
22 min. All acquired MS-data was searched against available databases. Statistics 
and analysis was performed on replicates (LC-MS/MS) and on replicates and 
technical replicates (DI-MS). PCA analyses were performed with http://www.
metaboanalyst.ca (ref. 36).
Bioenergetics. Seahorse Bioscience XFe24 Analyzer was used to measure extra-
cellular acidification rates (ECAR) in mpH (milli pH) per min and oxygen con-
sumption rates (OCR) in pmol O2 per min. Organoids were seeded in 3 μ l matrigel 
per well in XF24 cell culture microplates (Seahorse Bioscience). 1 h before the 
measurements, culture medium was replaced and the plate was incubated for 
60 min at 37 °C. For the mitochondrial stress test, culture medium was replaced 
by Seahorse XF Base medium (Seahorse Bioscience), supplemented with 20 mM 
glucose (Sigma-Aldrich), 2 mM l-glutamine (Sigma-Aldrich), 5 mM pyruvate 
(Sigma-Aldrich) and 0.56 μ l NaOH (1 M). During the test, 5 μ M oligomycin, 
2 μ M FCCP and 1 μ M of Rotenone and Antimycin A (all Sigma-Aldrich) were 
injected to each well after 18, 45 and 63 min, respectively. For the glycolysis 
stress test, culture medium was replaced by Seahorse XF Base medium, supple-
mented with 2 mM l-glutamine and 0.52 μ l ml−1 NaOH (1 M). During the test 
10 mM  glucose, 5 μ M oligomycin and 100 mM 2-deoxyglucose (Sigma-Aldrich) 
were injected to each well after 18, 36 and 65 min, respectively. After injections, 
 measurements of 2 min were performed in triplicate, preceded by 4 min of mixture 
time. The first measurements after oligomycin injections were preceded by 5 min 
mixture time, followed by 8 min waiting time for the mitochondrial stress test and 
5 min mixture time followed by 10 min waiting time for the glycolysis stress test.
Reconstitution assays. Reconstitution of Lgr5-EGFPhi stem cells (purity > 99%) 
with Paneth cells (CD24hiSSChi; purity > 98%) was performed by pelleting sorted 
cells at 300g for 5 min in Eppendorf LoBind Tubes, and by co-incubating them 
for 15 min at room temperature as previously described14. Lgr5-EGFPhi stem cells 
were co-incubated with Paneth cells in equal numbers as previously described24. 
Incubation with 20 mM DCA, 100 μ M pCMB, 50 μ M Floretin, 50 μ M Azide, 200 μ M 
Antimycin A (all purchased in Sigma) was performed for 2 h on ice. Cells were then 
pelleted at 300g for 5 min and washed twice with ENR medium and pelleted again 
at 300g. Cells were then co-incubated for 15 min and plated as previously described. 
Organoids grown from single Lgr5-EGFPhi stem cells with lactate or glucose 
were performed in ENR medium (base medium SILAC Advanced DMEM/F12 
supplemented with arginine and lysine) supplemented with 17.5 mM glucose, 
Na-pyruvate or lactate where indicated. Recombinant Wnt3a (R&D  systems) was 
used where indicated at 50 μ g ml−1 and 100 μ g ml−1 to promote organoid forma-
tion from single Lgr5-EGFPhi stem cells. Where indicated cells were treated with 
0.5 mM mitoTEMPO, 5 μ M EUK5099, 2 μ M php7879 or 5 μ M SB202190. Organoid 
number was counted at day 5 and after counting 5 mM glucose was added to 
all non-glucose conditions to allow crypt formation. Pictures of organoids for 
crypt counting were taken at day 12. A total of 35 organoids were counted per 
condition. Each independent experiment refers to mice intestinal crypt isolation, 
FACS sorting and treatments performed on different days.
Animal experiments. Experiments involving live mice (generation of organoids) 
were performed in compliance with local and national ethical regulations and 
codes (DEC, Dier Experimenteel Commissie).
Data availability. Source Data are provided for all figures with the online version 
of the paper, excluding mass-spectrometry metabolomics data, which is available 
from the corresponding author upon reasonable request.
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Extended Data Figure 1 | Metabolic compartmentalization and 
mitochondria and redox state in the crypt. a, Top 10 most different 
metabolites between Lgr5+ CBCs, Paneth cells (PCs) and all other 
differentiated cell types (‘Neg.’). P value and false discovery rate (FDR) 
refer to the significance, and post hoc tests indicate the groups being 
compared. Results were obtained by analysis with http://metaboanalyst.
ca. b, Live confocal microscopy of organoid crypts. All mitochondria 
(green) and high MMP (red) was determined by JC-1 staining. MMP/
mitochondria ratio is represented in fire intensity scale (ImageJ). c, Live 
imaging of Lgr5–GFP-derived organoid stained with Mitotracker Deep-
Red confirmed increased mitochondria in Lgr5+ CBCs. In both cases 
Hoechst was used to stain nuclei. Asterisks indicate stem cells in between 
Paneth cells (n = 1). d, Representative images of DTR–Lgr5–eGFP  
organoids grown in ENR medium or ENR medium supplemented with 
CHIR99021 (3 μ M) and valproic acid (2 mM) during 72 h. e, Mitochondrial 
respiration/glycolysis (basal) was measured during mitochondrial stress 
test using Seahorse technology. Organoids were grown in ENR medium 
and after 24 h CHIR99021 and valproic acid were added to half of the 
plate during 72 h before running the assay. Graph represents mean and 
s.d. of 6 independent Seahorse experiments. Two-tailed t-test, * P < 0.05. 
f, ROS in the crypt was stained with CellRox (cytosolic ROS), MitoSOX 
(mitochondrial superoxide) and Mitotracker (mitochondria). Dashed 
yellow regions indicate Paneth cells. g, Quantification of ROS in CBCs 
(16) and Paneth cells (6) from 3 organoids. One representative experiment 
of 2 independent ones. Graphs show mean and s.d. Two tailed t-test, 
****P < 0.0001, NS, not significant.
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Extended Data Figure 2 | See next page for caption.
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Extended Data Figure 2 | WENR organoids represent a homogeneous 
population of glycolytic dividing cells that retain pluripotency.  
a, Confocal images of organoid crypts. PC and nuclei were detected using 
WGA or Lyz antibody, and Hoechst, respectively. z-stacks are represented 
as 3D projections. b, Confocal live imaging of DTR–Lgr5–eGFP-derived 
mouse organoids. Lgr5+ cells are visualized in green. Dashed yellow region 
indicates a bud structure that constitutes a starting crypt. c, Confocal 
microscopy of immunostaining of an emerging crypt. Phalloidin was used 
to stain F-actin (in red) (n = 3 (a–c)). d, Gene expression of glycolytic 
genes in WENR organoids normalized by the expression in ENR organoids 
(dashed line) (n = 3). e, Bioenergetics was determined by Seahorse 
technology. Results show one representative experiment of 3 independent 
ones. f, Pyruvate/lactate ratio was analysed by DIMS metabolomics. Boxes 
and error bars correspond to mean and s.d. of 3 technical replicates of 
3 biological samples. g, DCA inhibition of glycolysis in ENR or WENR 
grown organoids was determined by Seahorse technology 1 representative 
experiment of n = 3. h, Proliferation was measured by Ki67 gene 
expression by qPCR. i, Gene expression of PC markers (n = 5 independent 
experiments). j, Representative images of a differentiation assay and the 
effect of DCA and azide; spherical organoids (grown in WENR) forming 
crypts (WENR→ ENR) and cryptic organoids (grown in ENR medium). 
k, Effect of glycolysis inhibition on crypt formation was analysed by 
differentiation assay using DCA or 2-deoxyglucose (one representative 
experiment, n = 2). l, Increased crypt formation by activation of 
mitochondria (h) was analysed by differentiation assay replacing glucose 
by galactose in ENR medium. Two-tailed t-test, * * * P < 0.001; * * P < 0.01; 
* P < 0.05.
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Extended Data Figure 3 | See next page for caption.
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Extended Data Figure 3 | Mitochondrial OXPHOS and ROS signalling 
drive differentiation and crypt formation. a, Mitochondrial DNA 
copy number was quantified by qPCR on total DNA. Plot represents one 
representative experiment (n = 2). b, Mitochondrial membrane potential 
and total mitochondria were analysed with the combination of Mitotracker 
Deep Red (mitochondria) and TMRM (mitochondrial membrane 
potential). Staining is represented as a ratio using fire intensity scale 
(ImageJ). Dashed yellow region indicates a bud structure that constitutes a 
starting crypt. c, Decreased crypt formation by inhibition of mitochondria 
was analysed by differentiation assay adding OXPHOS inhibitors: azide, 
myxothiazol (myxo.), rotenone and oligomycin (oligo.) (concentrations 
in μ M). d, Toxicity of OXPHOS inhibitors was measured by counting 
the number of organoids growing in the depicted conditions. Values are 
plotted as percentages of the WENR condition (mean). e, Mitochondrial 
inhibition enhances inhibition of crypt formation occurring when 
plating ENR organoids in WENR medium. Azide (50 μ M) was added 
to the medium, pictures were taken after 48 h and the number of crypts 
per organoid was counted using ImageJ. Average and s.d. are shown. 
Representative of one experiment (n = 2). f, The sensitivity to redox 
changes of the mtGrx1–roGFP in organoids was analysed by live imaging, 
applying 500 μ M hydrogen peroxide and following the redox response in 
time. Images represent the ratio of oxidized/reduced sensor.  
g, Mitochondria redox state of a forming crypt was assessed by live 
imaging of mtGrx1–roGFP. h, i, Effect of ROS scavengers on crypt 
formation was analysed by differentiation assay (h) and Paneth cell 
markers gene expression (i) in the presence of EUK134 (5 μ M) and 
mitoTEMPO (0.5 mM). j, k, The effect of triggering mitochondrial ROS on 
crypt formation was performed by differentiation assays applying paraquat 
and counting the number of crypts per organoids (j) and by the expression 
of Paneth cell markers by qPCR (k). One representative experiment of 
n = 3 (c, d) or n = 5 (h, j). Mean and s.d. are shown. Two tailed t-test; 
asterisks or NS indicate comparison to WENR→ ENR control, * P < 0.05, 
** P < 0.01.
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Extended Data Figure 4 | p38 activity drives differentiation and crypt 
formation in a mitochondrial ROS signalling dependent manner. 
a, b, P38 activation was analysed by western blot and quantified. For 
gel source data see Supplementary Fig. 1. Organoids were treated with 
mitoTEMPO (0.5 mM overnight) or paraquat (7.5 mM, 1.5 h) (n = 3) (b). 
c, p38KTRClover organoids were challenged with anisomycin (75 μ g ml−1) 
in order to analyse p38 activity. Images were obtained during 45 min after 
the addition of the compound. z-stacks of p38KTRClover or Hoechst/
p38KTRClover ratio are represented as 3D projections and surface plot 
of 3D projections. Ratios are represented in either fire or real glow scale 
(ImageJ). d, Immunohistochemistry of p38 on mouse intestinal sections. 
e, f, Decreased differentiation and crypt formation upon p38 inhibition 
was analysed by differentiation assays (one representative experiment of 
n = 5) (e) and gene expression of Lyz1 and Lyz2 (f) in the presence of p38 
inhibitors SB203580 and PH-797804. Mean and s.d. are shown (n = 5). 
Asterisks indicate comparison to WENR→ ENR control; two-tailed paired 
t-test, * P < 0.05, * * P < 0.01, * * * P < 0.001 and * * * * P < 0.0001.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
83
LetterreSeArCH
Extended Data Figure 5 | Mitochondrial activity, mitochondria ROS 
signalling and p38 activity regulate stem cell function of Lgr5+ CBCs.  
a, The effects of the indicated compounds on respiration and glycolysis 
were tested after 3 h of the treatments using mitochondrial stress test 
(Seahorse technology). Bars and error bars represent the mean of the basal 
ratios and s.e.m. of 4 independent experiments with 4 technical replicates 
each. b, Cell viability after mitochondria and glycolysis inhibition 
treatments on CBCs and Paneth cells. Primary intestinal Lgr5+ CBCs 
and Paneth cells were treated with the indicated compounds for 2 h and 
then washed and stained with PI before FACS. PI negative and positive 
cells were counted as alive and dead, respectively. Values are plotted as 
percentages of the untreated cells (100%) indicated as a dashed line.  
Mean and s.d. of 2 independent experiments with 2 technical replicates 
each are represented in the graph. c, Effect of lactate and inhibition of 
pyruvate mitochondrial transport on mitochondrial respiration.  
Maximal respiration was measured by performing mitochondrial stress 
test after two hours of incubation with glucose or lactate with or without 
UK5099. Mean and s.d. are shown of 3 independent experiments with  
4 technical replicates in each. d, Effect of lactate and inhibition of pyruvate 
mitochondrial transport on mitochondrial superoxide production. 
Mitochondrial superoxide was measured by FACS analysis of single 
cells stained with MitoSOX after 2 h of incubation with the indicated 
compounds. The graph represents the mean and s.d. of 4 independent 
experiments. e, P38 activity was monitored in p38KTRClover organoids 
growing for three days in the indicated conditions. P38 activity is 
measured by the ratio of cells with active (cytosolic localization)/inactive 
(nuclear localization) of the signal. The graph shows the counting of 
one representative experiment of 3 independent ones and each dot 
represents one organoid. f, The effect of inhibition of pyruvate transport 
to mitochondria on stem cell function was measured as number of 
reconstituted organoids from primary Lgr5+ CBCs in the depicted 
conditions. The graph represent the mean and s.d. of 3 independent 
experiments. Two-tailed t-test, * P < 0.05, * * P < 0.01, * * * P < 0.001.  
g, Number of crypts per reconstituted organoid and representative images 
of the referred conditions. The plot represents mean and s.e.m. of  
35 organoids of one representative experiment of n = 6. Mann–Whitney 
test, * * * * P < 0.0001. In a, c–e, organoids were grown on ENR, CHIR99021 
and valproic acid to enrich them with stem cells and the experiments  
were performed on single cells after trypsinization. In b, f, g, experiments 
were performed in mouse intestinal crypt FACS-sorted cells.
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96-well plate (Advion). A volume of 13 μ l was infused into the DI-HRMS  system 
in  triplicate (technical replicates). RAW data files were converted to mzXML 
format using MSConvert34. The data were processed using an in-house- developed 
untargeted metabolomics pipeline written in the R programming language 
(http://www.r-project.org). First, the mzXML files were converted to readable 
 format by the XCMS package35. For every sample, peak finding was performed and 
peaks with the same m/z (within 0.5 × full width at half maximum) were grouped 
over different samples. Peak groups that were not present in three out of three 
 technical replicates in at least one biological sample were discarded. The  intensities 
of the technical replicates were averaged. Peak groups were identified using all 
entries in the HMDB, including their most likely adducts (Na+, K+, NH4+ in 
positive mode and Cl− and formate in negative mode) and isotopes, using an 
 accuracy of 3 p.p.m. or better. For LC-MS/MS analysis, 200 μ l of the methanol 
extract was evaporated to dryness after the addition of internal standards. The 
residue was dissolved in 100 μ l 10% acetonitrile in ultrapure water of which 
5 μ l was injected for analysis. Analysis was conducted with a Thermo Scientific 
Acella UHPLC system and an Acquity BEH C-8 column (1 × 150 mm, 1.7 μ m). 
The  column outlet was coupled to a Thermo Scientific Orbitrap XL equipped 
with an electrospray ion source operated in either negative or positive mode. 
The system was operated at a flow rate of 150 μ l min−1 and 40 °C. The mobile 
phases  consisted of 6.5 mM ammonium carbonate pH 8 (solvent A), and 6.5 mM 
 ammonium  carbonate in methanol (solvent B) in negative mode. For positive mode 
analysis the solvents were 0.1% formic acid in ultrapure water and 0.1% formic 
acid in methanol, respectively. A 10-min linear gradient of 0–100% B was started 
3 min after the injection of the sample. The system was kept at 100% B for the next 
4 min, after which the system returned to its starting situation. Total  runtime was 
22 min. All acquired MS-data was searched against available databases. Statistics 
and analysis was performed on replicates (LC-MS/MS) and on replicates and 
technical replicates (DI-MS). PCA analyses were performed with http://www.
metaboanalyst.ca (ref. 36).
Bioenergetics. Seahorse Bioscience XFe24 Analyzer was used to measure extra-
cellular acidification rates (ECAR) in mpH (milli pH) per min and oxygen con-
sumption rates (OCR) in pmol O2 per min. Organoids were seeded in 3 μ l matrigel 
per well in XF24 cell culture microplates (Seahorse Bioscience). 1 h before the 
measurements, culture medium was replaced and the plate was incubated for 
60 min at 37 °C. For the mitochondrial stress test, culture medium was replaced 
by Seahorse XF Base medium (Seahorse Bioscience), supplemented with 20 mM 
glucose (Sigma-Aldrich), 2 mM l-glutamine (Sigma-Aldrich), 5 mM pyruvate 
(Sigma-Aldrich) and 0.56 μ l NaOH (1 M). During the test, 5 μ M oligomycin, 
2 μ M FCCP and 1 μ M of Rotenone and Antimycin A (all Sigma-Aldrich) were 
injected to each well after 18, 45 and 63 min, respectively. For the glycolysis 
stress test, culture medium was replaced by Seahorse XF Base medium, supple-
mented with 2 mM l-glutamine and 0.52 μ l ml−1 NaOH (1 M). During the test 
10 mM  glucose, 5 μ M oligomycin and 100 mM 2-deoxyglucose (Sigma-Aldrich) 
were injected to each well after 18, 36 and 65 min, respectively. After injections, 
 measurements of 2 min were performed in triplicate, preceded by 4 min of mixture 
time. The first measurements after oligomycin injections were preceded by 5 min 
mixture time, followed by 8 min waiting time for the mitochondrial stress test and 
5 min mixture time followed by 10 min waiting time for the glycolysis stress test.
Reconstitution assays. Reconstitution of Lgr5-EGFPhi stem cells (purity > 99%) 
with Paneth cells (CD24hiSSChi; purity > 98%) was performed by pelleting sorted 
cells at 300g for 5 min in Eppendorf LoBind Tubes, and by co-incubating them 
for 15 min at room temperature as previously described14. Lgr5-EGFPhi stem cells 
were co-incubated with Paneth cells in equal numbers as previously described24. 
Incubation with 20 mM DCA, 100 μ M pCMB, 50 μ M Floretin, 50 μ M Azide, 200 μ M 
Antimycin A (all purchased in Sigma) was performed for 2 h on ice. Cells were then 
pelleted at 300g for 5 min and washed twice with ENR medium and pelleted again 
at 300g. Cells were then co-incubated for 15 min and plated as previously described. 
Organoids grown from single Lgr5-EGFPhi stem cells with lactate or glucose 
were performed in ENR medium (base medium SILAC Advanced DMEM/F12 
supplemented with arginine and lysine) supplemented with 17.5 mM glucose, 
Na-pyruvate or lactate where indicated. Recombinant Wnt3a (R&D  systems) was 
used where indicated at 50 μ g ml−1 and 100 μ g ml−1 to promote organoid forma-
tion from single Lgr5-EGFPhi stem cells. Where indicated cells were treated with 
0.5 mM mitoTEMPO, 5 μ M EUK5099, 2 μ M php7879 or 5 μ M SB202190. Organoid 
number was counted at day 5 and after counting 5 mM glucose was added to 
all non-glucose conditions to allow crypt formation. Pictures of organoids for 
crypt counting were taken at day 12. A total of 35 organoids were counted per 
condition. Each independent experiment refers to mice intestinal crypt isolation, 
FACS sorting and treatments performed on different days.
Animal experiments. Experiments involving live mice (generation of organoids) 
were performed in compliance with local and national ethical regulations and 
codes (DEC, Dier Experimenteel Commissie).
Data availability. Source Data are provided for all figures with the online version 
of the paper, excluding mass-spectrometry metabolomics data, which is available 
from the corresponding author upon reasonable request.
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Extended Data Figure 1 | Metabolic compartmentalization and 
mitochondria and redox state in the crypt. a, Top 10 most different 
metabolites between Lgr5+ CBCs, Paneth cells (PCs) and all other 
differentiated cell types (‘Neg.’). P value and false discovery rate (FDR) 
refer to the significance, and post hoc tests indicate the groups being 
compared. Results were obtained by analysis with http://metaboanalyst.
ca. b, Live confocal microscopy of organoid crypts. All mitochondria 
(green) and high MMP (red) was determined by JC-1 staining. MMP/
mitochondria ratio is represented in fire intensity scale (ImageJ). c, Live 
imaging of Lgr5–GFP-derived organoid stained with Mitotracker Deep-
Red confirmed increased mitochondria in Lgr5+ CBCs. In both cases 
Hoechst was used to stain nuclei. Asterisks indicate stem cells in between 
Paneth cells (n = 1). d, Representative images of DTR–Lgr5–eGFP  
organoids grown in ENR medium or ENR medium supplemented with 
CHIR99021 (3 μ M) and valproic acid (2 mM) during 72 h. e, Mitochondrial 
respiration/glycolysis (basal) was measured during mitochondrial stress 
test using Seahorse technology. Organoids were grown in ENR medium 
and after 24 h CHIR99021 and valproic acid were added to half of the 
plate during 72 h before running the assay. Graph represents mean and 
s.d. of 6 independent Seahorse experiments. Two-tailed t-test, * P < 0.05. 
f, ROS in the crypt was stained with CellRox (cytosolic ROS), MitoSOX 
(mitochondrial superoxide) and Mitotracker (mitochondria). Dashed 
yellow regions indicate Paneth cells. g, Quantification of ROS in CBCs 
(16) and Paneth cells (6) from 3 organoids. One representative experiment 
of 2 independent ones. Graphs show mean and s.d. Two tailed t-test, 
****P < 0.0001, NS, not significant.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
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IBD syndromes such as Crohn’s disease and ulcerative colitis result from the persistent 
inflammation of specific intestinal segments. Although many studies have reported on the 
regenerative response of intestinal progenitors and stem cells to tissue injury, very little is known on 
the response of differentiated lineages to more clinically relevant inflammatory cues. Here, we show 
that acute inflammation of the mouse small intestine is followed by a rapid and dramatic loss of Lgr5+ 
stem cells. Instead, Paneth cells re-enter the cell cycle, lose their characteristic secretory expression 
signature, and acquire stem cell properties. As such they contribute to the tissue regenerative 
response to inflammation. Stem Cell Factor secretion upon inflammation triggers signaling through 
the c-Kit receptor and a cascade of downstream events culminating in GSK3 inhibition and Wnt 
activation in Paneth cells. Hence, the plasticity of the intestinal epithelium in response to 
inflammation goes well beyond stem and progenitor cells and extends to the fully differentiated and 






Adult stem cells have long been postulated to be intrinsically of slow-cycling nature, mainly based 
on the necessity to preserve the integrity of their genome by preventing mutations occurring during 
DNA replication (Fuchs, 2009). In the hematopoietic field in particular, there is a general consensus 
on the inverse correlation between cycling frequency and long-term stem cell activity (Orford and 
Scadden, 2008). However, tissues characterized by a high cellular turnover (e.g. intestine, skin) seem 
to represent notable exceptions to these rules-of-thumb as highly proliferative stem cells, e.g. the 
Lgr5+ crypt base columnar (CBC) cells in the intestinal crypt of Lieberkühn (Barker et al., 2007), have 
remarkable long-term self-renewal capacity. In these cases, a dichotomy of cycling and more 
quiescent stem cell lineages is thought to coexist within the niche: while actively cycling stem cells 
underlie daily homeostasis, their more quiescent equivalents are thought to play key roles in the 
response to tissue damage upon which they re-enter the cell cycle thus contributing to the 
regeneration process (Fuchs, 2009). 
In the intestinal epithelium, Lgr5+ stem cells are positioned at the very crypt bottom (pos. +1), usually 
flanked on both sides by secretory Paneth cells in the small intestine, and by analogous Paneth-like 
cells in the colon (Rothenberg et al., 2012; Sasaki et al., 2016; Sato et al., 2011; Schewe et al., 2016). 
Of note, apart from their canonical antimicrobial function exerted through the secretion of 
bactericidal compounds into the lumen (Clevers and Bevins, 2013), Paneth cells were also shown to 
play an essential niche role in supporting Lgr5+ CBCs both through cell-cell contacts and by secreting 
specific factors such as EGF, Wnt3a, and Dll4 (Sato et al., 2011).  
As for the less proliferative intestinal stem cell types, to date several candidates have been identified 
and partially characterized (Roth and Fodde, 2011). Among others, cells located at position +4 from 
the base of the crypt and earmarked by Bmi1 expression were shown to self-renew and give rise to 
all the differentiated cell lineages of the small intestine epithelium (Sangiorgi and Capecchi, 2008). 
Notably, the +4 position of these Bmi1+ stem cells is reminiscent of the BrdU-retaining cells originally 
identified by Potten and colleagues (Potten, 1998). However, the marker genes identified to date as 
proxies of these quiescent cell types are often not unique to a specific stem cell lineage but rather co-
expressed at lower levels in other cells (Clevers, 2016; Grun et al., 2016; Li et al., 2014; Munoz et al., 
2012).  
Previously, we employed an in vivo label-retaining method as a marker-free approach for the 
isolation of infrequently dividing cells and identified Paneth cells and their precursors as the least 
cycling and longest-lasting intestinal cell lineage. Notably, we showed that upon tissue injury, these 
secretory cells and their immature precursors are capable of losing expression of some Paneth-
specific genes (Roth et al., 2012). More recently, Buczacki et al. showed that label-retaining cells 
located at around position +3/+4 represent precursors committed to the Paneth and entero-
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endocrine lineages but also potentially capable of giving rise to all intestinal cell types (Buczacki et al., 
2013). These findings suggest that committed progenitors, and possibly even fully-differentiated and 
post-mitotic intestinal lineages as postulated in the present study, may serve as an alternative source 
of stem cells contributing to the regenerative response to tissue damage. Accordingly, irradiation-
induced injury is usually accompanied by loss of CBCs and by the de-differentiation of secretory 
progenitor cells earmarked by Dll1 expression (usually located at position +5 or higher) into stem-like 
cells (van Es et al., 2012). In addition to secretory lineages, enterocyte progenitors expressing the 
intestinal alkaline phosphate (Alpi) gene have also been shown to regain stem cell potential upon 
Lgr5+ CBCs ablation (Tetteh et al., 2016). 
The role played by precursors of secretory lineages and in particular by Paneth cells (PCs) in the 
regenerative response to intestinal tissue damage is of interest especially in the context of 
inflammatory bowel disease (IBD), a cumulative name for syndromes such as Crohn’s disease (CD) 
and ulcerative colitis (UC) featuring chronic inflammation of either both the small and large intestine 
(CD) or only the colon (UC) (Clevers and Bevins, 2013; Schewe and Fodde, 2018). In particular, 
Crohn's disease has been shown to be a disorder of the Paneth cell and vice versa PCs are regarded 
as the site of origin of intestinal inflammation in CD, as defects in its unfolded protein response 
function are likely to trigger the inflammatory reaction (Adolph et al., 2013).  
In this study we elucidated the role played by Paneth cells, a terminally differentiated and post-
mitotic secretory lineage, in the regenerative response to inflammation and its capacity to de-
differentiate and acquire stem cells characteristics to contribute to intestinal regeneration. Of note, 
expression of stem cell factor (SCF), i.e. the ligand of the c-Kit receptor specifically expressed in PCs, 
is enhanced in IBD patients and the DSS (dextran sodium sulfate) model. Indeed, the mechanisms 
underlying Paneth cell de-differentiation and stemness acquisition rely on the activation of PI3K/Akt 









Intestinal expression of the c-Kit ligand SCF is enhanced in IBD patients and in mouse models of 
pan-gastroenteritis.  
It has been previously reported that expression of stem cell factor (SCF) is increased in IBD 
patients (Andersson et al., 2017; Comar et al., 2012). This observation is of potential interest as the 
SCF gene, also known as KITLG, encodes the ligand of the tyrosine-kinase receptor c-KIT known to 
regulate survival, maintenance and self-renewal of stem cells (Lennartsson and Ronnstrand, 2012). 
Of note, both secretory Paneth cells (PCs) in the small intestinal epithelium and Paneth-like cells 
(PLCs) in the colon express the c-KIT receptor (Rothenberg et al., 2012). In contrast, the Lgr5+ CBCs do 
not express c-KIT (Clevers, 2016; Grun et al., 2016; Li et al., 2014; Munoz et al., 2012). In view of the 
known niche role played by Paneth cells in supporting Lgr5+ stem cells (Sato et al., 2011) and of their 
own capacity to respond to tissue damage by re-entering the cell cycle and acquiring stem-like cell 
properties (Buczacki et al., 2013; Roth et al., 2012; Schewe et al., 2016), we set to study the 
functional significance of SCF activation upon inflammatory insults by first validating the upregulation 
of SCF expression in IBD patients (i.e. Crohn’s disease (CD) and Ulcerative Colitis (UC)) and in the DSS 
mouse model of acute intestinal inflammation of the entire GI tract (pan gastroenteritis)(Elsheikh et 
al., 2012).  
SCF IHC analysis of a small cohort of IBD patients (n= 9, of which 5 UC and 4 CD, together with normal 
tissues from two colorectal cancer patients as controls) revealed increased expression in the 
epithelial lining, the mucosa and submucosa of the inflamed small intestinal and colon tissues from 
CD and UC patients, respectively (Figure 1A and S1A). As expected, Paneth cell metaplasia was also 
frequently observed in the colon of the analyzed IBD patients (3 out of 5 UC patients; Figure S1B). 
Next, we analyzed SCF expression in the DSS mouse model. DSS was administered orally (3% in 
drinking water) for a week in order to cause acute inflammation. At day 7 of DSS treatment, intestinal 
tissues were harvested and analyzed for SCF expression by RNA in situ hybridization which confirmed 
increased SCF expression in the small intestinal epithelium as well as the mucosa and submucosa of 
the treated mice (Figure 1B and S1C). RNA probes against PPIB (peptidyl-prolyl cis-trans isomerase 
B), here employed as positive controls, showed no differences between control and DSS-treated mice 
(Figure S1C). 
In order to assess whether increased SCF/c-Kit signaling plays a critical role during intestinal 
inflammation, we inhibited the pathway by administrating the specific c-Kit inhibitor ISCK03 in the 
drinking water together with DSS. ISCK03 alone had no effect on the overall health of the animals as 
shown by their unchanged body weight (Figure 1C), disease activity index (DAI; Figure 1D and S1D), 
and infiltrating CD3+ T-lymphocytes multiplicity (Figure S1E-F) when compared to control mice. 
However, mice treated with ISCK03 in combination with DSS suffered more severely compared to 
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mice treated with DSS alone, as shown by increased weight loss and DAI scores (Figure 1C-D and 
S1D) and number of infiltrating CD3+ T-lymphocytes (Figure S1E). 
Overall, these results confirm that expression of the c-Kit ligand SCF is enhanced upon intestinal 
inflammation and that activation of the SCF/c-Kit signaling axis is critical in the physiological response 
to the inflammatory insult. In view of the multifunctional nature of Paneth cells and of their 
expression of the c-Kit receptor, we set to analyze the functional consequences of the activation of 
the SCF/c-Kit signaling axis on the intestinal stem cell niche. 
   
Inflammation-driven SCF expression enhances intestinal stem cell function. 
In order to study the effects of inflammation and enhanced SCF expression on the intestinal stem 
cell niche, we employed ex vivo ‘mini-gut’ organoid formation as readout of stemness (Sato et al., 
2009; Schewe et al., 2016). To this aim we administered 3% DSS in the drinking water to C57BL/6J 
mice for one week and collected small intestinal crypts to assess their ability to form organoids at 
day 3 after withdrawal of DSS, i.e. at the peak of the regenerative response. As shown in Figure 1E, 
DSS treatment resulted in a significant increment in organoids multiplicity (~2 fold). Moreover, 
organoids from DSS-treated mice were of increased size and of more complex morphology (increased 
no. of budding events) when compared to the organoids from control animals (Figure 1E).  
To assess the role of increased SCF expression on the observed positive effect of DSS-driven 
inflammation on intestinal stem cell function, we harvested crypts from DSS-treated and control 
mice and supplemented the culture medium with a soluble c-Kit receptor, able to bind and sequester 
SCF thus preventing its interaction with its membrane-bound receptor (Dahlen et al., 2001). In 
parallel, c-Kit activity was also repressed by using the receptor tyrosine kinase inhibitor masitinib 
(Dubreuil et al., 2009). Whereas both the c-Kit receptor and masitinib had no significant effect on 
organoids derived from control animals, they substantially abrogated the increased organoid 
multiplicity observed in DSS-treated mice (Figure 1F).  
Next, we tested whether SCF alone was sufficient to improve organoid formation. As depicted in 
Figure 1G, the presence of SCF in the culture medium increased the overall number of intestinal 
organoids as well as the complexity of their morphology to a very similar degree of that observed in 
organoids of from DSS-treated animals (~2 fold). 
Hence, enhanced SCF expression upon inflammation appears to play a critical role in the tissue’s 
regenerative response by improving intestinal stem cell function. 
 
Lgr5+ stem cells are depleted upon inflammation. 
The observed positive effect of SCF on intestinal stem cell function in the regenerative response 




and overall multiplicity of Lgr5+ stem cells. To this aim, we administered 3% DSS to Lgr5EGFP (Lgr5–
EGFP–ires–CreERT2)(Barker et al., 2007) reporter mice for seven days followed by a three day 
recovery phase, to then determine Lgr5+ and PC multiplicity by FACS. Notably, Lgr5+ cells multiplicity 
was severely decreased in DSS-treated animals (~3 fold; Figure 2A-B and S2A-B), indicative of a 
severe loss of intestinal stem cells upon acute inflammation. No significant change in PCs multiplicity 
was observed upon DSS treatment compared to control mice (Figure 2B and S2A). 
We then compared the lineage tracing ability of Lgr5+ stem cells between control and DSS-treated 
mice. To this aim, we treated Lgr5-EGFP-IRES-CreERT2/R26-LSL-RFP mice with Tamoxifen to trigger 
recombination and lineage tracing from Lgr5+ CBCs. These animals were administered 3% DSS for one 
week to then be analyzed at day 3 after withdrawal of DSS. In line with the FACS data, confocal 
microscopy revealed a severe loss of Lgr5+ CBCs and a severe reduction of Lgr5-derived lineage 
tracing in the small intestine of DSS treated mice (Figure 2C-D and S2B). Of note, the residual tracing 
events extend throughout the length of the crypt villus axis, suggesting that the Lgr5+ stem cells that 
escape the DSS treatment fully retain their self-renewal and differentiation capacity.  
To rule out that the DSS-driven inflammation suppresses Lgr5 gene expression without affecting 
intestinal CBCs, we performed IHC analysis on intestinal tissues from DSS-treated mice with an 
antibody directed against the Olfm4 protein whose expression overlaps with that of Lgr5 (van der 
Flier et al., 2009a). As shown in Figure 2E-F and S2C, a significant reduction in Olfm4+ cells is evident 
in intestinal crypts from DSS-treated animals, especially at the crypt base where they normally are 
intermingled with PCs.  
Altogether, these results demonstrate that acute inflammation causes a severe loss of intestinal stem 
cells that are consequently no longer capable of contributing to the regenerative response to the 
tissue damage.  
 
Paneth cells underlie enhanced intestinal stem cell function upon inflammation. 
The loss of Lgr5+ stem cells upon acute inflammation is in sharp contrast with the positive effect 
exerted by DSS on intestinal stem cell function as shown by organoid assays. To assess whether any 
de novo proliferating cell type is detectable in the intestinal crypt upon inflammation, we performed 
Ki67 staining on small intestinal tissues from DSS-treated and control mice. In the latter, Ki67 
expression is restricted to the slender CBCs (Lgr5+) cells at the bottom of the crypt and to the 
transient amplifying compartment, whereas the post-mitotic PCs are negative (Figure 3A, left panel). 
In DSS-treated mice however, apart from the absence of cells morphologically similar to CBCs, the 
granulated PCs are Ki67-positive (Figure 3A, right panel). We confirmed the Paneth cell identity of 
these proliferating cells by confocal microscopy: lysozyme/Ki67 double positive cells are present in 
the intestinal crypts of DSS-treated mice (Figure S3A). Quantification of the number of crypts 
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encompassing proliferative PCs (Ki67+; >30%) highlights the relatively high frequency of reacquisition 
of proliferative capacity by Paneth cells upon tissue damage (Figure 3B). Notably, Ki67+ PCs could 
also be detected in the inflamed ileal tissues of CD patients (Figure S3B; 2 out of 4). 
In view of these and previous results (Roth et al., 2012), we addressed the functional role played by 
these secretory cells in the regenerative response of the intestinal stem cell niche to the 
inflammatory insult. To this aim, the organoid reconstitution assay (ORA) was employed (Schewe et 
al., 2016; Schewe et al., 2017). Here, Lgr5+ and PCs are sorted by FACS from control and DSS-treated 
Lgr5EGFP mice to then be reconstituted in different combinations to form intestinal organoids (Figure 
3C-D). As expected, reconstitution of Lgr5+ with PCs both from control mice led to the formation of 
organoids, whereas neither Lgr5+ nor Paneth cells alone were able to form organoids. Reconstitution 
of Lgr5+ and PCs from DSS-treated mice resulted in a significant increase in organoid numbers, similar 
to the effect of DSS on organoid formation from whole intestinal crypts. Reconstitution of Lgr5+ cells 
from DSS-treated mice with PCs from controls did not differ in organoids numbers from the control 
(both cell types from untreated mice), suggesting that stem cell function of the residual Lgr5+ cells, as 
also observed in vivo (Figure 2C), is unaffected. Last, Paneth cells from DSS-treated mice 
reconstituted with control Lgr5+ stem cells resulted in a significant increase in organoid multiplicity 
when compared to the reconstitution of control Lgr5+ and PCs. This indicates that the enhanced stem 
cell function elicited by inflammation is mediated by Paneth cells, possibly through their previously 
reported niche role in support of Lgr5+ stem cells (Sato et al., 2011). However, the observed 
proliferative response of PCs to inflammation suggests alternative scenarios where the post-mitotic 
secretory cells directly contribute to tissue regeneration by de-differentiation and acquisition of stem 
cell features. Indeed, Paneth cells from DSS-treated mice were able to form organoids autonomously 
(i.e. in the absence of Lgr5+ cells) (Figure 3C-D). 
Next, we took advantage of the ORA by exposing Paneth (and Lgr5+) cells sorted from control mice to 
recombinant SCF, prior to their reconstitution in different combinations (Figure 3E). As expected, 
untreated Lgr5+ or PCs gave rise to very low numbers of organoids when plated alone. The latter was 
also true for Lgr5+ cells pretreated with SCF. However, SCF treatment of PCs resulted in a striking 
increase in organoid multiplicity (approx. 10-fold). Accordingly, reconstitution of SCF-treated Lgr5+ 
cells with untreated PCs did not affect the number of organoids when compared to the controls. 
Instead, SCF-treated Paneth cells gave rise to the highest organoid multiplicity when reconstituted 
with untreated Lgr5+ cells (Figure 3E).  
To provide definitive evidence of the Paneth cell origin of these organoids, we repeated the DSS 
treatments and organoid experiments using LysCreERT2/R26LSL-YFP mice and YFP+ PCs isolated during the 
regenerative phase. The resulting organoids were entirely composed of YFP+ cells, confirming that, 




vivo (Figure 3F, left panel). Also in the case of SCF treatment we repeated the experiment with PCs 
from tamoxifen-treated LysCreERT2/R26LSL-YFP mice, and confirmed that the organoids are entirely 
composed of YFP+ cells (Figure 3F, right panel). 
To demonstrate that Paneth cells can also act in vivo as stem cells in response to inflammation, 
we administered DSS to LysCreERT2/R26LSL-YFP mice and analyzed their small intestine for lineage tracing 
events at several time points after withdrawal of DSS. In tamoxifen-treated control mice, YFP 
fluorescence was entirely restricted to PCs located at the crypt base (Figure 4A,C). However, FACS 
analysis of tamoxifen-treated LysCreERT2/R26LSL-YFP mice revealed that only a small proportion (~12%) of 
PCs express YFP after 3 consecutive injections of Tamoxifen (2 mg/20g bodyweight/day) (Figure S4A 
upper panel and S4B). Nonetheless, virtually all (97%) of the YFP+ cells were confirmed to be PCs by 
FACS (Figure S4B lower panel, and S4C). No YFP signal was detected prior to tamoxifen 
administration (Figure S4C). In DSS- (and tamoxifen-) treated animals, the YFP signal was still 
restricted to Paneth cells at the crypt base one day after DSS removal (Figure S4D). However, already 
at this time point a proportion of the YFP+ cells started to show nuclear Ki67, indicative of cell cycle 
re-activation in PCs (Figure 4B). Three days after DSS removal, short ribbons of YFP+ cells were 
observed within the intestinal crypts. Seven days after removal of DSS, YFP stained approximately 50-
70% of the crypt-villus axis and reached the tip of the villi at day 10 (Figure 4A). These in vivo results 
demonstrate that, upon DSS-driven acute inflammation, Paneth cells acquire stem cell features and 
repopulate the intestinal epithelium thus contributing to the tissue regenerative response.  
To assess the pluripotency of the Paneth-derived stem cells, we carried out IF analysis with lineage-
specific markers of the YFP+ ribbons from DSS-treated LysCreERT2/R26LSL-YFP mice at day 7 of the recovery 
phase. As shown in Figure 4D, YFP+ cells located at the bottom of the crypt co-expressed Olfm4 
indicating that new CBCs are generated from lysozyme-expressing PCs. As for the YFP+ cells located 
above the crypt base and along the villus axis, expression of entero-endocrine (ChrA+/YFP+), goblet 
(Muc2+/YFP+), and Tuft (Dclk1+/YFP+) lineage-specific markers was detected (Figure 4E). Hence, the 
Paneth-derived stem cells give rise to ribbons which recapitulate both the crypt-villus architecture 
and heterogeneous cell lineage composition of the intestinal epithelium.  
Taken together, our results show that upon acute inflammation Paneth cells de-differentiate into 
proliferating stem-like cells able to form 3D organoids ex vivo, and to repopulate in vivo the epithelial 
lining giving rise to stem cells as well as all the differentiated lineages of the adult intestinal 
epithelium. Activation of the SCF/c-Kit signaling pathway plays a central role in acquisition of stem-
like features by Paneth cells upon inflammation. 
 
Activation of the SCF/c-Kit signaling axis and of the downstream PI3K/Akt and Wnt pathways elicit 
stemness in Paneth cells upon inflammation. 
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SCF/c-Kit signaling has been shown to activate several downstream signaling pathways 
(Lennartsson and Ronnstrand, 2012). In order to assess which of these pathways may play a role in 
the observed de-differentiation and acquisition of stem-like features in Paneth cells upon 
inflammation and the consequent SCF/c-Kit signaling activation, we treated whole small intestinal 
crypts with SCF in combination with several inhibitors of known downstream pathways such as 
MAPK, mTor, PI3K/Akt and Jak/Stat signaling, and tested their capacity to form organoids (Figure 
S5A). As shown before, SCF treatment alone significantly increased organoid multiplicity when 
compared to untreated crypts. MAPK signaling inhibition completely repressed organoid growth both 
in the presence or absence of SCF thus indicating an essential role for this pathway in organoid 
growth independently of the activation of the SCF/c-Kit signaling axis. In contrast, the mTOR inhibitor 
rapamycin did not affect organoid multiplicity with or without SCF. Inhibition of Jak1 instead 
increased organoid numbers to the same extent both in the absence and presence of SCF. Out of the 
4 main downstream pathways tested, only the inhibition of PI3K/Akt signaling completely and 
specifically abrogated the positive effects exerted by SCF on organoid growth (Figure S5A).  
To establish whether SCF activates PI3K/Akt signaling in Paneth cells, whole intestinal crypts from 
Lgr5EGFP mice were treated with SCF and analyzed by IF with antibodies directed against pan- and 
phosphorylated Akt. Although Akt was expressed in all cell types of the intestinal crypt (Figure S5B), 
Akt phosphorylation was exclusively observed in Paneth cells upon SCF stimulation (Figure 5A and 
S5C). Western blot analysis of Paneth cells sorted by FACS and incubated with SCF confirmed the 
increased pAkt levels in the secretory cells. In contrast, analysis of the c-Kit negative Lgr5+ stem cells 
did not reveal any change (Figure 5B-C).  
To assess the relevance of the role played by PI3K/Akt signaling in the response to inflammation, PCs 
were sorted from DSS-treated mice and cultured to generate organoids in the presence of specific 
PI3K- (BKM120(Wen et al., 2012)) and Akt- (AKTVIII(Barnett et al., 2005)) inhibitors. In confirmation 
of the above result with whole intestinal crypts, both PI3K as well as Akt inhibition significantly 
reduced the number of organoids obtained from Paneth cells alone (Figure 5D-E). Likewise, in 
reconstitution assays, inhibition of PI3K or Akt in PCs significantly repressed organoid growth when 
Lgr5+ and Paneth cells from DSS-treated mice were employed though not from untreated mice 
(Figure 5D).  
In order to evaluate the global effects of acute inflammation on Paneth cells, we performed RNA 
expression analysis by NGS (RNAseq) on sorted cells from control and DSS-treated mice. In 
agreement with the in vivo data, the RNAseq results revealed the upregulation of genes related to 
cell proliferation and the cell cycle, and the downregulation of PC-specific markers such as lysozymes 
and defensins (Figure 5F). Of note, a group of genes known to earmark infrequently dividing and 




from DSS-treated mice, whereas the expression of other stem cell markers such as Lgr5, Bmi1, and 
Hopx appeared to be reduced (Figure S5D).  
Last, pathway analysis performed on the differentially expressed genes pointed at the activation of 
the canonical Wnt signaling pathway, as shown by the upregulation of several Wnt target genes of 
(Figure 5F). This is likely to be related with the observed role played by PI3K/Akt signaling 
downstream of SCF/cKit: it has been shown that PI3K/Akt activation can increase Wnt signaling 
activity through GSK3inhibitory phosphorylation at Ser-9(Doble and Woodgett, 2003). IF analysis of 
whole-mount intestinal crypts revealed that, as for Akt, GSK3 is expressed in all epithelial cells 
(Figure S6A). In these control crypts, Lgr5+ stem cells as well as the proliferative TA compartment 
express high levels of phosphorylated GSK3 as a result of Wnt signaling activation in these lineages 
(Figure 6A). In contrast, PCs appear negative for pGSK3, notwithstanding their characteristic nuclear 
-catenin localization(van Es et al., 2005). However, upon SCF treatment an increase of GSK3 
phosphorylation in Paneth cells becomes evident (Figure 6A-B). Western blot analysis of sorted Lgr5+ 
and Paneth cells confirmed the increased GSK3 phosphorylation in PCs, though not in CBCs upon 
DSS treatment (Figure 6C-D).  
GSK3 inhibitory phosphorylation in SCF-treated Paneth cells is expected to inhibit -catenin 
proteolytic degradation leading to its cytoplasmic accumulation and translocation into the nucleus 
where it acts as a co-transcriptional factor to activate expression of Wnt target genes. To validate the 
ability of SCF to increase Wnt signaling even in already Wnt-active cells, the TOP/FOP Wnt reporter 
gene assay was implemented in the colon cancer cell line CaCo2. Supplementation of the culture 
medium with recombinant SCF significantly enhanced Wnt signaling in this APC-mutant cell line 
(Figure 6E). In order to validate that SCF can activate Wnt signaling also in PCs, qRT-PCR analysis of 
specific Wnt target genes was performed on sorted Paneth cells treated with SCF. In line with the 
results of the reporter gene assay and in confirmation of the RNAseq data from DSS-treated mice, 
upregulation of Axin2, Jun, and Ccdn1 (cyclin D1) was found in SCF-treated PCs (Figure 6F). 
To confirm that inflammation enhances Wnt signaling in Paneth cells in vivo, we analyzed by IHC 
their intracellular -catenin distribution. As expected, nuclear -catenin was observed in PCs from 
control animals with hardly any cytoplasmic staining. In contrast, PCs from DSS-treated mice showed 
a clear increase in cytoplasmic -catenin, indicative of its increased stability and, consequentially, of 
enhanced Wnt signaling (Figure 6G). 
Since Paneth cell differentiation is known to be driven by Wnt (van Es et al., 2005), the functional 
consequences of its further activation downstream of the SCF/c-Kit signaling axis in a cell type 
already earmarked by nuclear -catenin in the context of the regenerative response to inflammation 
are yet unclear. In order to elucidate this aspect, we employed CHIR99021 (Chiron), a potent and 
selective GSK3 inhibitor leading to robust Wnt signaling activation, in organoid assays. As shown in 
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Figure 6H-I, upon Chiron supplementation in the culture medium PCs from control animals gave rise 
to high organoid numbers. As expected, Chiron treatment had a similar effect on Lgr5+ CBCs. Of note, 
although a majority of enterospheres, i.e. spherical structures primarily composed of stem cells and 
lacking budding and branching structures (Stelzner et al., 2012), was observed during the early phase 
of the culture, upon Chiron withdrawal differentiation occurred and ‘normal’ organoid morphologies 
were observed both from PCs and Lgr5+ cells (Figure 6I). Indeed, conversion between enterospheres 
and organoids has been shown to be regulated by Wnt signaling (Fordham et al., 2013; Mustata et 
al., 2013). 
Finally, in order to demonstrate the in vivo relevance of the activation of the SCF/c-Kit signaling 
axis in Paneth cells during the regenerative response to inflammation, we administered the specific 
c-Kit inhibitor ISCK03(Na et al., 2007) to DSS-treated mice. As previously shown (Figure 1C-D), mice 
treated with both DSS and ISCK03 suffered from increased loss of body weight and an overall 
decrease in DAI scores when compared to animals treated with DSS alone. To assess whether this 
deleterious effect parallels the lack of Wnt “super-activation” downstream of the SCF/cKit signaling 
axis, -catenin IHC analysis was again performed in small intestinal tissues from mice treated with 
DSS alone or in the presence of the ISCK03 inhibitor.  As shown in Figure 7A, DSS treatment alone 
causes enhanced -catenin accumulation in the cytoplasm and nucleus of PCs, indicative of increased 
Wnt signaling activation. This effect is almost entirely abrogated in mice treated simultaneously with 
both DSS and ISCK03. Furthermore, ISCK03 significantly reduced the number of Ki67+ PCs in DSS-
treated mice (Figure 7B-C and S7A). Accordingly, combined DSS/ISCK03 treatment of Lyz-Cre/YFP 
mice strongly compromised the ability of Paneth cells to lineage trace upon inflammation (Figure 7D-
E). 
Taken together, these results show that inhibition of the SCF/c-Kit signaling axis prevents 
downstream Wnt signaling activation in Paneth cells thus compromising their capacity to acquire 







Inflammatory bowel disease (IBD) is regarded as an emerging global ailment in view of its steadily 
rising incidence during the last decades (M'Koma, 2013). Apart from its profound negative effects on 
the patient’s quality of life, IBD is associated with an increased risk of developing intestinal cancer 
(Itzkowitz and Yio, 2004; Jia et al., 2008; Rosen and Jordan, 2009). From this perspective, the 
elucidation of the cellular and molecular mechanisms underlying the regenerative response of the 
intestinal stem cell niche to inflammatory tissue damage is of fundamental and translational 
relevance. Due to the complexity of the tissue response to injury and in view of the fact that IBD 
syndromes as ulcerative colitis and Crohn’s disease affect different segments of the digestive tract, 
we have here chosen to model IBD in the mouse through DSS administration in the drinking water 
(Elsheikh et al., 2012). The mucosal injury caused by DSS results in acute inflammation of the entire 
GI tract (pan gastroenteritis) through recruitment and activation of inflammatory cells, followed by a 
rapid tissue regeneration phase (Vowinkel et al., 2004) thus providing a useful preclinical in vivo  
inflammation model for both UC and CD.  
Enhanced secretion of the stem cell factor (SCF) has been reported in the plasma of IBD patients 
(Andersson et al., 2017; Comar et al., 2012) and here confirmed both in the intestinal epithelium and 
underlying stroma of UC and CD patients and in the DSS mouse model. This is of interest in view of 
the specific expression of the SCF transmembrane receptor c-Kit in Paneth cells and their equivalent 
in the colon (Rothenberg et al., 2012). Increased SCF expression was also observed in intestinal 
epithelial cells in response to Cholera Toxin or Salmonella thypimurium infection (Klimpel et al., 
1995; Klimpel et al., 1996). SCF/c-Kit signaling is a major regulator of proliferation and differentiation 
in the hematopoietic system (Broudy, 1997). Mast cells and dendritic cells express high c-Kit levels 
even when fully differentiated, yet retaining the capacity to re-enter the cell cycle in response to 
extracellular SCF stimulation (Metcalfe et al., 1997; Ray et al., 2010).  Besides, the functional analysis 
of the response of Paneth cells to SCF as shown here is of broader interest as indicated by the role 
played by SCF expression from differentiated tumor cells in the maintenance of c-Kit expressing colon 
cancer stem cells (Fatrai et al., 2015). 
We here show that severe loss of Lgr5+ CBCs characterizes the primary response to DSS-driven 
inflammation. Targeted ablation of Lgr5+ stem cells in the mouse intestinal epithelium showed that 
these cells are in fact dispensable and that their role is taken over by their quiescent counterparts 
(Tian et al., 2011; van der Flier et al., 2009b). Depletion of Lgr5+ stem cells has also previously been 
reported in the colon of DSS-treated mice where they reappear at day 5 of the recovery phase to 
then reach normal levels one day after (Davidson et al., 2012). Similarly, loss of Lgr5+ CBCs has been 
observed upon high-dose -irradiation (Yan et al., 2012). In both cases the depletion is temporary 
and the CBC pool at the base of the crypt is rapidly restored.  
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More persistant CBCs loss upon tissue injury is compensated by the regenerative response of 
alternative stem cell pools including the infrequently cycling Bmi1+ stem cells at position +4 
(Sangiorgi and Capecchi, 2008; Yan et al., 2012), secretory (Dll1+)(van Es et al., 2012) and enterocyte 
(Alpi+)(Tetteh et al., 2016) progenitors, in addition to LRCs expressing Paneth cell markers (Buczacki 
et al., 2013; Roth et al., 2012), capable of reacquiring proliferative and self-renewal cell capacity 
upon tissue injury or targeted CBCs ablation. As such, the intestinal epithelium shows remarkable 
plasticity with several stem and progenitors cell types contributing to the restoration of tissue 
integrity and the re-establishment of the actively cycling Lgr5+ CBCs (Yousefi et al., 2017). However, 
the ablation and tissue injury protocols employed in these studies are not directly relevant for IBD 
and the tissue damage caused by inflammation. Also, it is not clear whether the plasticity of the 
intestinal epithelium, apart from the above stem and progenitor cells, also extends to more 
committed and even post-mitotic lineages. Here, we show that, following the initial loss of Lgr5+ 
CBCs, the response to acute inflammation features fully differentiated Paneth cells capable of re-
entering the cell cycle, lose their secretory features, and acquire self-renewal and pluripotency thus 
contributing to the repair and regeneration of the damaged intestinal tissue.  
As mentioned above, the specific expression of the c-Kit receptor in Paneth cells and in their 
counterparts in the colon (Rothenberg et al., 2012; Schewe et al., 2016), and the increased secretion 
of its natural ligand SCF upon inflammation both in IBD patients and in the DSS mouse model are of 
functional relevance for cell cycle re-entry, dedifferentiation, and acquisition of stem cell properties 
by these mature and normally post-mitotic secretory cells. Stimulation of the SCF/c-Kit signaling axis 
results in a cascade of downstream events from PI3/Akt pathway activation to GSK3inhibitory 
phosphorylation. Of note, PI3K/Akt activation upon SCF/c-kit signaling induction has been shown to 
promote cell proliferation, growth, and survival in several models including colon cancer cell lines 
(Jeon et al., 2009; Vajravelu et al., 2015; Yasuda et al., 2007). Among the many pleiotropic effects of 
GSK3inhibition, Wnt/-catenin signaling activation is likely to play a central role in conferring 
proliferative and stem-like features to Paneth cells as here observed. However, it is well-established 
that Wnt signaling also underlies Paneth cell differentiation (van Es et al., 2005) and is retained in the 
mature secretory cells as indicated by their characteristic nuclear -catenin staining. Distinct Wnt 
signaling dosages are associated with different downstream target genes and stem cell 
differentiation outcomes, as previously shown by our laboratory (Gaspar and Fodde, 2004; Kielman 
et al., 2002). Moreover, ectopic activation of canonical Wnt signaling was shown to be essential for 
the quiescence exit of mTert+ stem cells as well as for Dll1+ progenitors to regain stemness 
(Montgomery et al., 2011; van Es et al., 2012). Indeed, ex vivo enhancement of Wnt signaling in 




role of the ‘super-activation’ of this pathway downstream the SCF/c-Kit axis in the de-differentiation 
and cell cycle re-entry of secretory cells during tissue regeneration.    
Of note, the regenerative capacity of Paneth cells is maintained ex vivo, as shown by their capacity to 
form small intestinal organoids when isolated from DSS-treated mice (or upon SCF-stimulation) in the 
absence of Lgr5+ CBCs. Thus, Paneth cells represent an additional pool of reserve stem cells capable 
of contributing to tissue regeneration upon injury. However, in view of their role in supporting Lgr5+ 
CBCs (Sato et al., 2011), it is also plausible that inflammatory cues may enhance their niche function 
next to the expansion of the stem cell pool. Although ex vivo reconstitution of Paneth cells from DSS-
treated animals with Lgr5+ CBCs from control mice resulted in a markedly increase in organoid 
multiplicity, analysis of their expression profiles did not reveal a significantly increase in the 
expression of niche signals (e.g. EGF, TGF, Wnt3 or Dll4; data not shown) usually provided by Paneth 
cells to maintain stemness of CBCs (Sato et al., 2011). Nevertheless, inflammation is likely to exert 
context-dependent effects in the small and large intestine. Indeed, SCF was found among the 
proteins previously shown to be present at significantly different abundances between UC and CD 
(Andersson et al., 2017). Paneth cell metaplasia, i.e. the appearance of Paneth cells in the colon 
where they normally do not belong (Paterson and Watson, 1961), is frequently observed among UC 
patients and may result from differentiation of the c-Kit+ cells to provide further niche support to 
stem cells in response to inflammation. On the other end, metaplastic Paneth cells have also been 
observed in colon adenomas and carcinomas (Lewin, 1968; Wada et al., 1992) and as such proposed 
to represent important precursors of IBD-associated colon cancer (Wada, 2009; Wada et al., 2005). 
Hence, the regenerative response to inflammatory tissue damage may differ between small intestine 
and colon and reflect the distinct predisposition to bowel cancer among IBD patients. Lineage tracing 
of the c-Kit+ Paneth-like cells of the colon upon DSS administration will likely clarify this aspect. 
The presence of multiple and distinct pools of low-cycling stem cells in the intestinal epithelium 
raises the issue of their individual roles and relative contributions to tissue regeneration upon 
inflammation. Two studies showed that Paneth cells depletion does not have major consequences 
and as such may be dispensable in intestinal tissue homeostasis/regeneration (Durand et al., 2012; 
Garabedian et al., 1997). However, it is unclear whether the ablation of Paneth cells in these mouse 
models is limited to fully mature cells as their secretory precursors may compensate for the loss of 
niche and stem cell functions. Also, these depletion models have not been challenged by 
inflammation. In support of their essential role, other studies demonstrated that Paneth cells are 
critical to provide niche support and maintain the Lgr5+ stem cell population during crypt 
regeneration (Geiser et al., 2012; Parry et al., 2013; Sato et al., 2011). Given these rather 
controversial observations, future studies should focus on the role of Paneth cells in ensuring 
intestinal tissue integrity particularly in the context of inflammation. Notably, inhibition of SCF/c-Kit 
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signaling resulted in an increased weight loss and disease activity index upon inflammation likely to 
result at least partially from the prevention of Paneth cells to take part in intestinal tissue repair. 
However, as c-Kit is expressed in other cell types regulating inflammatory responses such as mast, 
dendritic, and interstitial cells of Cajal (Miettinen and Lasota, 2005), further studies are required to 
reveal the specific role of c-Kit inhibition of Paneth cells in the response  to inflammation. 
In conclusion, we show that activation of the SCF/c-Kit signaling axis upon inflammation induces 
cell cycle re-entry, dedifferentiation, and acquisition of stem cell properties in Paneth cells by 
enhancing Wnt through PI3K/Akt activation and GSK3 inhibition. As such, beside their role as 
regulators of the intestinal microflora and as niche cells for actively cycling CBCs, Paneth cells serve 
as a pool of quiescent stem cells that can be reactivated upon tissue insults and contribute to tissue 
regeneration. The diversity and complexity of their functional roles in IBD, dysbiosis, and cancer 
make of Paneth(-like) cells in the small bowel and in the colon a central node for intestinal 
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All mice employed in this study were aged between 8-12 weeks of age, fed ad libitum, and maintained at the 
Erasmus MC animal facility (EDC) and the IPMC animal facility under conventional SPF conditions. Inbred 
C57BL/6J mice were from Charles River Laboratories. All procedures were performed in agreement with local 
animal welfare laws and guidelines. 




 model will be described elsewhere (JH van Es, in 
preparation). In short: the pLys
CreERT2
 mouse model was generated through homologous recombination in IB10 
embryonic stem cells (129/Ola). The CreERT2 gene was knocked onto the ATG start codon of the of the 
lysozyme (Lys) gene. Both flanking arms were generated by high-fidelity PCR reactions from male 129/Ola-
derived BAC DNA and subsequently cloned into PL451. The targeting construct (100 μg) was linearized and 
transfected into male 129/Ola-derived IB10 embryonic stem cells by electroporation (800V, 3F). Recombinant 
ES cell clones expressing the neomycin gene were selected in medium supplemented with G418 (250 μg/ml). 
Recombinant embryonic stem cell clones were screened by Southern blotting. The frequency of homologous 
recombination was 4%. Two positive clones were selected and injected into C57BL/6 derived blastocysts using 
standard procedures. Both  injected clones gave germline transmission. The neomycin selection cassette was 
flanked by Frt recombination sites and excised in vivo by crossing the mice with the general FLP deleter strain 
(Jackson Lab.). Lys
CreERT2
 mice were then crossed with R26
LSL-YFP 
mice (R26R-YFP, #006148, Jackson Lab).  




 mice were intraperitoneally (i.p) injected once with 




 were i.p. injected three times on 
consecutive days with 1 mg/20 g body weight. Tamoxifen was dissolved in 100% Ethanol (stock concentration 
200mg/ml). For i.p. injection the Tamoxifen stock solution was diluted 1:10 in sunflower oil (#S5007, Sigma). As 
controls, mice were injected with 10% Ethanol in sunflower oil.  
Disease Activity Index (DAI) scores upon DSS-induced inflammation were obtained according to (Cooper et al., 
1993) with minor modifications. Mice were administered 3% dextran sulfate sodium salt (colitis-grade; 
#0216011050, MP Biomedicals) through the drinking water for seven days during which the animals were 
monitored for a specific set of parameters including stool consistency, blood loss, appearance, and % weight 




gross bleeding (1); appearance = normal (0), hunched (1), starey coat (2), lethargic (3); % weight loss = none (0), 
0-10 (2), 10-20 (2), >20 (3).  
ISCK03 (#15781, Cayman Chemical) was administered via drinking water to the mice at a concentration of 0.1 
mg/ml. For lineage tracing experiments, IF, IHC, or RNA in situ hybridization (ISH) analysis, mice were sacrificed 
at indicated time points post DSS treatment. 
 
Immunohistochemistry (IHC) analysis 
Mouse tissues were fixed overnight in 4% PFA and embedded in paraffin. Human tissues (normal and IBD) were 
already available as paraffin blocks from the department of Pathology at the Erasmus MC. Four µm sections 
were mounted on slides. IHC was performed using antibodies against SCF (1:500; #600-401-EE1, Rockland), 
OLFM4 (1:200; #39141, CST), Mki67 (1:200; #NB500-170, Novus biologicals) β-catenin (1:500; #610154, BD 
Biosciences) and CD3 (1:400; #ab5690 Abcam). Briefly, paraffin embedded sections were dewaxed with Xylene 
and hydrated in 100% and 70% ethanol. Antigen retrieval was performed using pressure cooker pretreatment 
in a Tris-EDTA buffer (pH 9.0). Slides were then incubated at 25°C in 3% hydrogen peroxidase for 15’ to block 
endogenous peroxidase activity. Tissue sections were washed and blocked with 5% BSA in PBS-Tween for 1 
hour to then be incubated with the primary antibody overnight at 4 °C. Slides were washed twice with PBS-
Tween and incubated with Rabbit EnVision+ System-HRP (#K4011, Dako) or Mouse EnVision+ System-HRP 
(#K4007, Dako) for 30 min. Sections were counterstained with Mayer’s Hematoxylin and dehydration was 
performed by incubation in 70% and 100% ethanol followed by Xylene, before slides were mounted using 
Pertex (#00811, Histolab). The quantification of Ki67
+ 
Paneth cells refers to the amount of crypts containing at 
least one Ki67+ Paneth cell was detected.  
The quantification of Olfm4
+
 cells is based on the average number of Olfm4-positive cells per crypt throughout 
the length of the small intestine. The quantification of CD3
+
 cells is based on the average number of CD3
+
 -
positive cells infiltrating the intestinal epithelium per villus. For each quantification, at least 50 crypts or villi per 
mouse, and at least 3 experimental mice were employed.  
 
Immunfluoresence (IF) and lineage tracing analysis 
Paraffin embedded tissues were prepared as described for IHC up to the peroxidase blocking step. For cryo-
sections, tissue samples were first dissected and washed with PBS, to then be fixed for 2 hours at 25°C with 4% 
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buffered formaldehyde solution (Klinipath). Tissues were cryo-protected in 30% sucrose (Sigma) overnight at 
4°C, embedded in OCT (KP cryocompound, #1620-C, Klinipath), frozen on dry ice, and sectioned at −20°C. 
Tissues were cut in 4-8 µm thick sections. When applicable, sections were incubated in blocking buffer (5% milk 
powder in PBS-T) for 30 min. at 25°C, and stained with primary antibodies directed against the following 
proteins: Mki67 (1:100; #NB500-170, Novus biologicals), lysozyme (C19) (1:100; sc-27958, Santa Cruz), 
lysozyme EC 3.2.1.17 (1:1000; #A0099, Dako), OLFM4 (1:100; #39141, CST), Muc2 (H-300) (1:500; #sc-15334, 
Santa Cruz), chromogranin A (1:200; #NB120-15160, Novus Biologicals), and DCAMKL1 (1:200; #ab31704, 
Abcam) in blocking buffer overnight at 4°C. After washing in PBS-T, slides were incubated for 2 hours with the 
following secondary antibodies: Goat anti-Rabbit IgG (H+L) secondary Antibody, Alexa Fluor® 568 conjugate, 
(1:250; # A-11011, Life Technologies), Donkey anti-Rabbit IgG (H+L) secondary Antibody, Alexa Fluor® 568 
conjugate (1:250; # A-21202, Life technologies) or Donkey anti-Goat secondary Antibody, Alexa Fluor® 633 
conjugate (1:250; #A-21082, Life technologies). Tissues were counterstained with Alexa Fluor® 568 Phalloidin 
(1:100; #A12380, Invitrogen) or Alexa Fluor® 633 Phalloidin (1:100; #A22284, Invitrogen), and DAPI (#D8417, 
Sigma) for 30 min. at 25°C and washed in PBS-T. Tissues were mounted in VECTASHIELD HardSet Antifade 
Mounting Medium (#H-1400, Vector Labs) and imaged with a Zeiss LSM700 confocal microscope. Images were 
processed with ImageJ (U.S. National Institutes of Health, Bethesda, MD, USA).  




 was quantified by dividing the number of intestinal crypt/villus 
axes containing YFP
+




RNA in-situ hybridization (ISH) 
Paraffin embedded tissues were prepared as described for IHC. SCF ISH analysis was performed by using the 
RNAscope kit (ACDbio) according to the manufacturer’s instructions. Four μm formalin-fixed, paraffin-
embedded tissue sections were pretreated with heat and protease before hybridization with a target probe to 
SCF mRNA (RNAscope
®
 2.5 VS Probe- Mm-Kitl (#423409, ACDbio)). An HRP-based signal amplification system 
was then applied followed by colorimetric development with DAB. Positive staining was identified as brown, 
punctate dots. Specificity of the SCF-RNA probes were tested by using PPIB (Cyclophilin B) and DapB gene 






To establish organoid cultures ex vivo, two distinct sources of cells were employed namely either whole crypts 
or single cell suspensions both from freshly resected mouse intestinal tissues. Whole crypts were extracted 
from the small intestine by incubating the minced tissues with 2 mM EDTA for 30 min. at 4°C. Crypts were then 
pelleted and passed through a 70 μm strainer. Whole crypt cultures were performed as previously described in 
standard ENR medium (Sato et al., 2009) supplemented, when indicated, with SCF (150ng/ml; #250-03, 
Peprotech), soluble c-kit receptor (500ng/ml; #1356-SR-050, R&D Systems), masitinib (200nM; #S1064, 
Selleckchem), rapamycin (10 nM; #13346, Cayman Chemicals), U0126 (1 µM; #70970-1; Cayman Chemicals), 
LY294002 (5 µM; #70920, Cayman Chemicals),and ruxolitinib (0.5 µM; #11609-1, Cayman Chemicals). 
As for organoid reconstitution assays (ORA), isolated crypts were first digested to single cells after incubation 
with TrypLE (Life Technologies) and 2000 U/ml-1 Dnase (Sigma) for 10 min. at 37°C. Dissociated cells were 
passed through a 40 μm strainer, stained with an APC-conjugated CD24 antibody (clone M1/69 BioLegend), 
and, to exclude non-epithelial cells, with the following Ab’s for 30 min. at 4°C: BV421-conjugated TER119 (#TER-
119, Biolegend), CD31 (#390, Biolegend), CD45 (#30-F11, Biolegend). For Paneth cell analysis, an additional 
staining with a PE-conjugated CD117 antibody (#2B8, Biolegend) was also performed. Cells were then sorted by 
FACS (BD FACSAriaIII; BD Bioscience). Single viable epithelial cells were gated by CD24 and side scatter (SSC), 
and by negative selection against the above BV421-conjugated Ab’s and with DAPI to discriminate live from 
dead cells. Detailed FACS gating strategy for the small intestine was performed as previously described (Roth et 
al., 2012). Reconstitution of Lgr5-EGFP
hi
 stem cells (purity >99%) with Paneth cells (CD24hiSSChi; purity >98%) 
was performed by pelleting sorted cells at 300 g. for 5 minutes in Eppendorf LoBind Tubes, and by co-
incubating them for 15 min. at 25°C as previously described (Sato et al., 2011). In order to implement the 
reconstitution assay upon activation of sorted cells with SCF, Paneth or Lgr5-EGFP
hi
 cells were first incubated 
with 150 ng/ml of recombinant murine SCF for 30 min. at 37°C in DMEM F12 before reconstitution. In order to 
inactivate GSK3β, sorted Paneth and Lgr5
+
 cells were incubated with standard reconstitution medium + 5 µM 
Chiron (CHIR99021, #4423, Tocris) for 4 days followed by incubation in standard ENR medium. In order to 
inhibit PI3K and AKT, sorted Paneth cells were incubated with specific chemical inhibitors NVP-BKM120 for PI3K 
(1 µM; #11587, Cayman Chemical) and AKT inhibitor VIII for AKT (4µM; #14870, Cayman Chemicals) for 30 min., 
centrifuged at 300g for 5 min., and then washed in 200 l of Advanced DMEM F12.  
Following these treatments, Paneth and Lgr5
+
 stem cells were centrifuged at 300g for 5 minutes and 
subsequently reconstituted by resuspension in 30 μl Matrigel (BD Bioscience), and culture in 96 Well Flat 
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Bottom dishes (Corning).  Alternatively, they were plated singularly where indicated. The composition of the 
culture medium was as previously described for whole crypts after supplementation with 10 μM Y-27632 
(Sigma) and 1 mM Jagged-1 (AnaSpec). Brightfield pictures of organoids were taken using the Zeiss Primovert 
inverted microscope. 
 





 were treated with Tamoxifen as described above to induce Cre recombination. Mice were 
then either left untreated or treated with 3% DSS in drinking water for 7days. 3 days after removal of DSS, 
intestinal crypts were isolated, single cell digested and YFP
+ 





sorted by FACS.  YFP
+
 Paneth cells (n=4000) were then plated in 30 µl Matrigel in a single well of a glass bottom 
96 well plate and maintained at 37˚C and 5% CO2. Culture medium (as described for the reconstitution assay) 
was changed every other day. For SCF treatments, YFP
+
 cells from control mice were either left untreated or 
treated with 150 ng/ml SCF for 30 min. before plating. Also in this case, culture medium (including 150 ng/ml 
SCF, for the SCF treated conditions) was replenished on a daily basis. At day 7, organoids were counterstained 
with 2µg/ml (Hoechst 34580) and imaged using a Zeiss CLSM510 Meta confocal microscope. 
 
IF analysis of whole-mount intestinal crypts 
Whole crypts were extracted from the small intestine by incubating the minced tissues with 2 mM EDTA for 30 
min. at 4°C. Crypts were then pelleted and passed through a 70 μm strainer. Pelleted crypts were resuspended 
either in Advanced DMEM F12 or Advanced DMEM containing 50 ng/ml recombinant murine SCF ((#250-03, 
Peprotech), transferred to Eppendorf LoBind microcentrifuge tubes (#Z666505-100EA, Sigma) and incubated 
for 10 min. at 37°C. Subsequently, crypts were pelleted (300 g, 5 min. at 4°C) and fixed with 4% buffered 
formaldehyde solution (Klinipath) for 20 min. at 25°C. Crypts were washed twice with cold PBS and 
resuspended in block (5% milk powder in PBS-T) and incubated for 30 min. at 25°C. Afterwards, the crypts were 
stained with primary antibodies against the following proteins: phospho-GSK3β (Ser9) (1:100; #9323, CST), 
Gsk3β (D5C5Z) (1:100; #12456, CST), phospho-Akt (Ser473)(1:100; #9271, CST), panAkt (40d4) (1:100; #2920, 
CST), lysozyme (C19) (1:100; sc-27958, Santa Cruz), in blocking buffer overnight at 4°C. After washing in PBS-T, 
slides were incubated for 2 hours with the following secondary antibodies: goat anti-rabbit IgG (H+L) secondary 




secondary antibody, Alexa Fluor® 568 conjugate (1:250, # A-21202, Life technologies) or donkey anti-goat 
secondary antibody, Alexa Fluor® 633 conjugate (1:250; #A-21082, Life technologies). Tissues were 
counterstained with Alexa Fluor® 568 Phalloidin (1:100; #A12380, Invitrogen) or Alexa Fluor® 633 Phalloidin 
(1:100; #A22284, Invitrogen) and DAPI (#D8417, Sigma) for 30 min. at 25°C and washed in PBS-T. Crypts were 
then resuspended in VECTASHIELD HardSet Antifade Mounting Medium (#H-1400, Vector Labs), transferred to 
glass slides and covered with a coverslip. Images were taken with a Zeiss LSM700 confocal microscope and 
processed with ImageJ (U.S. National Institutes of Health, Bethesda, MD, USA). The relative phospho-GSK3β 
intensity of Paneth cells was quantified by setting Paneth cells as region of interest (ROI) and measuring the 
average intensity of the phospho-GSK3β signal within the ROI. Paneth cells of at least 10 crypts per mouse per 
condition were analyzed. 
 
Western blot analysis 
Paneth and Lgr5-EGFP cells from C57BL/6J mice were extracted  and FACS sorted as described for the organoid 
reconstitution assay. Sorted cells were incubated either in Advanced DMEM F12 medium or medium containing 
50 ng/ml recombinant murine SCF (#250-03, Peprotech) for 30 min. at 25°C. Subsequently, cells were lysed in 
RIPA lysis buffer (50 mM TrisHCl pH 7.5, 150 mM NaCl, 0.5% TritonX, 10% Glycerol, 10% DTT, and 1x NuPAGE 
LDS Sample Buffer (Life Technologies, #NP0008)). Lysates were subjected to standard SDS-PAGE and western 
blotting procedures using primary antibodies directed against c-Kit (D13A2)(1:1000; #3074, CST), phospho-Akt 
(Ser473) (1:1000; #9271, CST), panAkt (40d4) (1:2000; #2920, CST), phospho-GSK3β (Ser9) (1:1000; #9323, 
CST), Gsk3β (D5C5Z) (1:1000; #12456, CST), GFP (1:500; #GTX26658, Genetex) and β-actin (D6A8) (1:1000; 
#8457, CST) and anti-Rabbit-HRP (1:1000, #A16066), anti-Mouse-HRP (1:1000,#A16096) secondary antibodies 
(Life Technologies) as well as HRP-Streptavidin Conjugate (1:1000; #43-4323, Invitrogen). Signal detection was 
performed by using the enhanced chemiluminescence system (ECL; Thermo Fisher Scientific, Schwerte, 
Germany) and the Molecular Imager® Gel Doc™ XR System (Bio-Rad). Protein bands were quantified using 
ImageJ (U.S. National Institutes of Health, Bethesda, MD, USA). Phospho-Akt and phospho-Gsk3β bands were 
normalized to the total Akt or Gsk3β bands, respectively, as well as to β-actin bands and fold values were 
calculated upon comparison with the negative background of the C57BL/6J lysates. As no significant differences 
between the fold inductions of both ways of normalization was detected we used the normalization of 
phospho vs total protein bands as result in our manuscript. 
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FACS quantification and analysis of Lgr5
+
-, Paneth-, and YFP
+
 cells by  
Intestinal crypts from untreated or DS- treated Lgr5
EGFP-IRES-creERT2





were isolated, single cell digested, and subjected to FACS analysis. Lgr5
+
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) was quantified. 
 
TOP/FOP reporter assay 
For the β-catenin/TCF reporter assay (TOP-Flash assay), cells were plated on 24-well plates and, when 70% 
confluence was reached, transfected by Fugene HD (Roche) with 250 ng of the TOP-Flash or FOPFlash reporter 
constructs together with 25 ng of the Renilla luciferase vector for normalization purposes. SCF was added were 
indicated at 150ng/ml. Luciferase activity was measured by Dual–Luciferase Reporter Assay System (Promega) 
48h post-transfection. Luminescence was measured using a Glomax Luminometer. 
 
RNA isolation, RNA sequencing and quantitative real-time PCR 
Paneth cells [CD24hiSSChi] and Lgr5+ stem/progenitor cells derived from Lgr5-EGFP mice were sorted as 
described for the organoid reconstitution assay from crypt preparations of the small intestine and RNA was 
isolated from cells using TRIzol
TM
 Reagent (15596018, ThermoFisher Scientific) according to the manufacturer’s 
instructions. RNA quality and quantity was evaluated on a 2100 Bio-analyzer (Agilent) using the Agilent RNA 
6000 Pico Kit (5067-1513, Agilent Technologies). For RNA sequencing analysis, RNA samples were further 
processed by GATC-Biotech (Konstanz, Germany) according to the INVIEW
TM
 Transcriptome Explore library 
preparation protocol (Illumina based).  
RNA-seq data of Paneth cell samples (n = 7) was performed using UCSC mouse genome build mm10 (reference 
strain C57BL/6J) and GENCODE annotation release M15 (GRCm38.p5). FASTQC (v0.11.5)(Schmieder and 
Edwards, 2011) was applied on the single-end FASTQ files for quality control, both before and after running 
trimmomatic (v0.36) (Bolger et al., 2014), which removed TrueSeq adapter sequences. STAR (v2.5.3a)(Dobin et 
al., 2013)  was used as aligner, with 2-pass mapping for each sample separately. Mapping quality plot was 




number of reads for each gene were created with subread FeatureCounts (1.5.2)(Liao et al., 2014). R (version 
3.4.3) was used for further calculating statistics and data visualizations. Differential expression analysis were 
performed with condition ‘DSS treatment’ (n = 4) versus ‘Control’ (n = 3) using the DESeq2 package 
(v1.18.1)(Love et al., 2014) and the Wald-test. P-values were adjusted using the Benjamini-Hochberg 
procedure. Heatmap visualization (Z-Scores averages per condition) was performed with the ggplot2 package 
(v2.1.0) on Regularized Log (from the DESeq2 package) transformed data and Z-Score were calculated with the 
base R ‘scale’ function (column scaling, followed by column centering). For quantitative RT-PCR purposes, RNA 
was converted into cDNA using the High Capacity RNA-to-cDNA kit (Applied Biosystems) and employed in a pre-
amplification step using the Taqman®PreAmp Master Mix (Applied Biosystems) according to manufacturer’s 
instructions. The linearity of the pre-amplification reaction was controlled for all primers. Assays were carried 
out as duplicate reactions using the 7500 Real Time system (Applied Biosystems). Finally, quantitative PCR was 
performed using inventoried TaqMan assays (Applied Biosystems) according to manufacturer’s instructions. 
The Actb gene was employed as housekeeping gene. The assay number of the Taqman probes employed in this 
study for qRT-PCR purposes: Axin2 Mm00443610_m1, Actb Mm02619580_g1, Jun Mm00495062_s1, Ccnd1 
Mm00432359_m1 
The RNAseq data from this study have been submitted to the Gene Expression Omnibus (GEO) (Edgar et al., 
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Figure 1. SCF expression is increased upon intestinal inflammation and positively affects organoid growth.  
A) Comparison by IHC analysis of SCF expression in healthy (left) and CD-derived small intestinal tissues (right). 
The arrowheads indicate SCF expressing cells close to the intestinal crypts. The images are representative of 2 
healthy and 4 CD patients; scale bars = 100 µm.  
B) SCF ISH analysis of small intestinal tissues derived from control (upper panel) and DSS-treated (lower panel) 
mice 1 day after DSS removal. Increased SCF RNA levels can be observed in the intestinal epithelium and 
submucosa of inflamed mice. Pictures show representative examples of n= 3 mice; (scale bar: upper panel = 
200 µm, lower panel = 50 µm, grid lines indicate intestinal crypts).  
C) Weight loss graphs relative to mice treated with 3% DSS alone, ISCK03 alone (0.1 mg/ml in the drinking 
water), and 3% DSS + ISCK03 for 7 days (n=6 for DSS and DSS + ISCK03 treated mice; n=3 for ISCK03 treated 
mice).  
D) DAI score relative to the mice described in B (*p< 0.05). Details of scoring are shown in Figure S1D and in the 
Materials and Methods section.  
E) Organoid multiplicities from whole crypts of control and 3% DSS-treated mice (7 days). Crypts were isolated 
and plated 3 days after DSS withdrawal. Pictures show representative organoids of each condition at day 5 of 
culture (scale bar = 50 µm; **p < 0.01, n=4).   
F) Organoid multiplicities from whole crypts of control and 3% DSS-treated mice (7 days). Crypts were plated 3 
days after DSS withdrawal in the presence or absence of the soluble c-Kit receptor (500 ng/ml) or masitinib 
(200 nM)(**p < 0.01, n=3). 
G) Organoid multiplicities from whole crypts grown in control medium with or without murine SCF (50 ng/ml). 
Pictures show representative organoids of each condition at day 5 of culture (scale bar = 50 µm; **p < 0.01, 
n=3). 
 
Figure 2. DSS-induced intestinal inflammation causes loss of intestinal stem cells.  
A) FACS analysis of Lgr5
+
 cells from control or DSS-treated mice 3 days after DSS withdrawal (FACS plot are 
representatives of 5 independent experiments; Lgr5-EGFP
high
 cells are labelled in green).  
B) Average percentage of Lgr5
+
 and Paneth cells in control and DSS-treated mice, as quantified by FACS (**p 
<0.01, n.s.= not significant; n=5).  
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mice kept on normal or 3% DSS-supplemented drinking water for 7 days. Tissues were harvested 3 days after 
withdrawal of DSS.  




 mice (n=3,*p 
<0.05). 
E) Olfm4 IHC analysis of intestinal tissues from control and DSS-treated mice 1 day after removal of DSS. 
F) Quantification of Olfm4
+
 cells/crypt from control and DSS-treated mice (n=4, *p <0.05). 
  
Figure 3. Inflammation induces proliferation and de novo organoid formation from Paneth cells via activation 
of the SCF/c-Kit signaling axis.  
A) Ki67 IHC analysis of mouse small intestinal tissues from control and DSS-treated mice 1 day after DSS 
removal. Asterisks indicate Ki67-negative Paneth cells in control mice (left panels) and Ki67
+
 Paneth cells in 
DSS-treated mice (right panel)(scale bar upper panels = 25 µm; lower panel = zoom in). 
 B) Average percentage of Ki67
+
 Paneth cells in control and DSS treated mice (**p <0.01; n= 4). 
C) Organoid reconstitution assay of Lgr5
+
 and Paneth cells from control and DSS-treated mice (*p <0.05; 
**p<0.01; n.s.= not significant; n=3). 
D) Pictures showing representative examples of organoids derived from the reconstitution assays in (C) at day 7 
of culture (scale bar = 100µm). 
E) Organoid reconstitution assay of untreated and SCF-treated (50 ng/ml) Lgr5
+
 and Paneth cells (**p < 0.01; 
***p <0.005; n.s.= not significant; n=3). 












Figure 4. Paneth cells de-differentiate into stem-like cells in response to DSS induced inflammation.  




 mice at several time points after DSS 
treatment (scale bar = 100 µm). 




 mice, 1 day after DSS withdrawal (scale bar = 25µm). 












 mice, 7 days after DSS withdrawal (scale bar = 25µm). 
E) Analysis of expression of differentiation markers (Goblet cells = Muc2; entero-endocrine cells = ChrA; Tuft 




 mice, 7 days after DSS withdrawal (scale bar = 100µm). 
 
Figure 5. SCF triggers Paneth cell de-differentiation via the PI3K/AKT-signaling axis. 
A) IF analysis of phospho-Akt in untreated and SCF-treated (50 ng/ml) intestinal crypts from Lgr5-EGFP mice 
(arrows indicate phospho-Akt
+
 Paneth cells; scale bar = 25µm). Intestinal crypts were counterstained with DAPI 
and phalloidin. Picture shows one representative example from at least 3 independent experiments. 
B) Western blot analysis of untreated and SCF- (50 ng/ml) treated Lgr5
+
 and Paneth cells using antibodies 
against c-Kit, phospho-Akt, total-Akt, GFP and actin.  
C) Quantification of pAkt/Akt signal intensity from the western blot in (B)(*p<0.05; n=3).  
D) Organoid reconstitution assay of Lgr5
+
 and Paneth cells from control and DSS-treated mice. Paneth cells 
were either left untreated or treated with BKM120 (PI3K inhibitor; 1µM), or AKTVIII (Akt-inhibitor; 4 µM) (*p < 
0.05; **p <0.01; n.s.= not significant; n=3). 
E) Representative pictures of PC-derived organoids as described in (D)(scale bar = 50 µm). 
F) RNAseq analysis of Paneth cells from control (=3) and DSS-treated (n=4) mice 3 days after DSS withdrawal. 
Heat maps show differentially expressed genes (left panel = Wnt target genes: middle panel = lysozymes and 
alpha-defensins; right panel = cell proliferation marker genes). Color codes indicate average Z-scores of each 
condition. 
 
Figure 6. Activation of the SCF/c-Kit signaling axis inhibits Gsk3β and activates Wnt in Paneth cells. 
A) IF analysis of phospho-GSK3β in untreated and SCF-treated intestinal crypts from Lgr5-EGFP mice. Arrows 
indicate phospho-GSK3β-negative Paneth cells in untreated crypts (upper panel). Among SCF treated crypts 
(lower panel), phospho-GSK3β Paneth cells become evident (also indicated by arrows; scale bar = 25µm). 
Intestinal crypts were counterstained with DAPI and phalloidin.  Picture shows one representative example out 
of at least 3 independent experiments.  
B) Relative fluorescence intensity of phospho-GSK3β in Paneth cells treated as described in (B). Paneth cells 
were set as ROI (region of interest) for the measurement of phospho-GSK3β intensity (*p <0.05; n=3). 
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C) Western blot analysis of untreated and SCF- (50 ng/ml) treated Lgr5
+
 and Paneth cells using antibodies 
directed against c-Kit, phospho-GSK3β, total-GSK3β, GFP and actin.  
D) Quantification of phospho-GSK3β/GSK3β signal intensity in the western blot shown in (C)(*p <0.05; n=3). 
E) TOP-Flash luciferase reporter assay of control and SCF- (50 ng/ml) treated CaCo2 cells (*p <0.05; n=3). 
F) qRT-PCR analysis of control and SCF- (50 ng/ml) treated Paneth cells using primer sets specific for the Wnt 
target genes Axin2, c-Jun, and Cyclin D1 (**p <0.01; n = 3). 
G) β-Catenin IHC analysis of intestinal tissues from control and 3% DSS- treated (7 days) mice 1 day after DSS 
withdrawal (arrows indicate Paneth cells with cytoplasmic β-Catenin; scale bar = 25 µm). Pictures show 
representative examples of crypts from 3 independent mouse experiments. 
H) Number of organoids derived from control or Chiron- (10 µM) treated Lgr5
+
 or Paneth cells sorted by FACS 
(***p <0.005). 
I) Representative pictures of organoids derived from control and Chiron- (10 µM) treated Lgr5
+
 or Paneth cells 
sorted by FACS. Left panel: untreated cells did not give rise to organoids. Middle panel: Chiron-treated Lgr5
+
 
and Paneth cells generate enterospheres. Right panel: upon Chiron withdrawal enterospheres give rise to 
differentiated enteroids.  
 
Figure 7. SCF/c-Kit signaling inhibition counteracts DSS-induced Wnt activation and Paneth cells de-
differentiation. 
A) β-Catenin immunohistochemistry analysis of intestinal tissues from control and DSS, ISCK03 or DSS + ISCK03 
treated mice 1 day after stop of treatment (arrows indicate Paneth cells with cytoplasmic β-Catenin; scale bar = 
25 µm). Pictures show representative examples of crypts from 3 independent mice. 
B) Ki67 immunohistochemistry analysis of intestinal tissues from control and DSS, ISCK03 or DSS + ISCK03 
treated mice 1 day after stop of treatment (arrows indicate Ki67 expressing Paneth cells; scale bar = 25 µm). 
Pictures show representative examples of crypts from 3 independent mice. 
C) Quantification of the percentage of crypts with Ki67
+
 Paneth cells in intestinal tissues of control, DSS and DSS 
+ ISCK03 treated mice (*p < 0.05; ***p <0.005; n=3).  
D) Lineage tracing analysis of Tamoxifen injected Lyz-Cre-R26-LSL-YFP mice (left= control; middle= DSS; right = 
DSS + ISCK03). Tissues were harvested and analyzed 7 days after removal of DSS (scale bar = 100 µm).  
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Supplementary Figure Legends 
Supplementary Figure 1 
A) SCF IHC analysis of normal and ulcerative colitis colonic tissues. Picture shows a representative example of 2 
controls and 5 UC patients (scale bars = 100 µm). 
B) Lysozyme IF analysis of colonic tissues from UC patients. Picture shows a representative example of 
metaplastic Paneth cells in the colon were found in 3 out of 5 patients (scale bar = 100µm). 
C) SCF RNA ISH analysis of small intestinal tissues derived from control (left) and DSS-treated mice (right) 1 day 
after DSS removal. SCF expression is increased in the intestinal epithelium and submucosa of inflamed mice. 
PPIB RNA probes were used as positive controls. Pictures show representative examples of n= 3 mice; scale bar 
= 200µm). 
D) Table of DAI scores and the individual parameters relative to mice treated for 7 days with DSS or DSS + ISCK. 
Mice were sacrificed one day after treatment withdrawal. Mice treated with ISCK03 alone (n=3) did show 
normal stool consistency, no blood loss, normal appearance and no weight loss and were not included in the 
table.  
E) CD3 IHC analysis of intestinal tissues derived from control and DSS-, ISCK03-, and DSS/ISCK03-treated mice. 
Tissues were collected 1 day after treatment withdrawal. Asterisks indicate infiltrating CD3
+
 T-lymphocytes 
(scale bar = 50 µm). 
F) Quantification of infiltrating CD3
+
 T-lymphocytes/villus in control and DSS-, ISCK03-, and DSS/ISCK03-treated 
mice, as described in A (*p< 0.05; n.s. = not significant; n=3).  
 
Supplementary Figure 2 








) in control and DSS-treated mice, 3 days after 
DSS withdrawal (FACS plots are representrative of 5 independent experiments;  cells within the PC gate are 
labelled in red; Lgr5-EGFP
+
 cells, as defined in Fig. 2A, are labelled in green). 





mice on normal drinking water or 3% DSS. Tissues were harvested 3 days after DSS withdrawal. The relatively 
low magnification provides an overview of Lgr5 lineage tracing events in small intestinal tissues (scale bar = 200 
µm).  




C) Olfm4 IHC analysis of intestinal tissues from control and DSS-treated mice, 1 day after DSS removal. Picture 
shows an overview of Olfm4 expression in small intestinal tissues (scale bar = 250 µm).  
 
Supplementary Figure 3 
A) Ki67/lysozyme IF analysis of small intestinal tissues from untreated (upper panel) or DSS-treated mice (lower 
panel). Tissues were harvested 1 day after DSS treatment (arrow indicates a Ki67/lysozyme double positive cell; 
scale bar = 25 µm). 
B) Ki67/lysozyme IF analysis of small intestinal tissues from a CD patient (arrow indicates a Ki67/lysozyme 
double positive cell; scale bar = 25 µm). 
 
Supplementary Figure 4 
A) FACS analysis of Paneth cells and YFP
+




 mice. Upper left plot: 


















 cells can be resolved by Lyz-YFP/SSC-A analysis (upper right plot). Lower left and right plots: YFP
+ 





B) Quantification of the FACS analysis in (B). Approximately 12% of Paneth cells are labeled by YFP upon 
Tamoxifen administration. 97% of YFP
+
 cells were detected within the Paneth cell gate (n=5). 




 mice injected with 10% ethanol in sunflower oil (control, 
upper panel) or Tamoxifen (lower panel) (scale bar = 200µm). 




 mice using antibodies against 
lysozyme. The mice were treated for 7 days with 3% DSS and analyzed at day 1 after DSS withdrawal. Paneth 
cells are only detected at the base of the crypt. YFP expression could be only detected in lysozyme
+
 Paneth cells 
(scale bar = 100µm). 
 
Supplementary Figure 5 
A) Number of organoids derived from control and SCF-treated (150 ng/ml) whole intestinal crypts. Crypts were 
plated in the presence or absence of inhibitors against Mapk  (U-0126, 1 µM), mTor (Rapamycin 10 nM), PI3K 
(LY294002, 0.5 µM), and Jak1 (Ruxolitinib, 0.5µM)(**p< 0.01, n=3). 
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B) Pan-Akt IF analysis of intestinal crypts from Lgr5-EGFP mice (scale bar = 25µm). The images show one 
representative example from 3 independent experiments. 
C) Phospho-Akt IF and lysozyme analysis of control and SCF-treated intestinal crypts from Lgr5-EGFP mice 
(arrows indicate phospho-Akt/lysozyme double positive cells; scale bar = 25µm). The images depict one 
representative example from 3 independent experiments. 
D) RNAseq analysis of Paneth cells from control (n=3) and DSS-treated (n=4) mice, 3 days after DSS withdrawal. 
The heat map shows differentially expression of stem cell related genes. Color codes indicate average Z-scores 
of each condition. 
 
Supplementary Figure 6 
A) Pan-GSK3β IF analysis of intestinal crypts from Lgr5-EGFP mice (scale bar = 25µm). The images are relative to 
one representative example from 3 independent experiments. 
 
Supplementary Figure 7 
A) Ki67/lysozyme IF analysis of small intestinal tissues from control (left panel), DSS- (middle left panel), 
DSS/ISCK03- (middle right panel), and ISCK03-treated mice (right panel). Tissues were harvested 1 day after DSS 






Supplementary Fig.1 (related to Fig. 1)
A B
Mouse ID Genotype Treatment Stool consistency (0-2) Blood loss (0-1) Appearance (0-3) Weight loss (0-3) DAI score
1 C57BL/6J DSS Diarrhea (2) Gross bleeding (1) Starey coat (2) 10,18% (2) 7
2 C57BL/6J DSS Loose (1) No blood (0) hunched (1) 10,75% (2) 4
3 C57BL/6J DSS Loose (1) Gross bleeding (1) hunched (1) 7,5% (1) 4
4 C57BL/6J DSS Loose (1) No blood (0) hunched (1) 9% (1) 3
5 C57BL/6J DSS Loose (1) No blood (0) Starey coat (2) 7,27% (1) 4
6 C57BL/6J DSS Diarrhea (2) Gross bleeding (1) Hunched (1) 10% (2) 6
7 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Lethargic (3) 20,3% (3) 9
8 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Starey coat (2) 22,5% (3) 8
9 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Lethargic (3) 16,73% (2) 8
10 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Starey coat (2) 16,96% (2) 7
11 C57BL/6J DSS+ISCK03 Diarrhea (2) Gross bleeding (1) Lethargic (3) 19,91% (2) 8
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PANETh CELLS  ARE ThE METABOLIC NIChE OF LGR5 + 
INTESTINAL CELLS
Paneth cells have been proven to provide a niche for the intestinal stem cells 1 as they 
positively regulate Lgr5+ stem cell maintenance and self-renewal by secreting Wnt3, 
EGF, Dll1 as well as give structural support1,2. In chapter 4 of this thesis the metabolic 
interactions between Lgr5+ intestinal stem cells and Paneth cells have been elucidated 
for the first time. The analysis of the metabolite profiles revealed a striking difference 
between cells at the bottom of the crypt. The metabolite content of Paneth cells showed 
a glycolytic program whereas Lgr5+ stem cells have been found to have an oxidative 
metabolic program. Accordingly, the stem cells in the intestine were more sensitive to 
inhibitors of oxidative metabolism, and appear to have more mitochondria than Paneth 
cells. 
Oxidative metabolism was found to be required for maintaining intestinal stem 
cell function and glycolysis in Paneth cell was found act as fuel for the Lgr5+ stem cells 
metabolic program. 
Paneth cells through their glycolytic program secrete lactate which is taken up by 
intestinal stem cells and converted into pyruvate to boost their oxidative phosphorylation. 
This metabolic interconnection between these two cell types was already previously 
suggested under caloric restriction conditions where Paneth cells are sensitive to scarcity 
or abundance of nutrient availability3. This would suggest Paneth cells provide certain 
nutrients depending on the nutritional state of the organism4.
In another study by Schell et al.5, it has been found that inhibition of the mitochondrial 
pyruvate transporter MPC increased stem cell function, and the regenerative capacity of 
ex-vivo isolated crypts. Active mitochondria in Lgr5+ stem cells rather than for oxidative 
phosphorylation are suggested to be used to oxidize lipids5. however, the authors of 
this study added Chiron and valproic acid to the culture media to grow organoids, the 
addition of these two drugs might switch the metabolism of the stem cells being cultured 
as it is the case in chapter 4 of this thesis for the WENR (Wnt, Egf, Noggin, R-spondin) 
cultured organoids6. Further studies are required to elucidate the metabolic profile 
of stem cells and Paneth cells in inflammation and cancer as well as under different 
nutritional statuses such as high fat diet. 
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Phosphol ipases  determine f ine-tuning of  Wnt s ignal ing in  the epithel ia l 
intest inal  stem cel l  n iche
In chapter 3 of this thesis, secretory phospholipase A2 group IIA and group X (Pla2g2a 
and Pla2g10) have been found to down-regulate Wnt signaling in Paneth cells and 
Paneth-like colonic niche cells and negatively affect stemness in Lgr5+ cells when localized 
intracellularly on their way to secretion7. however, when secreted under inflammatory 
conditions both of these proteins exhibit a positive effect on Lgr5+ driven stemness. This 
study showed that phospholipases act as regulators of Wnt signaling in Paneth cells and 
keep the balance between cell supply and demand in homeostasis and inflammation7. 
Secretory phospholipases such as Pla2g2a and Pla2g10 are lipid remodeling 
enzymes. The fatty acid composition of cellular membranes determines their biophysical 
properties and thus influence several cellular processes. The Pla2g2a gene was first 
found to be a modifier of intestinal tumorigenesis in 1993 by the group of Dove and was 
named main modifier of Min 1 (Mom1)8. Modifiers have since been defined as genes 
that alter multiplicity of Wnt-driven tumorigenesis in the intestine8,9. In chapter 3 we 
found that the absence of both phospholipase genes Pla2g2a and Pla2g10) confers 
susceptibility to colon cancer in a chemical induced inflammation model such as dextran 
sodium sulfate and azoxymethane (DSS and AOM) treated mice or in Apc mutated mice, 
suggesting these enzymes are both modifiers of colon cancer7. Notably, these mice were 
on a C57Bl6/J background, a strain resistant to colon tumorigenic protocols10.
In our study the catalytic function of phospholipases Pla2g2a and Pla2g10 on their 
substrate (extracellular phospholipids) did not play a role in altering Wnt signaling. 
however, recent studies suggest that Lpcat3, a phospholipid-remodeling enzyme 
and critical determinant of polyunsaturated phospholipid abundance and membrane 
fluidity11-13 , affects intestinal Lgr5+ stem cell proliferation by controlling cholesterol 
biosynthesis14. In this study the increase in cellular cholesterol was sufficient to drive 
Lgr5+ stem cell proliferation in-vivo as well as ex-vivo. The presence of Lpcat3 suppressed 
Apc-min driven tumorigenesis suggesting a link between phospholipid remodeling, 
cholesterol biosynthesis and Lgr5+ proliferation. Lpcat 3 has been found to play an 
important role in Lands cycle that involve hydrolysis of sn-2 fatty acids by Pla2g2a and 
their reacylation by lysophospholipid acyltransferases. The study of Wang et al. claims 
that Lpcat3 suppressed Apc-min tumorigenesis in a Wnt independent fashion. however, 
no functional assay to determine Wnt signalling up or downregulation in the presence or 
absence of Lpcat3 has been performed and more experiments are required to determine 
whether Wnt signaling is involved in this mechanism.
 As elucidated in chapter 3, we found that in Paneth cells as well as in colonic niche 
cells Pla2g2a and Pla2g10 are secreted in higher doses under inflammatory conditions. 
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Notably, in-vitro the catalytic activity of the Pla2g2a and Pla2g10 proteins did not 
display any effect on organoid growth as shown by the use of the catalytically inactive 
versions of these proteins mutated in the h48Q residue. The use of a mouse deficient 
for the Phospholipase A2 receptor 115, suggested that phospholipases can bind to this 





) synthesis. The relevance of this pathway in inflammation has been 
confirmed by a genome wide associated study (GWAS)16. Further in-vivo studies with a 
genetic mouse model mutated in the catalytic site of both Pla2g10 and Pla2g2a need to 
be performed to understand whether both the catalytic activity and the regulation of 
the subcellular localization of yap1 in colonic niche cells play a role in modulating tumor 
multiplicity in the mouse. One of the features transgenic Pla2g2a mice showed was a 
Paneth cell maturation defect7. The Paneth cells of these mice lacked fully mature Paneth 
cell markers such as Lysozyme and showed a clear-cut decrease in the expression of 
secreted Paneth cell specific antimicrobial peptides. In another study as well, Nakanishi 
et al. found that the absence of protein kinase c lambda/iota (Prkci) led to a Paneth cell 
maturation defect and to a striking increase in tumor size and multiplicity in both small 
intestine and colon in an Apc mutated background17. Interestingly, the positive effect 
brought upon tumor multiplicity by the absence of Prkci could be abrogated by treating 
the mice with antibiotics, suggesting that the microbiome plays a major role in this mouse 
model in increasing tumor multiplicity17. Pla2g2a and Pla2g10 are both lipid remodeling 
enzymes and secreted antimicrobial proteins. In these mice the change in gene expression 
of several Paneth cell specific antimicrobial peptides might lead to dysbiosis. Whether the 
microbiome also has an effect in the tumor multiplicity increase brought upon the absence 
of these two proteins remains to be seen. Interestingly, a recent discovery found cancer-
causing bacterial biofilms in the colon of FAP patients. Individuals affected by FAP syndrome 
(familial adenomatous polyposis), a hereditary condition caused by germline mutation 
in the APC tumor suppressor gene, develop hundreds to thousands of colorectal polyps 
through the accumulation of somatic mutations18. The variation in onset and frequency 
of polyps within families with the same APC mutation suggests that environmental factors 
such as the microbiota play a role as well. Two pro-tumorigenic variants of E. Coli and 
Bacteroides fragilis secreting mainly two oncotoxins, colybactin and Bacteroides fragilis 
toxin, have been found to be specifically associated with an earlier onset of colorectal 
polyps and a more severe disease progression18. Colonization of Apc/min deficient mouse 
strains with these two bacterial strains confirmed this hypothesis as it led to a more 
severe phenotype and earlier disease onset in these mice18. Further studies are required 
to understand the role of microbiota in colorectal cancer initiation and progression and 
whether Apc mutation in Paneth cells and colonic Paneth-like cells lead to a change in the 
antimicrobial peptide secretion and initiation and progression of colorectal cancer.
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Ful ly  mature Paneth cel ls  acquire  stem cel l  character ist ics  under 
inf lammatory condit ions
As previously described in the introduction, mammalian tissues have evolved to harbour 
both rapid and slow cycling stem cells19. The adaptation of fast renewing mammalian 
tissues to have both quiescent and rapid cycling stem cells is linked to longevity of the 
organism and functions as a mechanism to avoid adult stem cell exhaustion20. In the 
small intestine, stem cells have been found to be earmarked by the expression of the 
Lgr5 gene and they are rapid cycling dividing every 24 hours (Figure 1)21. Several studies 
have proposed an alternative quiescent stem cell pool in the intestine which resides at 
the +4 position in the crypt and is able to retain DNA label, indicating that these cells 
have stem cell properties. Many markers have been proposed for this alternative stem 
cell pool such as Bmi1, mTert, hopx and Lrig122-25. however, none of these markers are 
uniquely expressed at the +4 position and as a matter of fact their highest expression has 
been found in Lgr5+ cells. RNA-sequencing analysis indicates that quiescent stem cells 
have a mixed gene signature between Lgr5+ stem cells and cells committed towards the 
secretory lineage, suggesting that a population of daughter cells arising from Lgr5+ stem 
cells and retaining Lgr5 mRNA represents this quiescent stem cell population26. Recently 
another marker for quiescent intestinal stem cells has been identified namely the RNA 
binding protein Mex3A. Mex3A expressing cells as predicted also express Lgr5 and are 
found at the +4 position (Figure 1)27. The current model of cell hierarchy in the intestine 
presupposes that rapid cycling stem cells are at the top of the hierarchy giving rise to 
both differentiated and quiescent Lgr5+ Mex3aA+ stem cells.
Figure 1. Stem cells under homeostati c conditi ons. under homeostati c conditi ons Lgr5+ rapidly 
dividing stem cells regenerate the ti ssue, slow dividing Lgr5+Mex3A+ positi ve stem cells reside at +4. 
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All tissues occasionally face traumatic injuries. As the current model suggests, rapid 
cycling stem cells are exquisitely sensitive to injury stimuli, such as inflammation and 
radiation, and when exposed to these stimuli rapid cycling stem cells undergo apoptosis. 
On the contrary, slowly dividing stem cells are thought to exit their quiescent status 
upon injury, become actively proliferating and repair the tissue19. Lgr5+ intestinal stem 
cells as predicted have been proved to be sensitive to radiation injury and chemically 
induced inflammation28, (Schmitt et al. submitted). Furthermore, genetic ablation of 
Lgr5+ stem cells showed that other cell types can contribute to tissue regeneration 
in their absence29. Nonetheless, Lgr5+ cells have been proved to be indispensable for 
tissue repair28. This postulates that different cell types contributing to regeneration will 
either start expressing Lgr5 or divide and give rise to a Lgr5+ stem cell. Depending on the 
gravity of the stress and injury, terminally differentiated cells have also been described 
to acquire stem cell capabilities and be able to regenerate the tissue as resident adult 
stem cells would do30. The phenomenon of dedifferentiation is described in chapter 
5 of this thesis. The intestine is thus a prime example of cellular plasticity, where not 
only the two-stem cell model rapid and slow cycling stem cells, but also many other 
cell types can contribute to tissue repair under the right environmental cues or severe 
damage. Secretory precursors that reside right above the stem cell zone express the 
Notch ligand Delta like 1 (Dll1)31. under homeostatic conditions these cells give rise 
to short lived clones of Paneth, goblet and enteroendocrine cells31. however, when 
Lgr5+ stem cells are genetically ablated, these cells can give rise to Lgr5+ stem cells and 
contribute to intestinal regeneration (Figure 2). Another cell type able to de-differentiate 
and repopulate the crypt are enterocyte precursors expressing Alpi as a marker30. 
These cells residing at position +6 in the crypt and on their way to become fully mature 
absorptive enterocytes, are able to repopulate the crypt and give rise to Lgr5+ stem cells 
under radiation injury (Figure 2)30. In chapter 5 of this thesis we investigated the role of 
Paneth cells in severe injury conditions such as high dose radiation injury (10 Gy), acute 
inflammation (3%DSS) and chronic inflammation (3 cycles of 1,5% DSS). Surprisingly, the 
terminally differentiated post-mitotic Paneth cells were able to dedifferentiate and give 
rise to all intestinal lineages (Figure 2)(Schmitt et al. submitted). In the model presented 
in Chapter 5, dedifferentiation of Paneth cells occurs through and increase in Wnt via the 
SCF/c-kit signalling axis. Interestingly, Paneth cells already exhibit hallmarks of activated 
Wnt signalling (nuclear Beta catenin accumulation) and this pathway is required for 
their maturation32. We suggested that increased Wnt dosage, namely “super-activation”, 
might guide these cells to dedifferentiate and lead to intestinal regeneration (Schmitt 
et al. in press). In a recent study by yu et al. Notch signalling and its reactivation have 
been found to be the main driver for dedifferentiation of Paneth cells in mice treated 
with 10 Gy irradiation33. In this study the authors found that dedifferentiation of Paneth 
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cells occurred in a Wnt independent manner. By using a mouse model where exon 3 
of beta catenin was deleted and plating ex-vivo isolated Paneth cells the authors 
showed that super activation of Wnt signalling is not sufficient for these cells to form 
organoids33. however the authors of this study used a company based patented medium 
called Intesticult which already shows signs of Wnt “super-activation” when added to 
organoid cultures. This renders the study of the Notch pathway unreliable as it does 
not consider whether “superactivation” of Wnt signalling is required or not for Paneth 
cells to dedifferentiate. Furthermore, the use of 10 Gy radiation as a mean to mimic 
chronic inflammatory stimuli and inflammatory bowel disease raises questions about 
the relevance of the model. Dextran sulfate sodium salt has been proven to cause 
inflammation throughout the gastrointestinal tract, a condition called pan-gastroenteritis 
and as such it would be more relevant as a model in this scenario7,34. In chapter 5 of this 
thesis, by using a chronic colitis model (3 cycles of 1,5% DSS) in the mouse increased 
frequency of Paneth cell lineage tracing was demonstrated (Schmitt et al. submitted). 
The increased frequency of lineage tracing in this model suggested a major role for 
Paneth cells in regeneration in patients affected by Chron’s disease and ulcerative colitis. 
however, the percentage of lineage tracing, and as such tissue regeneration, from 
Paneth cells does not account for all the regeneration occurring under inflammatory 
conditions. This thus suggests a communal effort from different types of cells able to 
de-differentiate and to contribute together to the common goal of tissue repair. As 
also Paneth cells are able to de-differentiate and contribute to tissue regeneration, all 
cell types in positions 0 to +6 of the crypt have been shown to be able to behave as 
facultative stem cells under the right environmental cues. It is possible that intestinal 
cells behave as a community to achieve homeostasis and balance between cell division 
and apoptosis. To achieve this common goal, redundancy between several cell types and 
constant replenishment of the rapid dividing Lgr5+ stem cell pool under tissue injury in 
the crypt is a key feature. Redundancy is commonly found in nature when the goal to be 
achieved is critical and necessary for the functioning of the system or community. The 
more a system is redundant, the more it is resilient to disturbance or conditions that in 
this case alter homeostasis. In the case of the intestine, the critical goal is to still remain 
within a stable state able to absorb nutrients, while maintaining a rapid cell turnover. 
understanding the cellular plasticity of the intestine and how cells work in a community 
to regulate each other’s fate through metabolic, stromal or immune cell mediated 
signals in response to environmental stimuli, will be of critical importance for prevention 
and treatment of cancer as well as for auto-immune and chronic inflammatory diseases. 
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Figure 2. Paneth cells dediﬀ erenti ate under infl ammatory conditi ons. As shown in this fi gure, 
Paneth cells a terminally diff erenti ated post-mitoti c cell type acquire stem cell features and 
contribute to ti ssue regenerati on. Enterocyte precursors as well as secretory precursors contribute 
to ti ssue regenerati on under these circumstances as well.
Plast ic i ty  and the environment:  a  stem cel l  i s  def ined by i ts  n iche
Cell plasticity under severe damage is essential for restoring homeostasis. Cell types 
endowed with plasticity and the molecular mechanisms governing such plasticity 
are still being elucidated. A central role in cell plasticity is played by the local tissue 
environment, which under damage undergoes drastic changes in the quantity and 
quality of stimuli such as molecules secreted by neighbouring stromal and epithelial 
cells, alterations in extracellular matrix (ECM) composition and tissue architecture35. As 
such, the capacity of cells to differentiate or dedifferentiate is highly dependent on the 
niche or microenvironment in which they are located35. This is the case for the fate of 
hair follicles stem cells which is niche dependent and differentiated cell compartments 
can rapidly compensate for stem cell loss36. however, in the absence of the perineural 
niche the plasticity of upper bulge hair follicle stem cells is inhibited37. 
In this thesis, as elucidated in Chapter 5, the ligand of the c-kit receptor or stem 
cell factor (SCF) secreted from neighbouring epithelial and stromal cells in acute 
and chronically inflamed mice induces de-differentiation of Paneth cells. Notably 
SCF expression is significantly increased in IBD patients as well, suggesting that this 
environmentally regulated plasticity plays a major role in this category of patients. 
Plasticity is not only regulated via secreted factors from the stem cell niche but also via 
direct cell-cell contact. In the trachea, the dedifferentiation of secretory Clara cells is 
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inhibited by direct cell-cell contact with basal stem cells38. Nutrients as well are able to 
modify and influence stem cell activity. Calorie restriction affects intestinal Lgr5+ stem cell 
behaviour by modulating cyclic-ADP production in Paneth cells3. ECM factors are a key 
component of the stem cell niche and necessary for maintaining stem cell function and 
differentiation39. The stiffness of the ECM affects stem cells and their differentiation40,41. 
Also transient expression of yap1, a transcription factor relevant in mechanosensing and 
the translation of ECM stiffness into gene expression patterns42,43, is able to reprogram 
mammary, neural and pancreatic cells into stem or progenitor cells44. Plasticity is 
likely governed by epigenetic modifications that act in concert with cell type specific 
transcription factors. however, as it is the case for the intestine, active chromatin marks 
at tissue specific enhancers and promoter methylation patterns showed surprisingly 
little dynamics during intestinal stem cell differentiation, hinting that changes in 
transcription factors in response to external stimuli are sufficient for differentiated cells 
to switch to a different state45,46.  This suggested that cells can switch fate by expressing 
or repressing specific transcription factors in response to various stimuli, as it is the case 
in the ablation of the transcription factor Cdx2 that converts intestinal stem cells into 
gastric stem cells47, or the ablation of the Atoh transcription factor which leads to the 
loss of the secretory lineage in the intestine48. 
In conclusion more studies are required to further understand how transcription 
factors and epigenetic mechanisms might control cell plasticity in order to be a useful 
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SuMMARy
The focus of this thesis is the study of Paneth cells and their role in the intestinal stem 
cell niche in homeostasis, injury and tissue repair and cancer. Paneth cells are niche cells 
for the rapidly dividing Lgr5+ intestinal stem cells. In chapter 2 we describe a method 
designed to elucidate and dissect genetic and/or biochemical modifications in Lgr5+ 
intestinal stem cells or Paneth cells. We used the striking ability of these cells to attach to 
each other and form organoids or 3D “mini-guts” ex-vivo. The developing of this method 
was essential for the rest of the discoveries elucidated in this thesis. In chapter 3 the 
role of the secretory phospholipase A2 group IIa (Pla2g2a) or Mom1 in Paneth cells is 
studied. The study elucidated the role of phospholipases in homeostasis to downregulate 
canonical Wnt signalling in Paneth cells by upregulating yes associated protein 1 (Yap). 
under tissue injury conditions Pla2g2a was highly secreted and acted in opposite 
fashion thus by upregulating canonical Wnt signaling. In Chapter 4, the metabolism of 
the intestinal niche and stem cells is elucidated. Strikingly Paneth cells were found to 
be highly glycolytic whereas Lgr5+ stem cells used oxidative phosphorylation for their 
metabolic needs. The work done elucidated that lactate, the end product of glycolysis, 
secreted by Paneth cells was taken up by Lgr5+ stem cells and used by stem cells to fuel 
their metabolism. In other terms Paneth cells provide a metabolic niche for intestinal 
stem cells. In chapter 5 of this thesis another important role of Paneth cells is described. 
under severe tissue injury conditions these cells can de-differentiate and regenerate the 
small intestine, giving rise to all intestinal cell lineages.
In Chapter 4, the metabolism of the intestinal niche and stem cells is elucidated. 
Strikingly Paneth cells were found to be highly glycolytic whereas Lgr5+ stem cells used 
oxidative phosphorylation for their metabolic needs. The work done elucidated that 
lactate, the end product of glycolysis, secreted by Paneth cells was taken up by Lgr5+ 
stem cells and used by stem cells to fuel their metabolism. In other terms Paneth cells 
provide a metabolic niche for intestinal stem cells. In chapter 5 of this thesis another 
important role of Paneth cells is described. under severe tissue injury conditions these 





De focus van dit proefschrift ligt op de studie van Paneth-cellen en hun rol in de intestinale 
stamcellen niche in homeostase, letsel en weefselherstel en kanker. Paneth-cellen 
zijn nichecellen voor de zich snel delende Lgr5+ intestinale stamcellen. In hoofdstuk 2 
beschrijven we een methode om genetische en/of biochemische modificaties in Lgr5+ 
intestinale stamcellen of Paneth-cellen te bestuderen. We gebruikten het opvallende 
vermogen van deze cellen om zich aan elkaar te hechten en organoïden of 3D “mini-
darmen” ex-vivo te vormen.
het ontwikkelen van deze methode was essentieel voor de rest van de ontdekkingen 
die in dit proefschrift worden toegelicht. In hoofdstuk 3 wordt de rol van de secretoire 
fosfolipase A2 groep IIa (Pla2g2a) of Mom1 in Paneth cellen bestudeerd.
De studie ontdekte de rol van fosfolipasen in de homeostase om canonieke Wnt-
signalering in Paneth-cellen te downreguleren door yap-associated protein 1 (yap) 
te reguleren. Onder omstandigheden van weefselbeschadiging werd Pla2g2a sterk 
uitgescheiden en werkte het op tegenovergestelde wijze, dus door de canonieke Wnt-
signalering op te waarderen.
In hoofdstuk 4 wordt het metabolisme van de “niche” en stamcellen in de darm 
toegelicht. Opvallend was dat Paneth-cellen zeer glycolytisch bleken te zijn, terwijl Lgr5 + 
-stamcellen oxidatieve fosforylering gebruikten voor hun metabole behoeften. het werk 
verduidelijkte dat lactaat, het eindproduct van glycolyse, uitgescheiden door Paneth-
cellen, werd opgenomen door stamcellen van Lgr5 + en werd gebruikt door stamcellen 
om hun metabolisme te voeden. Met andere woorden: Paneth-cellen vormen een 
metabolische nis voor intestinale stamcellen. In hoofdstuk 5 van dit proefschrift wordt 
een andere belangrijke rol van Paneth-cellen beschreven. Onder omstandigheden 
van ernstig weefselbeschadiging kunnen deze cellen differentiëren en de dunne darm 
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